case nos. 17-70810, 17-70817 united states court of ... · 4/11/2018 · case nos. 17-70810,...
TRANSCRIPT
Case Nos. 17-70810, 17-70817
UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT
______________________________________________________________________________
NATIONAL FAMILY FARM COALITION, ET AL., Petitioners,
v. UNITED STATES ENVIRONMENTAL PROTECTION AGENCY, et al.,
Respondents, DOW AGROSCIENCES LLC,
Respondent-Intervenor. ______________________________________________________________________________
NATURAL RESOURCES DEFENSE COUNCIL, Petitioner,
v. SCOTT PRUITT, ET AL.,
Respondents, DOW AGROSCIENCES LLC,
Respondent-Intervenor. ______________________________________________________________________________
On Petition for Review of an Order of the United States Environmental Protection Agency
______________________________________________________________________________
BRIEF OF PETITIONER NATURAL RESOURCES DEFENSE COUNCIL Margaret T. Hsieh Mitchell S. Bernard Kaitlin Morrison Natural Resources Defense Council 40 West 20th Street New York, NY 10011 Telephone: (212) 727-2700
Peter J. DeMarco Natural Resources Defense Council 1152 15th Street NW Suite 300 Washington, DC 20005 Telephone: (202) 289-6868
Counsel for Petitioner Natural Resources Defense Council Dated: April 11, 2018
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 1 of 139
i
CORPORATE DISCLOSURE STATEMENT REQUIRED BY FED. R. APP. P. 26.1
Petitioner Natural Resources Defense Council, Inc. (NRDC) is a non-profit
corporation with no parent corporation and no outstanding stock shares or other
securities in the hands of the public. NRDC does not have any parent, subsidiary,
or affiliate that has issued stock shares or other securities to the public. No publicly
held corporation owns any stock in NRDC.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 2 of 139
ii
TABLE OF CONTENTS
CORPORATE DISCLOSURE STATEMENT .......................................................... i TABLE OF AUTHORITIES .................................................................................... iv INTRODUCTION ..................................................................................................... 1 STATEMENT OF JURISDICTION.......................................................................... 4 ISSUES PRESENTED ............................................................................................... 6 STATUTORY AND REGULATORY FRAMEWORK ........................................... 6 I. Unconditional pesticide registration ................................................................ 7 II. Conditional pesticide registration .................................................................... 8 STATEMENT OF THE CASE ................................................................................ 10 I. Enlist Duo is a new pesticide combining 2,4-D and glyphosate that will increase 2,4-D use and bolster glyphosate use ....................................... 10 II. Enlist Duo poses a significant risk to monarch butterflies ............................ 14 III. Enlist Duo may pose serious risks to human health ...................................... 22 IV. Procedural history .......................................................................................... 23 A. EPA’s previous registration orders (2014 and 2015) .......................... 23 B. EPA’s current registration order (2017) .............................................. 25 SUMMARY OF ARGUMENT ............................................................................... 30 STANDARD OF REVIEW ..................................................................................... 33
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 3 of 139
iii
ARGUMENT ........................................................................................................... 35 I. EPA’s registration of Enlist Duo is unlawful because FIFRA does not
authorize EPA to register a new pesticide under § 136a(c)(7)(B) ................ 35 A. EPA’s registration of Enlist Duo contravenes the plain text of § 136a(c)(7)(B) ........................................................................ 35 B. EPA fails to provide a reasonable explanation that reconciles its registration of Enlist Duo with the plain text of § 136a(c)(7)(B) ........................................................................ 38 C. EPA’s misguided approach to § 136a(c)(7)(B) undermines
FIFRA’s core purpose because it allows new pesticides on the market without adequate assessment of their risks .................. 40
II. EPA’s registration of Enlist Duo under § 136a(c)(7)(B) is not supported by substantial evidence because EPA failed adequately to consider increased risk of harm to monarch butterflies and human health ................. 43 A. EPA declined to assess harm to milkweed and monarchs from Enlist Duo’s expansion of 2,4-D use .......................................... 44 B. EPA ignored evidence that registering Enlist Duo would result in increased glyphosate use over time and thereby amplify risks that glyphosate poses to both monarchs and humans ................. 47 III. NRDC has standing to challenge EPA’s registration of Enlist Duo ............. 49 CONCLUSION ........................................................................................................ 52 STATEMENT OF RELATED CASES ................................................................... 54 CERTIFICATE OF COMPLIANCE ....................................................................... 55 CERTIFICATE OF SERVICE ................................................................................ 56 ADDENDUM OF STATUTES AND REGULATIONS ............................ ADD 001 ADDENDUM OF DECLARATIONS IN SUPPORT OF STANDING ..... ADD 049
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 4 of 139
iv
TABLE OF AUTHORITIES
CASES Benitez v. Califano, 573 F.2d 653 (9th Cir. 1978) ......................................................................... 38 Burlington Truck Lines v. United States, 371 U.S. 156 (1962)....................................................................................... 34 Cent. Delta Water Agency v. United States, 306 F.3d 938 (9th Cir. 2002) ......................................................................... 51 Containerfreight Corp. v. United States, 752 F.2d 419 (9th Cir. 1985) ......................................................................... 33 Cty. of Amador v. U.S. Dep’t of Interior, 872 F.3d 1012 (9th Cir. 2017) ...................................................................... 42 Dilley v. Gunn, 64 F.3d 1365 (9th Cir. 1995) ......................................................................... 49 Friends of the Earth, Inc. v. Laidlaw Envtl. Servs. (TOC), Inc., 528 U.S. 167 (2000)....................................................................................... 50 Hunt v. Wash. State Apple Advert. Comm’n, 432 U.S. 333 (1977)................................................................................. 49, 50 L.A. Lakers, Inc. v. Fed. Ins. Co., 869 F.3d 795 (9th Cir. 2017) ......................................................................... 35 Lujan v. Defs. of Wildlife, 504 U.S. 555 (1992)................................................................................. 50, 51 Ma v. Ashcroft, 361 F.3d 553 (9th Cir. 2004) ......................................................................... 43 Mont. Wilderness Ass’n v. McAllister, 666 F.3d 549 (9th Cir. 2011) ....................................................... 34, 46, 47, 49
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 5 of 139
v
Motor Vehicle Mfrs. Ass’n of U.S. v. State Farm Mut. Auto. Ins. Co., 463 U.S. 29 (1983) ....................................................................... 34, 46, 47, 49 Nat’l Ass’n of Mfrs. v. Dep’t of Def., 138 S. Ct. 617 (2018) ..................................................................................... 37 NRDC v. EPA (Nanosilver I), 735 F.3d 873 (9th Cir. 2013) ....................................................... 33, 34, 39, 51 NRDC v. EPA (Nanosilver II), 857 F.3d 1030 (9th Cir. 2017) ..................................................... 33, 34, 39, 48 Nw. Coal. for Alternatives to Pesticides v. EPA, 544 F.3d 1043 (9th Cir. 2008) ......................................................................... 7 N.Y. State Pesticide Coal., Inc. v. Jorling, 874 F.2d 115 (2d Cir. 1989) .......................................................................... 42 Pollinator Stewardship Council v. EPA,
806 F.3d 520 (9th Cir. 2015) ......................................... 1, 7, 33-34, 34, 41, 46 Sultan Chemists, Inc. v. EPA, 281 F.3d 73 (3d Cir. 2002) ...................................................................... 40, 42 Union Oil Co. of Cal. v. Fed. Power Comm’n, 542 F.2d 1036 (9th Cir. 1976) ................................................................. 33, 46 Util. Air Regulatory Grp. v. EPA, 134 S. Ct. 2427 (2014) ................................................................................... 37 United Farm Workers of Am., AFL-CIO v. Adm’r, EPA, 592 F.3d 1080 (9th Cir. 2010) ......................................................................... 4 Yith v. Nielsen, 881 F.3d 1155 (9th Cir. 2018) ....................................................................... 35
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 6 of 139
vi
STATUTES AND REGULATIONS 7 U.S.C. § 136 .......................................................................................................... 36 7 U.S.C. § 136(a) ....................................................................................................... 7 7 U.S.C. § 136(bb) ........................................................................................... 1, 7, 40 7 U.S.C. § 136(t) ........................................................................................................ 6 7 U.S.C. § 136(u) ....................................................................................... 6, 7, 36, 38 7 U.S.C. § 136a(a) ................................................................................................ 6, 43 7 U.S.C. § 136a(c)(1)(F) .......................................................................................... 42 7 U.S.C. § 136a(c)(5) ............................................................................... 7, 26, 31, 41 7 U.S.C. § 136a(c)(5)(C) ............................................................................ 7, 8, 28, 31 7 U.S.C. §136a(c)(5)(D) .................................................................................. 7, 8, 31 7 U.S.C. § 136a(c)(7) ............................................................................................. 7, 8 7 U.S.C. § 136a(c)(7)(A) ................................................................................... 26, 29 7 U.S.C. § 136a(c)(7)(B) ...................................................................................passim 7 U.S.C. § 136a(g) ..................................................................................................... 9 7 U.S.C. § 136n(b) ........................................................................................... 4, 5, 33 40 C.F.R. § 23.6 ......................................................................................................... 5 40 C.F.R. § 152.44 ..................................................................................................... 7 40 C.F.R. § 152.112(b) ........................................................................ 7-8, 31, 41, 42 40 C.F.R. § 152.112(c) ......................................................................................... 8, 31
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 7 of 139
vii
40 C.F.R. § 152.112(e) ......................................................................................... 7, 31 40 C.F.R. § 155.40 ..................................................................................................... 9 40 C.F.R. § 155.42 ..................................................................................................... 9 40 C.F.R. § 155.53(a) ................................................................................................. 9 40 C.F.R. § 158.75 ............................................................................................... 7, 31
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 8 of 139
1
INTRODUCTION
Petitioner Natural Resources Defense Council (NRDC) challenges the
unlawful order of Respondents Scott Pruitt and U.S. Environmental Protection
Agency (together, EPA) registering Enlist Duo herbicide under the Federal
Insecticide, Fungicide, and Rodenticide Act (FIFRA). EPA’s order violates FIFRA
because the agency applied the wrong legal standard in registering Enlist Duo. In
the alternative, the order contravenes that standard because EPA had “no real
idea,” Pollinator Stewardship Council v. EPA, 806 F.3d 520, 532 (9th Cir. 2015),
of whether Enlist Duo will “significantly increase the risk of any unreasonable
adverse effect” on human health or the environment, 7 U.S.C. § 136a(c)(7)(B); see
id. § 136(bb). Of particular concern, EPA failed to consider Enlist Duo’s potential
to destroy crucial monarch butterfly habitat, and ignored recent science on the
herbicide’s human health risks.
Enlist Duo threatens the vulnerable remnant of North American monarch
butterflies. The monarch butterfly, Danaus plexippus, is an iconic species famed
for its annual migration across the continent. But the migrating population of
butterflies has declined precipitously in recent years. This decline has been driven
in large part by the sharply increasing use of herbicides enabled by herbicide-
resistant crops, which has decimated milkweed, the sole food source for monarch
caterpillars. In 1997, nearly 700 million monarchs journeyed from summer habitat
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 9 of 139
2
in the United States and Canada to wintering grounds in Mexico. That number has
fallen by over 80 percent. A 2014 survey found only about 25 million butterflies—
a record low—in their winter refuge. Scientists warn that the monarch population
faces a significant risk of collapse within the next twenty years.
Enlist Duo is a new herbicide that combines the active ingredients 2,4-
dichlorophenoxyacetic acid (2,4-D) and glyphosate. Both 2,4-D and glyphosate kill
the milkweed that sustains the monarch migration. Enlist Duo is designed for use
on corn, soybeans, and cotton that have been engineered to resist 2,4-D and
glyphosate. This allows more Enlist Duo to be sprayed on the crops to kill weeds,
without damaging the crops themselves. Registration of the herbicide will
significantly increase overall 2,4-D use and bolster glyphosate use. Although
NRDC requested that EPA evaluate Enlist Duo’s potential to harm monarchs by
destroying milkweed, EPA evaded the issue and registered the herbicide for use in
thirty-four states squarely within the butterflies’ migration path.
The agency also ignored NRDC’s request to fully evaluate the effects of
glyphosate on human health. Over the past decade, scientists have published a
significant number of peer-reviewed studies on glyphosate’s health risks, including
research suggesting that glyphosate may cause serious harms such as kidney
toxicity and birth defects. Despite troubling questions that the recent studies raise
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 10 of 139
3
about glyphosate’s safety to humans, EPA declined to review much of this new
science prior to registering Enlist Duo.
EPA may not rely on 7 U.S.C. § 136a(c)(7)(B), the FIFRA standard under
which the agency unlawfully chose to register Enlist Duo, to justify its failure to
evaluate critical evidence of the herbicide’s risks. Section 136a(c)(7)(B) narrowly
authorizes EPA to “amend” previously approved registrations. But Enlist Duo is a
new herbicide without any preexisting registration to amend; consequently, EPA
may not register Enlist Duo under that provision. To circumvent this limitation,
EPA treated the application to register Enlist Duo as if it were simply an
application to amend a prior registration of 2,4-D. But § 136a(c)(7)(B) provides no
basis for transmuting an amended registration for 2,4-D into a brand-new
registration for Enlist Duo. This approach violates the plain statutory text.
In the alternative, even if EPA may register the new uses of Enlist Duo
under § 136a(c)(7)(B) in defiance of the unambiguous statutory language, the
registration is not supported by substantial evidence. The agency failed to make the
mandatory showing that Enlist Duo would not “significantly increase the risk of
any unreasonable adverse effect on the environment,” because it ignored evidence
of amplified risks to monarchs from milkweed destruction, and of extended risks to
human health. 7 U.S.C. § 136a(c)(7)(B). EPA’s registration of Enlist Duo therefore
violates FIFRA and should be vacated.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 11 of 139
4
STATEMENT OF JURISDICTION
This Court has jurisdiction under FIFRA, which provides for review in the
courts of appeals of “any order issued by the Administrator following a public
hearing.” 7 U.S.C. § 136n(b). NRDC is challenging EPA’s final order registering
Enlist Duo for use in thirty-four states. ER 1-36. The order followed a public
hearing because EPA solicited and reviewed public comments before issuing the
order. See United Farm Workers of Am., AFL-CIO v. Adm’r, EPA, 592 F.3d 1080,
1082-84 (9th Cir. 2010).
NRDC may bring this action because it was “a party to the proceedings”
before EPA and is “adversely affected” by EPA’s order registering Enlist Duo.
7 U.S.C. § 136n(b). NRDC participated in the agency proceedings by timely
submitting comments opposing the proposed registration. ER 144-211. In its
comments, NRDC asserted that EPA cannot lawfully register Enlist Duo without
adequately assessing potential adverse effects on monarch butterflies and human
health. ER 146-51, 158-78.
NRDC and its members are adversely affected by EPA’s registration of
Enlist Duo.1 NRDC has members who live in agricultural regions in states where
EPA approved the use of Enlist Duo, and EPA’s action increases the risk that these
1 As discussed further below, these adverse effects give NRDC standing to challenge the registration order. See infra Argument III.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 12 of 139
5
members will suffer health harms from exposure to the herbicide. See Bristol Decl.
¶¶ 2-8 (ADD 051-53); Gruber Decl. ¶¶ 3-9 (ADD 058-61); Wetzel Decl. ¶¶ 3-9, 15
(ADD 069-72, 074).2 Registration of Enlist Duo also injures NRDC’s members
who derive aesthetic and recreational enjoyment from watching and interacting
with monarchs, because Enlist Duo kills milkweed and hence exacerbates monarch
decline. See Bristol Decl. ¶¶ 10-14 (ADD 053-54); Gruber Decl. ¶¶ 10-12 (ADD
061); Wetzel Decl. ¶¶ 10-15 (ADD 072-74).
Finally, NRDC’s petition is timely and venue is proper in this Court because
NRDC filed the petition “in the United States court of appeals for the circuit
wherein [NRDC] resides or has a place of business, within 60 days after the entry
of [the challenged] order.” 7 U.S.C. § 136n(b). EPA’s final order registering Enlist
Duo for use in thirty-four states was signed on January 12, 2017, and entered
fourteen days later, on January 26, 2017. See 40 C.F.R. § 23.6; Case No. 17-70817,
ECF No. 22-1, at 1-2. NRDC filed a petition for review challenging that order on
March 21, 2017. See ER 1; Case No. 17-70817, ECF No. 1-5. Venue is proper
because NRDC has offices within the Ninth Circuit, in San Francisco and Santa
Monica, California, and in Bozeman, Montana. Trujillo Decl. ¶ 4 (ADD 065).
2 “ADD” indicates the page number in the addendum of standing
declarations bound with this brief.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 13 of 139
6
ISSUES PRESENTED
I. Did EPA violate FIFRA by registering Enlist Duo—a new pesticide—under
§ 136a(c)(7)(B), which authorizes the agency only to “amend the registration of a
pesticide to permit additional uses of such pesticide”? 7 U.S.C. § 136a(c)(7)(B).
II. In the alternative, even if EPA may register the inaugural uses of Enlist Duo
under § 136a(c)(7)(B), did the agency lack substantial evidence to conclude that
the herbicide would not “significantly increase the risk of any unreasonable
adverse effect on the environment,” id., because it failed to consider the
registration’s potential to destroy additional monarch butterfly habitat and to
extend risk to human health?
STATUTORY AND REGULATORY FRAMEWORK
Under FIFRA, any pesticide must be “registered” by EPA before it can be
sold or distributed in the United States. 7 U.S.C. § 136a(a). A “pesticide” includes
“any substance or mixture of substances intended for preventing, destroying,
repelling, or mitigating any pest,” id. § 136(u), including any “weed,” id. § 136(t),
and thus includes chemicals commonly known as herbicides (or weed killers).
Enlist Duo herbicide is a “pesticide,” because it is a mixture of active and inert
ingredients that is intended to kill weeds.3 Although glyphosate and 2,4-D are
3 EPA’s registration documents and this brief refer to Enlist Duo alternately
as an “herbicide” and a “pesticide.”
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 14 of 139
7
“pesticides” as well, they are also “active ingredients” when used in the “pesticide”
Enlist Duo. See id. § 136(a), (u) (defining “active ingredient” and “pesticide”).
EPA may issue either an “unconditional” or “conditional” registration for a
pesticide. See id. § 136a(c)(5), (7).
I. Unconditional pesticide registration
FIFRA authorizes EPA to unconditionally register a new pesticide, or
unconditionally amend an existing pesticide registration, only upon determining
that the pesticide “will perform its intended function without unreasonable adverse
effects on the environment,” and that “when used in accordance with widespread
and commonly recognized practice it will not generally cause unreasonable
adverse effects on the environment.” Id. § 136a(c)(5)(C), (D); see 40 C.F.R.
§§ 152.112(e), 152.44; Nw. Coal. for Alternatives to Pesticides v. EPA, 544 F.3d
1043, 1045 (9th Cir. 2008). The statute defines “unreasonable adverse effects on
the environment” to include “any unreasonable risk to man or the environment,
taking into account the economic, social, and environmental costs and benefits of
the use of any pesticide.” 7 U.S.C. § 136(bb).
“Unconditional registration necessarily requires sufficient data to evaluate
the environmental risks.” Pollinator Stewardship Council, 806 F.3d at 523; see 40
C.F.R. § 158.75. Before unconditionally registering a pesticide under § 136a(c)(5),
EPA must review “all relevant data in the possession of the Agency,” 40 C.F.R.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 15 of 139
8
§ 152.112(b), and conclude “that no additional data are necessary to make the
determinations required by [that standard],” id. § 152.112(c)—including the
determinations that use of the pesticide will not cause unreasonable adverse
effects, see 7 U.S.C. § 136a(c)(5)(C), (D); Pollinator Stewardship Council, 806
F.3d at 528.
II. Conditional pesticide registration
If EPA lacks sufficient data to determine whether an application for a new or
amended pesticide registration warrants unconditional approval, the agency may
conditionally grant a new or amended registration for that pesticide—but only if
certain criteria are met. 7 U.S.C. § 136a(c)(7). Conditional registration allows a
pesticide to be marketed temporarily for specific uses on the condition that the
registrant submit, within a limited time, all remaining data necessary for EPA to
determine whether unconditional registration of those uses are justified. See id.
Although EPA may grant a conditional registration under three “special
circumstances,” id., only one is relevant here because it is the only one on which
the agency relied to register Enlist Duo, see ER 4, 30. Under § 136a(c)(7)(B):
The [EPA] Administrator may conditionally amend the registration of a pesticide to permit additional uses of such pesticide notwithstanding that data concerning the pesticide may be insufficient to support an unconditional amendment, if the Administrator determines that (i) the applicant has submitted satisfactory data pertaining to the proposed additional use, and (ii) amending the registration in the manner proposed by the applicant would not significantly increase the risk of any unreasonable adverse effect on the environment.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 16 of 139
9
Id. § 136a(c)(7)(B).
An applicant seeking amended registration under this provision “shall
submit such data as would be required to obtain registration of a similar pesticide
under [the unconditional registration standard].” Id. However, “[i]f the applicant is
unable to submit an item of data (other than data pertaining to the proposed
additional use) because it has not yet been generated,” the EPA Administrator may
amend the registration on the condition that the applicant submit the outstanding
data “not later than the time such data are required to be submitted with respect to
similar pesticides already registered.” Id. That time is usually during the periodic
“registration review” process, pursuant to which EPA must review every pesticide
registration to make sure it “still satisfies the FIFRA standard for registration” in
light of “new data or information.” 40 C.F.R. § 155.53(a); see 7 U.S.C. § 136a(g).
Registration review must be completed for each registered pesticide every fifteen
years, and the agency assesses all pesticide products containing the same active
ingredient as part of a single registration review case. See 40 C.F.R. §§ 155.40,
155.42.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 17 of 139
10
STATEMENT OF THE CASE
I. Enlist Duo is a new pesticide combining 2,4-D and glyphosate that will increase 2,4-D use and bolster glyphosate use
Enlist Duo is a pesticide manufactured by Dow AgroSciences, LLC (Dow)
that contains the active ingredients 2,4-D and glyphosate. ER 2. Although there are
various forms of 2,4-D and glyphosate, the specific forms found in Enlist Duo are
2,4-dichlorophenoxyacetic acid choline salt (2,4-D choline salt) and glyphosate
dimethylammonium salt. See id.
Enlist Duo is designed and registered for use on Enlist Duo-resistant corn,
soybean, and cotton crops—that is, crops that have been genetically engineered
(GE) to resist both 2,4-D and glyphosate, allowing Enlist Duo to be sprayed later
in the growing season and in greater amounts, to kill weeds without killing treated
crops. ER 321, 558, 1763-64. Although EPA had previously registered other
pesticides containing 2,4-D for limited uses on 2,4-D-resistant corn, soybeans, and
cotton, Enlist Duo is the first pesticide that EPA registered for additional,
expanded uses on those crops. See ER 28. In contrast, all of Enlist Duo’s uses of
glyphosate on glyphosate-resistant corn, soybeans, and cotton are shared by
previously registered pesticides containing glyphosate (many developed by
Monsanto Co. and marketed under the trade name Roundup). See ER 1-3, 387.
EPA acknowledged that registration of Enlist Duo “will result in an
increased usage of 2,4-D.” ER 83, 158. This is primarily because of the new and
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 18 of 139
11
expanded ways in which the registration allows 2,4-D to be used. See ER 28, 158.
Compared to other pesticides containing 2,4-D, Enlist Duo contemplates use of
2,4-D on 2,4-D-resistant corn for a significantly longer part of the growing season;
on 2,4-D resistant soybean plants after they have emerged from the ground; and on
2,4-D-resistant cotton plants after they have emerged from the ground but before
they are harvested.4 See ER 28 (explaining in further detail why registration of
Enlist Duo would expand 2,4-D use), 547, 558, 1763-64. The U.S. Department of
Agriculture made similar findings and predicted that approval of Enlist Duo will
cause a 200 to 600 percent increase in the overall use of 2,4-D. See ER 353.
While recognizing that registration of Enlist Duo would augment overall
2,4-D use, EPA failed to consider evidence that the registration would bolster total
glyphosate use. The agency assumed (without citing any evidence) that Enlist Duo
will not “significantly change the locations, methods, or volume of glyphosate used
on corn, soybeans, or cotton” and that “any decision on the Enlist DuoTM
registration . . . would only impact which glyphosate product would be used.” ER
4; accord ER 84. But the agency did not actually assess how registration of Enlist
4 Enlist Duo entails the very first uses of 2,4-D choline salt on 2,4-D-
resistant corn, soybeans, and cotton. See ER 3. However, non-choline-salt forms of 2,4-D have previously been registered for more limited uses on these crops, including use on 2,4-D-resistant corn during an early phase of the growing season; use on 2,4-D-resistant soybeans before planting; and use on 2,4-D-resistant cotton before planting, for spot treatment, and after harvest. See ER 28.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 19 of 139
12
Duo would affect total herbicide loading in the environment. See ER 1769. Rather,
EPA noted that the analysis was “difficult” and the agency could reach no
conclusions. Id.
Contrary to EPA’s unsubstantiated assumption that registration of Enlist
Duo would have no material effect on overall glyphosate use, evidence in the
record indicates that the registration would abate or even reverse likely declines in
glyphosate use. The evidence indicates that widespread use of glyphosate is
causing weeds to develop resistance to the chemical, and that Enlist Duo provides
growers with a unique means of addressing that problem. See ER 155-57, 1763,
1769.
In 2014, the U.S. Department of Agriculture recognized that the “nearly
exclusive use of glyphosate over the past fifteen years led to the selection of
glyphosate-resistant . . . weeds, weeds that could survive an application of the
herbicide.” ER 346. A 2012 survey of farmers in thirty-one states found that 49
percent reported having glyphosate-resistant weeds in their fields. ER 2005.
During the Enlist Duo registration process, Dow represented that “increasing
prevalence of glyphosate-resistant” weeds is “rapidly getting worse.” ER 2133,
2136. EPA concurred, acknowledging that “resistance to glyphosate . . . has
become a significant economic and pest management issue to growers.” ER 28; see
ER 559.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 20 of 139
13
Glyphosate is rapidly losing efficacy, falling victim to its own popularity.
ER 156-57. In comments to EPA, members of the agricultural industry reported
that many growers are resorting to non-glyphosate-based pesticides. See, e.g., ER
459 (“[O]nce glyphosate resistant weeds started to show up nearly everyone would
use 2,4-D or some dicamba product to control weeds.”). Agricultural scientists
echoed this observation. See, e.g., ER 508. Likewise, in case studies that Dow
submitted to EPA, growers in areas infested with glyphosate-resistant weeds used a
“variety of alternatives” to glyphosate, including not only other pesticides, but also
increased tillage. ER 1766; see also ER 2136 (asserting that without new pesticides
like Enlist Duo “to address problems with glyphosate-resistant weeds, U.S.
growers will be forced to revert to earlier cultural practices”). Recognizing the
severity of the problem, EPA concluded that “[t]he continued viability of the
glyphosate . . . technology is widely predicated on the containment of currently
resistant weed biotype populations and the delay of any future resistant weed
biotype population development.” ER 1768.
Enlist Duo is a “tool that could prolong the viability of the glyphosate
herbicide technology.” ER 1769; accord ER 28, 156, 558, 1763. Its two active
ingredients have different mechanisms of action, which means that the 2,4-D in
Enlist Duo can kill glyphosate-resistant weeds and stave off further weed
resistance to glyphosate. ER 28, 156-57, 1762-64, 1768-69. This would allow more
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 21 of 139
14
glyphosate to remain on the market, for a longer time. Therefore, at a minimum,
Enlist Duo is likely to perpetuate glyphosate use at levels well above what would
otherwise be expected. See ER 1763, 1769. Enlist Duo may even cause glyphosate
use to increase beyond current levels by, for example, allowing growers to expand
crop acreage. See, e.g., ER 458, 503; see also ER 560 (noting that “use of Enlist
Duo on GE cotton is not expected to eliminate the use of any other herbicide”). But
for Enlist Duo, there would be less use of both 2,4-D and glyphosate.
II. Enlist Duo poses a significant risk to monarch butterflies
The use of herbicides on herbicide-resistant crops is a leading cause in the
sharp decline of the eastern population of North American monarch butterflies.5
ER 159-73. Each spring, the monarch population embarks on a multi-generational
migration that begins in the forests of central Mexico. ER 266. The butterflies fly
north across the United States, reproducing along the way. Id. By mid-to-late
summer, over the span of four to five generations, the population reaches southern
Canada. See id. In the fall, the last generation of monarchs flies back to the same
forests in Mexico where the population’s journey began. See id. The butterflies
5 Monarch butterflies are found both east and west of the Rocky Mountains, although the western population is much smaller. ER 148 n.10. This brief focuses on the eastern population of North American monarchs because that population migrates across the thirty-four states where EPA has approved the use of Enlist Duo. See id.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 22 of 139
15
overwinter in Mexico until spring, when the migration cycle begins again. See id.;
infra Figure 1. The entire migration spans over 2,500 miles. ER 170.
Fig. 1. Aerial photo showing trees tinged orange by an overwintering monarch butterfly colony at El Rosario Monarch Reserve, Michoacán, Mexico. (C) Lincoln Brower 1999.
Monarchs cannot complete this extraordinary migration without milkweed.
See ER 166-68, 212, 221-24, 266. Because monarch caterpillars eat only
milkweed, migrating female monarchs lay their eggs only on milkweed. ER 167,
231, 403. When milkweed is scarce, females deplete large amounts of body fat in
search of the plant, which can cause them to lay fewer eggs or even die before
laying any eggs. ER 167-68, 303-04. Fewer eggs means fewer monarchs. ER 270.
Reduction of milkweed also decreases the number of caterpillars that survive to
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 23 of 139
16
adulthood, by intensifying competition over a limited food supply. ER 298, 303-
04.
EPA registered the first pesticide containing glyphosate in 1974. ER 160. As
a non-selective herbicidal active ingredient, glyphosate does not discriminate
between target and non-target plant species: it can damage and kill both crops and
weeds. ER 2, 160, 267. For this reason, growers previously limited their use of
herbicides containing glyphosate. ER 267.
In the mid-to-late 1990s, however, glyphosate-resistant crops were
introduced to farmers and rapidly gained market share. ER 161, 257, 391. This
triggered a dramatic increase in the application of glyphosate-based herbicides. ER
161-63, 391-92. In 1995, before the introduction of glyphosate-resistant crops,
agricultural use of glyphosate totaled under 28 million pounds; by 2014,
agricultural use of glyphosate skyrocketed to nearly 250 million pounds—an
approximate tenfold increase. ER 391.
Glyphosate use has already decimated a substantial portion of the milkweed
on which monarchs rely. ER 164-66, 267, 320-21. Milkweed loss, particularly in
the Midwest, has been well documented, and is in large part attributed to increased
glyphosate use. ER 257, 266. A survey of milkweed in Iowa corn and soybean
fields in 1999 found milkweed in at least 50 percent of the fields. ER 257. By
2009, milkweed was recorded in only 8 percent of the fields. Id. Additionally, the
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 24 of 139
17
overall area occupied by milkweed within the fields decreased by 90 percent. Id.
Relying on these and other data, one study extrapolated the loss of milkweed in
both agricultural and non-agricultural areas across the entire Midwest and found a
58 percent decline in milkweed from 1999 to 2010. ER 266, 270.
The extensive loss of milkweed has devastated the monarch population. ER
166-73. The Midwest, in particular, constitutes a significant portion of the
monarchs’ migratory pathway. ER 229, 303-04. Fifty percent of monarchs that
overwinter in Mexico feed on Midwestern milkweed as caterpillars, so reduced
milkweed availability in this region has significant effects on the population. ER
229. Furthermore, monarchs tend to lay more eggs in agricultural areas than in
non-agricultural areas. ER 239, 273. The decline of milkweed in the agricultural
Midwest has thereby caused a greater-than-proportional reduction in monarch
reproduction. See ER 168, 266, 273. Between 1999 and 2010, monarch
reproduction in the Midwest declined by 81 percent. ER 266, 273.
Decreased monarch reproduction has caused the monarch population to
plummet. See ER 168-69. During the same period that herbicide-resistant crops
became prevalent in the United States, leading to rapidly accelerating herbicide use
and milkweed loss, there has been a dramatic, corresponding decline in the
overwintering monarch population in Mexico. ER 168-69, 266-73. That population
dropped from a high of nearly 700 million butterflies in 1997 to a low of
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 25 of 139
18
approximately 25 million butterflies in 2014.6 ER 377, 382. While interannual
variation in the population size is expected, the long-term trend of decline is clear.
See ER 403, 409-11.
It is widely acknowledged among monarch experts that a driving force
behind the butterfly’s decline is milkweed loss in the United States caused by
widespread use of herbicides, particularly those containing glyphosate, on
herbicide-resistant crops. See ER 168-70; 319-22, 2191-92; see, e.g., ER 257-58;
261-62; 267, 303-04, 360-65, 403. A 2014 study examining the relative magnitude
of different threats to monarchs found that “[r]ecent population declines stem from
reduction in milkweed host plants in the United States that arise from increasing
adoption of genetically modified crops and land-use change, not from climate
change or degradation of forest habitats in Mexico.” ER 297. The study concluded
that “conserving monarch butterflies by addressing the negative impacts of
changing land-use and the adoption of genetically-modified, herbicide-resistant
crops on host plant abundance is the highest conservation priority.” ER 304.
6 The number of monarchs overwintering in Mexico is estimated by
multiplying the total number of hectares occupied by the butterflies by their density per hectare. ER 377. Monarchs occupied 18.19 hectares of forest during the winter of 1996-1997 compared with .67 acres in the winter of 2013-2014. Id. The density of overwintering monarchs was recently estimated at 37.5 million butterflies per hectare. ER 382. To the extent that NRDC’s comments used an older density estimate to calculate overwintering population size, the population estimates in the comments differ from those in this brief. See, e.g., ER 159.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 26 of 139
19
EPA’s registration of Enlist Duo poses a significant risk to the beleaguered
monarch population, threatening to drive it towards collapse. Enlist Duo is
intended to suppress milkweed, and both 2,4-D and glyphosate are toxic to
milkweed. ER 112, 158-60, 321-322. EPA’s approval of Enlist Duo for use on
herbicide-resistant crops is particularly problematic for monarchs. Herbicides are
applied more frequently, and at higher rates, when used on herbicide-resistant
crops. ER 320-21; see, e.g., ER 28. In addition, herbicides that cause limited
damage to target plants when applied at lower rates are often much more damaging
when sprayed at higher rates. ER 321. Furthermore, milkweed tends to regrow
when it is mowed, damaged by tilling, or treated with herbicides that are applied
before milkweed shoots emerge in late spring. ER 320. But when herbicides are
paired with herbicide-resistant crops, they can be applied later in the growing
season during the milkweed plant’s most vulnerable flowering stage. Id.
The final, approved label for Enlist Duo recommends application “when
most [common milkweed] plants have reached the late bud to flower stage of
growth,” thereby reducing the chances that affected plants can recover and regrow.
ER 112; see ER 320. Compounding the risk to monarchs, EPA registered Enlist
Duo for use in thirty-four states that fall directly within the pathway of migrating
butterflies. Compare ER 2, with ER 212-14, 229.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 27 of 139
20
The migrating monarch population is already so diminished that its
prospects for recovery are fading. ER 171-73. Continued milkweed loss renders the
population susceptible to further decline, compromising its ability to withstand
additional stressors such as severe weather, freezing temperatures, disease,
predation, and deforestation. See ER 223, 262-63. In 2002, a single storm killed
more than 450 million monarchs, which constituted approximately 75 percent of
the overwintering population—and exceeded, by over three times, the 150 million
monarchs overwintering in Mexico during the 2015-2016 season. See ER 252;
compare ER 382 (estimating overwintering monarch population density of 37.5
million butterflies per hectare), with ER 409-11 (reporting that overwintering
monarchs occupied 4.01 hectares during the 2015-2016 winter season).
Severe storms occur periodically, leaving the diminished monarch
population in a precarious state. In 2004, another serious storm killed about 70
percent of the overwintering monarch population, with casualties far exceeding the
total number of monarchs overwintering in Mexico during the recent 2015-2016
season. Compare ER 409 (reporting that overwintering monarch colonies occupied
approximately 8 to 11.12 hectares during the 2003-2004 winter season, but only
4.01 hectares during the 2015-2016 winter season), with ER 412. Subsequently, a
2010 storm killed approximately 50 percent of the monarchs overwintering in
Mexico. ER 262-63. Owing to its current size, the monarch population is
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 28 of 139
21
susceptible to complete eradication by comparable storms. ER 1097-1098; see also
ER 406 (explaining that “tightly clustered overwintering colonies convey
important microclimate advantages that diminish as colony size decreases,” so that
“[d]iminishing colony size can therefore result in higher winter mortality rates”).
The smaller the population becomes, the more vulnerable it is to these kinds of
natural events. ER 172-73, 1098.
Continued suppression of milkweed across the butterflies’ breeding grounds
perpetuates the risk of monarch population collapse, and additional milkweed
destruction exacerbates that risk. ER 172-73. The population is so precariously
small that experts—including those at the Department of Agriculture—have
warned that the monarch migration may be coming to an end. See, e.g., ER 263,
279-80, 405-06. In 2016, a group of academic researchers and scientists from
federal and state agencies jointly published a study finding that migrating eastern
monarchs face a “high probability of quasi-extinction [that is, population collapse]
over the next two decades.” ER 405. “Given the population’s present low
numbers,” the study concluded, “poor reproductive success by monarchs in future
breeding seasons due to weather conditions and reduced breeding habitat, followed
by catastrophic mortality while over-wintering in Mexico, could bring the monarch
migration to the brink of extinction.” Id.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 29 of 139
22
III. Enlist Duo may pose serious risks to human health
There is a growing body of published scientific literature suggesting that
exposure to either of Enlist Duo’s active ingredients may cause significant human
health risks. Glyphosate is the most widely used pesticide in the country, with
about 250 million pounds applied to fields each year. ER 347, 391. People can be
exposed to glyphosate on or near the many farms where the pesticide is used, as
well as when they eat food, or drink water, contaminated with glyphosate. See ER
179-80, 3158-60, 3180 n.56.
Recent studies link exposure to glyphosate and glyphosate products to
serious health harms, including kidney damage, birth defects, pre-term deliveries,
miscarriages, and neural tube defects. See, e.g., ER 173-74 & nn. 134-35, 176-77,
462-63; see also ER 515-16 (former EPA senior research scientist expressing
concern about glyphosate’s health risks, including its potential for endocrine
disruption). Although EPA recently concluded that glyphosate is not likely to be
carcinogenic to humans, ER 53, the agency registered Enlist Duo without
considering new, peer-reviewed literature on glyphosate’s non-cancer health risks
highlighted by commenters, including NRDC. See ER 3 (refusing to conduct any
new assessment for glyphosate); see, e.g., ER 173-74 & nn. 134-35, 176-77.
2,4-D’s exposure pathways are similar to glyphosate’s; they include food
residues, contaminated drinking water, spray drift, and vapor residues emitted from
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 30 of 139
23
treated fields. See ER 11-12, 14-16, 190-95. As with glyphosate, there are many
published studies implicating 2,4-D in significant human health risks, such as
thyroid problems and Non-Hodgkin lymphoma. ER 183-87, 463, 466-67. Although
EPA concluded that 2,4-D does not present significant health risks, the agency’s
analyses are flawed. EPA disregarded evidence of 2,4-D’s carcinogenicity and
thyroid toxicity, and underestimated individuals’ aggregate exposures to 2,4-D. ER
182-97, 463-67. The agency did not fully account for health risks posed by the
2,4-D in Enlist Duo, particularly to pregnant women and children. ER 188-97.
IV. Procedural history
EPA’s current order registering Enlist Duo supersedes two previous
registration orders of more limited scope. Compare ER 1-2, 5, 37, with ER 1371-
72, 1401, and ER 1019, 1055-56.
A. EPA’s previous registration orders (2014 and 2015)
On October 15, 2014, EPA issued a final order registering Enlist Duo for use
on Enlist Duo-resistant corn and soybeans in six states.7 ER 1371-72, 1394, 1400.
EPA’s decisional documents were unclear as to whether the registration was
unconditional or conditional.8 Because EPA failed to consider harm to monarchs
7 Those states are Illinois, Indiana, Iowa, Ohio, South Dakota, and
Wisconsin. ER 1400. 8 Although the agency’s Final Registration Decision referenced FIFRA’s
provision for conditional amendment, the Notice of Registration that EPA
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 31 of 139
24
and to fully evaluate glyphosate’s health risks before registering Enlist Duo,
NRDC petitioned this Court for review of EPA’s order. Petition for Review,
NRDC v. EPA, No. 14-73353 (9th Cir. Oct. 30, 2014), ECF No. 1-1; see ER 1372,
1436. The Center for Food Safety and other petitioners (CFS Petitioners) also
challenged EPA’s registration order on other grounds. Petition for Review, CFS v.
EPA, No. 14-73359 (9th Cir. Oct. 30, 2014), ECF No. 1-2.
On March 31, 2015, EPA issued a second final order amending the
registration of Enlist Duo to allow use on Enlist Duo-resistant corn and soybeans in
nine additional states.9 See ER 1055-56. Because EPA still had not examined harm
to monarchs or fully assessed glyphosate’s health risks, NRDC filed an additional
petition for review challenging the amended registration order. Petition for
Review, NRDC v. EPA, No. 15-71213 (9th Cir. Apr. 20, 2015), ECF No. 1-2. CFS
Petitioners also filed an additional petition for review challenging this amended
order. Petition for Review, CFS v. EPA, No. 15-71207 (9th Cir. Apr. 20, 2015),
ECF No. 1-2.
concurrently issued deemed the registration unconditional. Compare ER 1394, with ER 1401. In defending the registration in litigation, EPA characterized the registration as unconditional. See, e.g., Resp’ts’ Mot. for Voluntary Vacatur and Remand at 3-4, NRDC v. EPA, No. 14-73353 (9th Cir. Nov. 24, 2015), ECF No. 121-1.
9 Those states are Arkansas, Kansas, Louisiana, Minnesota, Mississippi, Missouri, Nebraska, North Dakota, and Oklahoma. ER 1056.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 32 of 139
25
While the cases were pending, EPA discovered that Dow had filed an
application with the U.S. Patent and Trademark Office claiming synergism
between 2,4-D and glyphosate. ER 2-3. This discovery prompted the agency to
concede that it “could no longer represent to the Court that its conclusions were
correct regarding whether issuance of the registration met the standard in FIFRA.”
ER 3. Accordingly, EPA moved for remand and vacatur of the registration. Id.
Dow opposed vacatur. See Resp. to Resp’ts’ Mot. for Voluntary Vacatur and
Remand at 2, NRDC v. EPA, No. 14-73353 (9th Cir. Dec. 7, 2015), ECF No. 122.
On January 25, 2016, the Court granted the motion for remand but denied vacatur.
ER 3.
B. EPA’s current registration order (2017)
On October 31, 2016, EPA issued a new proposal to register Enlist Duo on
Enlist Duo-resistant corn, soybeans, and cotton in thirty-four states. ER 521, 523.
EPA invoked FIFRA’s conditional registration provision generally, without
specifying which of the three types of conditional registration it was considering.
See ER 549. In addition, the agency explained that it had assessed some of the
anticipated risks from the expanded use of 2,4-D that the registration would cause,
but concluded that “no new assessment is needed for glyphosate” because “no new
use patterns and no new exposures for glyphosate are being considered with this
registration action.” ER 522. EPA provided no indication that it had ever
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 33 of 139
26
considered 2,4-D’s or glyphosate’s potential to harm monarchs by destroying
milkweed, or that it had evaluated recent literature on glyphosate’s health risks.
NRDC timely submitted comments opposing the proposed registration on
December 1, 2016. ER 144-211. In its comments, NRDC asserted that EPA may
not conditionally register Enlist Duo, and explained that EPA must, consistent with
FIFRA’s unconditional registration provision, undertake the full range of analyses
necessary to determine whether the registration would cause unreasonable adverse
impacts on human health and the environment.10 ER 206-11; see 7 U.S.C.
§ 136a(c)(5). The comments underscored EPA’s obligation to “consider the
substantial adverse impacts that Enlist Duo will have on monarch butterflies,
insofar as both glyphosate and 2,4-D destroy milkweed, which is critical to the
monarch life cycle.” ER 151; see ER 158-73. In addition, the comments called on
EPA to “complete an updated assessment of glyphosate’s human health risks.” ER
151. NRDC urged EPA to consider recent studies that had been published on
glyphosate’s health effects, including studies suggesting that glyphosate may cause
kidney toxicity and birth defects. ER 173-78. Other commenters likewise requested
10 NRDC’s comments assumed that EPA was proposing to register Enlist
Duo under § 136a(c)(7)(A) and explained why registration under that provision would be unlawful. ER 206-11. As described below, EPA ultimately relied on a different conditional registration provision, § 136a(c)(7)(B), to register Enlist Duo; the agency specified this choice for the first time in its Final Registration Decision. See ER 4, 30.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 34 of 139
27
that EPA assess Enlist Duo’s effects on monarch habitat and evaluate up-to-date
science on glyphosate’s health risks. See ER 484 (incorporating previous CFS
comments); see, e.g., ER 462-65, 515-16, 1714-22, 2191-92.
Disregarding these comments, EPA issued its third final order
registering Enlist Duo on January 12, 2017. Mirroring the proposed order,
the final order included “three new decisions”:
First, EPA is issuing a new decision on the currently registered Enlist DuoTM for use on GE soybean and corn in 15 states, following the remand decision . . . . Second, the EPA is granting the approval of Enlist DuoTM for use on GE soybean and corn in an additional 19 states.[11] Third, EPA is granting a new use for Enlist DuoTM on GE cotton in 34 states (corresponding with the 15 states previously registered [sic], plus the 19 additional states approved for use of Enlist DuoTM on GE corn and soybean).
ER 2. Together, the three decisions registered Enlist Duo for use on Enlist
Duo-resistant corn, soybeans, and cotton in thirty-four states. See id.
Despite expressly characterizing these decisions as registration
decisions for Enlist Duo, EPA simultaneously insisted that it was merely
registering new uses of 2,4-D on 2,4-D-resistant corn, soybeans, and cotton.
See ER 1-4, 29. The agency emphasized that the “application in front of
11 Those states are Alabama, Arizona, Colorado, Delaware, Florida, Georgia,
Kentucky, Maryland, Michigan, North Carolina, New Jersey, New Mexico, New York, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, and West Virginia. ER 2.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 35 of 139
28
EPA is for a new use for 2,4-D choline salt” and that “this new use action is
specific to the 2,4-D.” ER 3-4. As before, EPA maintained that it was “not
taking any action as it relates to the glyphosate component of Enlist Duo.”
ER 4. Because “Enlist DuoTM uses on GE corn, soybeans, and cotton are
already registered on other glyphosate products,” EPA averred, “no new use
patterns and no new exposures for glyphosate are being considered” and “no
new assessment is needed for glyphosate.” ER 3.
To justify its decisions, EPA haphazardly referenced three different
FIFRA registration standards. ER 4, 28-30. First, the agency asserted that it
“only registers a pesticide when it determines that it will not cause
unreasonable adverse effects on man or the environment.” ER 28. This is a
criterion specific to the unconditional registration standard. See 7 U.S.C.
§ 136a(c)(5)(C). The order concluded that both glyphosate (based on data
from preexisting pesticide registrations) and 2,4-D (based on currently
available data), meet this criterion. See ER 4, 28-29. It is ambiguous whether
EPA determined that Enlist Duo, as a whole, likewise meets this criterion.
See ER 30 (concluding that “registering these uses will not generally cause
unreasonable adverse effects on human health or the environment,” but not
specifying whether “these uses” refer to the new uses of 2,4-D, Enlist Duo,
or both).
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 36 of 139
29
In addition, EPA referenced two different conditional registration
standards to explain its new decisions. EPA purported to treat the glyphosate
component of Enlist Duo “as if it were” a registration under § 136a(c)(7)(A).
ER 3 & n.3, 4; see 7 U.S.C. § 136a(c)(7)(A) (allowing EPA to conditionally
register, or conditionally amend an existing registration for, any pesticide or
proposed use that is “identically or substantially similar to any currently
registered pesticide and use thereof”). The agency qualified, however, that it
was not actually relying on that provision to register either glyphosate or
Enlist Duo. ER 3-4.
At the same time, EPA stated that it was registering the 2,4-D
component of Enlist Duo under a different conditional registration provision,
§ 136a(c)(7)(B). ER 4. Ultimately, EPA also indicated that it was registering
Enlist Duo under § 136a(c)(7)(B). ER 30. But not once did the agency
explicitly address whether registration of Enlist Duo would “significantly
increase the risk of any unreasonable adverse effect on the environment,” as
required for registration under that provision. 7 U.S.C. § 136a(c)(7)(B). Of
particular concern here, EPA neglected to consider Enlist Duo’s potential to
harm monarch butterflies through its suppression of milkweed, and the
agency ignored new evidence of glyphosate’s human health risks.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 37 of 139
30
On March 21, 2017, NRDC filed a petition for review in this Court
challenging the registration. Case No. 17-70817, ECF No. 1-5. That same
day, a group of petitioners led by the National Family Farm Coalition filed a
separate petition for review challenging the registration. Case No. 17-70810,
ECF No. 1-2. The Court consolidated the two lawsuits. Case No. 17-70810,
ECF No. 14.
SUMMARY OF ARGUMENT
I. EPA violated FIFRA by registering Enlist Duo, a new pesticide, under
§ 136a(c)(7)(B), even though that provision authorizes EPA only to “amend”
existing registrations. 7 U.S.C. § 136a(c)(7)(B). To escape the plain meaning of the
statute, EPA treated the application to register Enlist Duo as though it were simply
an application to amend an existing registration of one of Enlist Duo’s two active
ingredients: 2,4-D. But even if EPA may amend an existing registration of 2,4-D
under § 136a(c)(7)(B), this does not mean that the agency may register Enlist Duo,
a new pesticide, under the same provision. EPA fails to provide a reasonable
explanation for how the plain language of § 136a(c)(7)(B) permits the agency to
register the inaugural uses of Enlist Duo.
In addition, EPA may not rely on § 136a(c)(7)(B) to avoid assessing all
available, relevant information on the full range of Enlist Duo’s risks. Section
136a(c)(7)(B) requires EPA to assess only the incremental risks associated with the
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 38 of 139
31
additional uses of a previously registered pesticide, based on data specific to those
additional uses. See id. In contrast, unconditional registration requires EPA to
comprehensively assess all of a pesticide’s risks, based on data sufficient to inform
that thorough analysis. See id. § 136a(c)(5); 40 C.F.R. §§ 152.112(c), 158.75. To
grant an unconditional registration, EPA must determine—based on all relevant
data before the agency—that Enlist Duo would not cause “unreasonable adverse
effects” on human health or the environment.12 7 U.S.C. § 136a(c)(5)(C), (D); see
40 C.F.R. § 152.112(b), (e).
Here, EPA evaded the analysis for unconditional registration through its
improper reliance on § 136a(c)(7)(B). The agency refused even to consider
pertinent, recent studies indicating that glyphosate may cause serious human health
harms such as kidney toxicity and birth defects. Similarly, despite having never
assessed, in relation to any prior pesticide application, glyphosate’s potential to
harm monarchs by destroying milkweed, EPA declined to consider the weighty
evidence that NRDC and others put before the agency substantiating this harm.
II. In the alternative, even if EPA may conditionally register the very first uses
of Enlist Duo under § 136a(c)(7)(B), the agency must first determine that those
uses “would not significantly increase the risk of any unreasonable adverse effect
12 EPA must also make other determinations that are not relevant here. See 7
U.S.C. § 136a(c)(5).
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 39 of 139
32
on the environment” beyond the risks posed by currently registered pesticides
containing 2,4-D or glyphosate. 7 U.S.C. § 136a(c)(7)(B).
In public comments, NRDC and others timely notified EPA of extensive
evidence that use of herbicides on herbicide-resistant crops has been a dominant
cause of monarch-habitat destruction and resulting population decline. 2,4-D kills
milkweed, and EPA recognized that registering Enlist Duo for new uses on 2,4-D-
resistant crops will expand overall use of 2,4-D. The agency nonetheless failed to
assess how Enlist Duo’s expanded uses of 2,4-D would affect milkweed and
monarchs. In addition, EPA ignored evidence that registration of Enlist Duo for
use on glyphosate-resistant crops will bolster widespread use of glyphosate, insofar
as the novel combination of 2,4-D and glyphosate in Enlist Duo will stave off
rapidly spreading weed-resistance to glyphosate that would otherwise limit
glyphosate’s efficacy. Because Enlist Duo is likely to reinvigorate glyphosate use,
EPA must consider glyphosate’s potential to harm milkweed and monarchs, and to
adversely affect human health—concerns repeatedly identified in recent scientific
literature that EPA failed to consider.
By declining to assess evidence of Enlist Duo’s incremental impacts on
monarchs and human health, EPA lacked substantial evidence to conclude that
registration of Enlist Duo “would not significantly increase the risk of any
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 40 of 139
33
unreasonable adverse effect on the environment.” 7 U.S.C. § 136a(c)(7)(B). The
registration should therefore be vacated.
STANDARD OF REVIEW
Under FIFRA, a pesticide-registration order “shall be sustained if it is
supported by substantial evidence when considered on the record as a whole.” 7
U.S.C. § 136n(b). “Substantial evidence means more than a mere scintilla but less
than a preponderance; it is such relevant evidence as a reasonable mind might
accept as adequate to support a conclusion.” NRDC v. EPA (Nanosilver II), 857
F.3d 1030, 1036 (9th Cir. 2017) (quoting NRDC v. EPA (Nanosilver I), 735 F.3d
873, 877 (9th Cir. 2013)). “Although the substantial evidence standard of review is
relatively deferential to the agency factfinder, [the Court’s] review still must be
searching and careful, subjecting the agency’s decision to close judicial scrutiny.”
Containerfreight Corp. v. United States, 752 F.2d 419, 422 (9th Cir. 1985)
(internal quotation marks omitted).
To the extent that the “substantial evidence” test differs from arbitrary-and-
capricious review under the Administrative Procedure Act, “Congress expected
greater scrutiny when the enabling statute contains a substantial evidence test.”
Union Oil Co. of Cal. v. Fed. Power Comm’n, 542 F.2d 1036, 1041 (9th Cir.
1976). Consequently, “if the EPA’s pesticide registration is arbitrary and
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 41 of 139
34
capricious, the EPA cannot show it was supported by substantial evidence.”
Pollinator Stewardship Council, 806 F.3d at 1188 (Smith, N.R., J., concurring).
To survive the arbitrary-and-capricious test, and hence substantial-evidence
review, an “agency must examine the relevant data and articulate a satisfactory
explanation for its action including a ‘rational connection between the facts found
and the choice made.’” Motor Vehicle Mfrs. Ass’n of U.S. v. State Farm Mut. Auto.
Ins. Co., 463 U.S. 29, 43 (1983) (quoting Burlington Truck Lines v. United States,
371 U.S. 156, 168 (1962)). An agency’s decision cannot be supported by
substantial evidence if the agency failed to consider adequate relevant data. See
Pollinator Stewardship Council, 806 F.3d at 532. (“Without sufficient data, the
EPA has no real idea whether sulfoxaflor will cause unreasonable adverse effects
on bees, as prohibited by FIFRA. Accordingly, the EPA’s decision to register
sulfoxaflor was not supported by substantial evidence.”). Nor can the agency meet
this standard if it “entirely failed to consider an important aspect of the problem.”
State Farm, 463 U.S. at 43; accord Mont. Wilderness Ass’n v. McAllister, 666 F.3d
549, 555, 558, 561 (9th Cir. 2011). Further, “[i]t is well-established that an
agency’s action must be upheld, if at all, on the basis articulated by the agency
itself.” Nanosilver II, 857 F.3d at 1036 (alteration in original) (quoting Nanosilver
I, 735 F.3d at 877).
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 42 of 139
35
ARGUMENT
I. EPA’s registration of Enlist Duo is unlawful because FIFRA does not authorize EPA to register a new pesticide under § 136a(c)(7)(B)
Section 136a(c)(7)(B)’s grant of authority to EPA is narrow: the agency may
only “amend” existing pesticide registrations conditionally to “permit additional
uses.” 7 U.S.C. § 136a(c)(7)(B). Enlist Duo is a new pesticide, never before
registered. For this reason, it is not eligible for amended registration under
§ 136a(c)(7)(B).
A. EPA’s registration of Enlist Duo contravenes the plain text of § 136a(c)(7)(B)
“The preeminent canon of statutory interpretation requires [courts] to
presume that [the] legislature says in a statute what it means and means in a statute
what it says there.” L.A. Lakers, Inc. v. Fed. Ins. Co., 869 F.3d 795, 802 (9th Cir.
2017) (second alternation in original) (internal quotation marks omitted).
Section 136a(c)(7)(B) plainly states that EPA may “conditionally amend the
registration of a pesticide to permit additional uses of such pesticide.” 7 U.S.C.
§ 136a(c)(7)(B) (emphases added). In accordance with the ordinary meaning of
those terms, EPA cannot “amend” the registration of “a pesticide,” or add
“additional uses” to the registration of “such pesticide,” if there is no lawful
registration of that pesticide in the first place. See Yith v. Nielsen, 881 F.3d 1155,
1165 (9th Cir. 2018) (“[U]nless otherwise defined, words will be interpreted as
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 43 of 139
36
taking their ordinary, contemporary, common meaning.”); 7 U.S.C. § 136
(providing no definition for “amend” or “additional”). This means that new
pesticides do not qualify for registration under § 136a(c)(7)(B).
As a novel mixture of glyphosate, 2,4-D, and various inert ingredients, Enlist
Duo is a new pesticide. See 7 U.S.C. § 136(u) (defining pesticide as “any substance
or mixture of substances intended for preventing, destroying, repelling, or
mitigating any pest”). The registration challenged here is the only operative
registration for Enlist Duo, because it supersedes EPA’s earlier registration orders,
which this Court remanded to the agency. See ER 3; Resp’ts’ Opp’n to Pet’rs’ Mot.
to Adjudicate Pending Claims or, in the Alternative, to Stay the Mandate and
Retain Jurisdiction at 8-9, NRDC v. EPA, No. 14-73353 (9th Cir. Mar. 21, 2016),
ECF No. 130-1 (conveying EPA’s intent that the previous registration orders be
fully incorporated into, or replaced by, the new final registration order issued by
the agency following remand); compare ER 1-2, 5, 37 (2017 final registration
documents), with ER 1371-72, 1401 (2014 final registration documents), and ER
1019, 1055-56 (2015 final registration documents). There is thus no valid,
preexisting registration of Enlist Duo for EPA to “amend.” Similarly, because there
are no lawful, previously approved uses of Enlist Duo, the new uses approved by
EPA do not qualify as “additional uses” of the pesticide. As a consequence, EPA
may not register Enlist Duo under § 136a(c)(7)(B).
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 44 of 139
37
It is a “core administrative-law principle that an agency may not rewrite
clear statutory terms to suit its own sense of how the statute should operate.” Util.
Air Regulatory Grp. v. EPA, 134 S. Ct. 2427, 2446 (2014); see also id. at 2445.
Defying this fundamental principle, EPA has essentially rewritten § 136a(c)(7)(B)
to say:
The Administrator may conditionally amend grant the registration of a pesticide to permit additional uses of such pesticide notwithstanding that data concerning the pesticide may be insufficient to support an unconditional amendment registration, if the Administrator determines that (i) the applicant has submitted satisfactory data pertaining to the proposed additional use, and (ii) amending granting the registration in the manner proposed by the applicant would not significantly increase the risk of any unreasonable adverse effect on the environment.
7 U.S.C. § 136a(c)(7)(B). “[T]he need to rewrite clear provisions of the statute
should have alerted EPA that it had taken a wrong interpretive turn.” Util. Air
Regulatory Grp., 134 S. Ct. at 2446. Instead, EPA ignored the plain language of
§ 136a(c)(7)(B) and proceeded to register Enlist Duo under its distorted
interpretation of that provision.
“An agency,” however, “has no power to ‘tailor’ legislation to bureaucratic
policy goals by rewriting unambiguous statutory terms.” Id. at 2445. Here,
FIFRA’s plain text forecloses EPA from relying on § 136a(c)(7)(B) to register
Enlist Duo. Because the Court’s “inquiry begins with the statutory text, and ends
there as well,” the registration is unlawful and must be nullified. Nat’l Ass’n of
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 45 of 139
38
Mfrs. v. Dep’t of Def., 138 S. Ct. 617, 631 (2018); see also Benitez v. Califano, 573
F.2d 653, 655 (9th Cir. 1978) (holding that regardless of whether an agency’s
findings are supported by substantial evidence, a decision “should be set aside if
the proper legal standards were not applied in weighing the evidence and making
the decision”).
B. EPA fails to provide a reasonable explanation that reconciles its registration of Enlist Duo with the plain text of § 136a(c)(7)(B)
EPA attempts to circumvent § 136a(c)(7)(B)’s plain inapplicability to Enlist
Duo by claiming that the “new use . . . being conditionally registered under FIFRA
section 3(c)(7(B) [sic]” is merely “a new use for 2,4-D choline salt.” ER 4; see ER
29. But both EPA’s Final Registration Decision and its Notice of Registration state
that the agency registered “Enlist Duo”—and not “2,4-D Choline Salt.” ER 1, 37.
Simply put, Enlist Duo is not 2,4-D. EPA may not claim that it registered only new
uses of the active ingredient 2,4-D when it actually registered new uses of Enlist
Duo, a distinct and novel pesticide. See 7 U.S.C. § 136(u). That EPA voluntarily
moved to remand and vacate its previous registrations of Enlist Duo to scrutinize
potential synergistic effects between the pesticide’s active ingredients underscores
that a pesticide containing multiple active ingredients must be evaluated as an
integrated unit, and confirms that it is Enlist Duo, and not just 2,4-D, that is a
subject of this registration. See ER 4-5, 23-24, 54-56, 66-69. Despite the agency’s
attempted sleight-of-hand, the “pesticide” at issue in this § 136a(c)(7)(B) analysis
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 46 of 139
39
is Enlist Duo, and the phrases “a pesticide” and “such pesticide” in that provision
must refer to Enlist Duo. 7 U.S.C. § 136a(c)(7)(B).
Although EPA could “conditionally amend the registration of [Enlist Duo]
to permit additional uses of [Enlist Duo]” after Enlist Duo has already been
lawfully registered, EPA may not rely on § 136a(c)(7)(B) to register Enlist Duo in
the first instance. Id. If, as EPA represents, “the application in front of EPA is for a
new use for 2,4-D choline salt”—and if, as EPA asserts, it “only assess[ed] the
risks and benefits of the active ingredient [2,4-D choline salt]”—then the
registration EPA granted should have been limited to “a new use for 2,4-D choline
salt,” and not extended to the inaugural use of Enlist Duo. ER 3, 4.
“[A]n agency’s action must be upheld, if at all, on the basis articulated by
the agency itself.” Nanosilver II, 857 F.3d at 1036 (quoting Nanosilver I, 735 F.3d
at 877). Here, EPA failed to explain how its registration of Enlist Duo under
§ 136a(c)(7)(B) can be squared with the plain text of that provision.13 The
convoluted reasoning that EPA offered to support its decisions—mixing and
matching elements of three different registration standards to justify the agency’s
diverging approaches to the 2,4-D component of Enlist Duo, the glyphosate
component of Enlist Duo, and Enlist Duo herbicide overall—goes further to show
13 Nor has EPA attempted to demonstrate that there is substantial evidence to
support registration of Enlist Duo under any other FIFRA registration provision.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 47 of 139
40
that EPA cannot articulate an interpretation of § 136a(c)(7)(B) that permits it to
register Enlist Duo. See supra Statement of the Case IV.B.
C. EPA’s misguided approach to § 136a(c)(7)(B) undermines FIFRA’s core purpose because it allows new pesticides on the market without adequate assessment of their risks
FIFRA aims “to protect against the risk of harm from pesticide products.”
Sultan Chemists, Inc. v. EPA, 281 F.3d 73, 83 (3d Cir. 2002). EPA’s unlawful
reliance on § 136a(c)(7)(B) has the practical consequence of allowing the agency
to defer evaluating evidence relating to the full range of Enlist Duo’s risks, in
defiance of the statute’s fundamental purpose. In particular, EPA relied on
§ 136a(c)(7)(B) to ignore evidence before the agency regarding the glyphosate
component of Enlist Duo.14
Section 136a(c)(7)(B) instructs EPA to determine whether “amending the
registration” of a pesticide to grant additional uses will “significantly increase the
risk of any unreasonable adverse effect” on human health and the environment. 7
U.S.C. § 136a(c)(7)(B); see id. § 136(bb). Under this standard, the agency
evaluates only the incremental increase in risk created by a pesticide’s additional
14 Although EPA also disregarded evidence relating to risks posed by the
2,4-D in Enlist Duo, the agency did not attempt to justify its failure to consider that evidence through its reliance on § 136a(c)(7)(B). Instead, the agency simply glossed over the omission without providing any responsive explanation. See infra Argument II.A.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 48 of 139
41
uses—and does so based on the limited set of data pertinent to that incremental
risk. By contrast, when EPA unconditionally registers a new pesticide, the agency
conducts a comprehensive assessment of all risks of unreasonable adverse effects
posed by the pesticide. See id. § 136a(c)(5). This assessment requires EPA to
evaluate “all relevant data in the possession of the Agency.” 40 C.F.R.
§ 152.112(b); accord Pollinator Stewardship Council, 806 F.3d at 528. Through its
unlawful invocation of § 136a(c)(7)(B), EPA selected a narrower scope for its risk
assessment than would be required for unconditional registration, both in terms of
the breadth of the risks evaluated and the range of the data necessary to support
that analysis.
As a result, EPA ignored critical evidence of risks posed by Enlist Duo.
NRDC presented EPA with overwhelming evidence that the glyphosate in Enlist
Duo harms monarchs by killing milkweed. See supra Statement of the Case II; ER
15-30. NRDC also referred EPA to new peer-reviewed studies indicating that
glyphosate may cause serious health risks, including kidney toxicity and birth
defects. See supra Statement of the Case III. EPA had never evaluated this
information in connection with any previous registration of a glyphosate-
containing pesticide. Yet, the agency refused to consider this new evidence of
glyphosate’s harms before registering Enlist Duo. See ER 3-4. EPA did not find
that the new data were irrelevant or not credible. Instead, it claimed that registering
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 49 of 139
42
Enlist Duo would not significantly affect glyphosate use,15 and thus no new risk
analysis of glyphosate was necessary. See id.
But had EPA used the § 136a(c)(5) standard for unconditional registration to
assess Dow’s application to register Enlist Duo, the agency could not have ignored
new, “relevant data in the possession of the Agency,” 40 C.F.R. § 152.112(b)—
even if EPA were correct that Enlist Duo would not materially change overall
glyphosate use. While EPA certainly could have drawn on past assessments of
glyphosate, see 7 U.S.C. § 136a(c)(1)(F), the agency could not disregard new data
before it about glyphosate’s health and environmental harms. Compare ER 3-4,
with ER 1438 (“Proposed new registrations are held to the most current data
requirements and up-to-date risk assessment practices and must meet the FIFRA no
unreasonable adverse effects standard to be registered.”).
Affirming EPA’s misuse of § 136a(c)(7)(B) would allow the agency to defer
evaluating relevant evidence of Enlist Duo’s risks, thereby undermining the
statute’s core purpose to prevent unreasonable harm from pesticide use. See Cty. of
Amador v. U.S. Dep’t of Interior, 872 F.3d 1012, 1022 (9th Cir. 2017) (noting that
a statute should be interpreted with respect to its purpose); Sultan Chemists, 281
F.3d at 83; N.Y. State Pesticide Coal., Inc. v. Jorling, 874 F.2d 115, 117 (2d Cir.
15 As discussed below, this determination is not supported by substantial
evidence. See infra Argument II.B.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 50 of 139
43
1989) (explaining that Congress passed FIFRA to protect humans and the
environment from the “deleterious effects” of pesticides); see also 7 U.S.C.
§ 136a(a) (authorizing EPA to restrict the sale or distribution of any unregistered
pesticide “[t]o the extent necessary to prevent unreasonable adverse effects on the
environment”); Ma v. Ashcroft, 361 F.3d 553, 558 (9th Cir. 2004) (stating that
statutory interpretations producing absurd results are to be avoided).
II. EPA’s registration of Enlist Duo under § 136a(c)(7)(B) is not supported by substantial evidence because EPA failed adequately to consider increased risk of harm to monarch butterflies and human health
In the alternative, even if FIFRA allows EPA to conditionally register new
uses of Enlist Duo under § 136a(c)(7)(B) in the atextual manner proposed, the
agency must still determine that the registration “would not significantly increase
the risk of any unreasonable adverse effect on the environment.” 7 U.S.C.
§ 136a(c)(7)(B). EPA lacked substantial evidence to conclude that Enlist Duo
satisfies this criterion,16 because it ignored evidence that the pesticide’s new uses
of 2,4-D would harm the imperiled monarch population through destruction of
additional milkweed habitat; as well as evidence that the registration would bolster
glyphosate use and the associated risks to milkweed and monarchs, and to human
health.
16 If EPA reached this conclusion for Enlist Duo, as opposed to just 2,4-D, it
did so implicitly rather than explicitly. See ER 28-30. For the sake of this argument in the alternative, Petitioners assume that the agency did reach this conclusion.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 51 of 139
44
A. EPA declined to assess harm to milkweed and monarchs from Enlist Duo’s expansion of 2,4-D use
In public comments on EPA’s proposed decisions to register Enlist Duo,
NRDC and others brought to the agency’s attention an extensive body of scientific
literature documenting the significant decline of the North American monarch
butterfly population. See ER 159, 164-73, 319-20. The comments alerted EPA to
the considerable risk that Enlist Duo poses to monarchs, and specifically noted that
this risk arises in part from Enlist Duo’s inclusion of 2,4-D, which kills the
milkweed that monarchs need to survive. ER 158-73, 319-22, 2191-92.
Although, in contrast to its approach toward glyphosate, EPA did conduct
new analyses of some risks posed by 2,4-D, it failed to consider harm to monarch
habitat. The new uses of Enlist Duo approved by EPA present an acute threat to
monarchs by increasing 2,4-D use and thereby reducing agricultural milkweed
habitat. EPA’s registration of Enlist Duo will increase 2,4-D use by as much as 600
percent. ER 83, 353. But the risk to monarchs comes not just from the steep rise in
use of an active ingredient that targets milkweed, but also from changes in how
that chemical can now be used. EPA’s registration of Enlist Duo allows 2,4-D to
be applied both at higher rates and later in the growing season, during milkweed’s
vulnerable flowering stage. See ER 28, 320-21, 547, 1765. Without evaluating
potential harm to monarchs’ milkweed habitat from Enlist Duo’s new uses of 2,4-
D, EPA lacked substantial evidence to conclude that Enlist Duo would not
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 52 of 139
45
“significantly increase the risk of any unreasonable adverse effect on the
environment.” 7 U.S.C. § 136a(c)(7)(B).
Although the question of risks to monarchs through increased milkweed
destruction was properly before the agency, EPA refused to consider it before
registering Enlist Duo. In its Response to Comments, EPA skirted the issue
through two oblique responses. First, EPA proffered its completion of a 2,4-D-
related “non-target direct effects risk assessment for terrestrial invertebrates,
specifically referencing monarch butterflies as a member of this taxa” and cited its
underlying 2016 Ecological Risk Assessment. ER 63-64; see ER 568. But the
“direct effects” that EPA studied included only acute oral and contact toxicity to
monarchs from direct 2,4-D exposure—and did not include any indirect effects that
the 2,4-D in Enlist Duo would have on monarchs through destruction of the
butterflies’ milkweed habitat. See ER 626-28, 66; see also ER 173 (commenting to
EPA that “it is not sufficient for EPA to examine whether 2,4-D is toxic to
monarchs or other invertebrates”).
Second, EPA asserted that it had “conducted a risk assessment for the
combined toxic effects to non-target plants . . . for glyphosate and 2,4-D
choline” and concluded “that effects to non-target plants . . . would be
limited to the treated field itself.” ER 63. But EPA was silent as to how
Enlist Duo’s effects on milkweed—a target plant that grows within treated
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 53 of 139
46
fields, see ER 112—would affect the monarch population. Notably, there is
evidence that monarchs have a pronounced preference for milkweed in
agricultural fields and lay more eggs there. ER 239, 273. Consequently,
further milkweed decline in agricultural fields across thirty-four states
squarely within the monarch migration pathway could have particularly
significant repercussions for the species’ survival. See ER 168, 266, 273.
Without considering how Enlist Duo’s novel uses of 2,4-D would impact
monarchs through their effects on milkweed, EPA lacked substantial evidence to
conclude that Enlist Duo “would not significantly increase the risk of any
unreasonable adverse effect on the environment,” as required for registration under
§ 136a(c)(7)(B). 7 U.S.C. § 136a(c)(7)(B); see Pollinator Stewardship Council,
806 F.3d at 532. Because EPA “entirely failed to consider an important aspect of
the problem,” its registration decisions were arbitrary, capricious, and not in
accordance with the law. State Farm, 463 U.S. at 43; accord Mont. Wilderness
Ass’n, 666 F.3d at 555, 558, 561. It follows that the decisions fail the substantial
evidence test under FIFRA, which is at least as rigorous as arbitrary-and-capricious
review. See Union Oil Co. of Cal., 542 F.2d at 1041.
The Court need not find that Enlist Duo increases risks to monarchs to
vacate the unlawful registration: that is a question for EPA. It is possible that had
EPA considered Enlist Duo’s harm to monarch habitat, it would have concluded
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 54 of 139
47
that the pesticide “would not significantly increase the risk of any unreasonable
adverse effect on the environment.” 7 U.S.C. § 136a(c)(7)(B). The agency’s legal
error was in refusing even to consider the matter before registering Enlist Duo. See
State Farm, 463 U.S. at 43; Mont. Wilderness Ass’n, 666 F.3d at 555, 558, 561.
Without having done so, EPA’s decisions lack substantial evidence and violate the
law.
B. EPA ignored evidence that registering Enlist Duo would result in increased glyphosate use over time and thereby amplify risks that glyphosate poses to both monarchs and humans
There is considerable evidence in the record suggesting that glyphosate use
would decrease but for EPA’s registration of Enlist Duo. As the agency observed,
“weed control experts warn that the problem of glyphosate resistance is increasing,
and that significant economic consequences will continue to increase without
effective alternatives for weed control.” ER 29-30. In other words, glyphosate is
losing efficacy, as confirmed by comments from growers and experts reporting
adoption of non-glyphosate-based alternatives. See, e.g., ER 459, 507.
Enlist Duo presents a pathway for reversing, or at least slowing,
glyphosate’s descent toward obsolescence: “the herbicide combination in this weed
control systems approach could potentially prolong the effectiveness of the
glyphosate technology if the two herbicides are controlling weeds that are not
resistant to either herbicide.” ER 28. As a result, Enlist Duo may perpetuate
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 55 of 139
48
glyphosate use at higher levels, for a longer time, in comparison to a landscape
without Enlist Duo.
Compared to that status quo, registration of Enlist Duo will thus likely
amplify glyphosate use and any risks inherent in that use. These include not only
risks to monarchs from destruction of milkweed, see supra Statement of the Case
II, but also risks to human health, as identified in recent scientific studies that EPA
declined to consider, see supra Statement of the Case III. EPA assumed, without
evidence, that registration of Enlist Duo will not “significantly change the
locations, methods, or volume of glyphosate used on corn, soybeans, or cotton.”
ER 4. But without any analysis to support this “expect[ation],” id., and without
considering the new evidence of glyphosate’s potential to harm monarchs and
human health, the agency lacked substantial evidence to conclude that Enlist Duo
“would not significantly increase the risk of any unreasonable adverse effect on the
environment.” 7 U.S.C. § 136a(c)(7)(B); see Nanosilver II, 857 F.3d at 1039-40
(holding as unsupported by substantial evidence EPA’s finding that registration of
a new nanosilver pesticide was in the public interest because it may reduce the
total amount of silver released to the environment, where the agency failed to
substantiate the assumptions underlying that finding).
As with 2,4-D’s potential to harm milkweed and monarchs, the Court need
not decide that the glyphosate in Enlist Duo actually increases risk of harm to
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 56 of 139
49
monarchs or human health. The agency erred by failing to evaluate evidence of
those risks before registering Enlist Duo, and this failure warrants vacatur.17 See
State Farm, 463 U.S. at 43, 56; Mont. Wilderness Ass’n, 666 F.3d at 555, 558, 561.
III. NRDC has standing to challenge EPA’s registration of Enlist Duo
To establish standing, NRDC must show that the interests it seeks to protect
are germane to its organizational purposes, that this litigation will not require its
members’ individual participation, and that its members would have standing to
sue in their own right. See Hunt v. Wash. State Apple Advert. Comm’n, 432 U.S.
333, 343 (1977).
NRDC satisfies this test. Protection of wildlife and human health is germane
to NRDC’s organizational mission, which is “to safeguard the Earth: its people, its
plants and animals, and the natural systems on which all life depends.” Trujillo
Decl. ¶¶ 6-8 (ADD 065-66). In addition, this lawsuit does not require the
17 To the extent that vacatur of the 2017 registration order would result in
reinstatement of the 2014 and 2015 registration orders, those earlier orders should also be vacated. The Supreme Court has “[made] clear that the touchstone of vacatur is equity,” Dilley v. Gunn, 64 F.3d 1365, 1370 (9th Cir. 1995), and it would be inequitable to allow EPA to reinstate the 2014 and 2015 orders following vacatur of the 2017 order. Those earlier orders are fully incorporated into the 2017 order, see ER 5 (“[T]he agency has made the decision to maintain the previously approved uses of Enlist DuoTM on GE corn and soybeans in 15 states with no changes to the original registration, as amended.”), and are unlawful for the same reasons. Furthermore, Petitioners timely challenged the earlier orders, but this Court dismissed Petitioners’ challenge after granting EPA’s voluntary motion for remand. See Order, NRDC v. EPA, No. 14-73353 (9th Cir. Jan. 25, 2016), ECF No. 128; Order, NRDC v. EPA, No. 14-73353 (9th Cir. Mar. 28, 2016), ECF No. 132.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 57 of 139
50
participation of individual NRDC members, because NRDC does not seek any
individualized relief for its members. See Hunt, 432 U.S. at 344.
NRDC’s members would have standing to sue on their own because they
suffer “injury in fact” that is fairly traceable to the challenged EPA order and likely
to be redressed by a favorable decision. See Friends of the Earth, Inc. v. Laidlaw
Envtl. Servs. (TOC), Inc., 528 U.S. 167, 180-81 (2000) (citing Lujan v. Defs. of
Wildlife, 504 U.S. 555, 560-61 (1992)). NRDC members suffer at least two injuries
from the Enlist Duo registration: health risks from potential exposure to Enlist Duo
and diminished enjoyment of their natural environment resulting from loss of
monarch butterflies.
First, NRDC’s members include individuals who live in areas where Enlist
Duo is registered for use and who risk exposure to the pesticide during their daily
activities. Gruber Decl. ¶¶ 4-9 (ADD 059-61); Bristol ¶¶ 2-8 (ADD 051-53);
Wetzel Decl. ¶¶ 3-9 (ADD 069-72). Because both active ingredients in Enlist Duo
are linked to serious health harms, NRDC’s members are reasonably concerned
that exposure to Enlist Duo may harm them. See ER 148-51, 173-97, 202-05
(identifying potential health risks from exposure to glyphosate and 2,4-D); Gruber
Decl. ¶¶ 4-9 (ADD 059-61); Bristol ¶¶ 2-8 (ADD 051-53); Wetzel Decl. ¶¶ 3-9
(ADD 069-72). These members have no control over whether, when, how, and
where Enlist Duo will be applied to corn, soybean, and cotton crops grown in their
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 58 of 139
51
communities. Gruber Decl. ¶ 9 (ADD 060-61); Bristol ¶¶ 2-8 (ADD 051-53);
Wetzel Decl. ¶¶ 3-9 (ADD 069-72). This “credible threat of harm” to NRDC
members’ health interests “is sufficient to constitute actual injury for standing
purposes.” Cent. Delta Water Agency v. United States, 306 F.3d 938, 950 (9th Cir.
2002); see Nanosilver I, 735 F.3d at 878-79 (holding that NRDC had standing to
challenge EPA’s registration of a pesticide that “increase[d] the threat of future
harm to NRDC’s members”).
In addition, NRDC’s members include individuals who enjoy observing,
studying, and interacting with monarch butterflies in the states where EPA has
approved the use of Enlist Duo. Gruber Decl. ¶¶ 10-12 (ADD 061); Bristol ¶¶ 10-
14 (ADD 053-54); Wetzel Decl. ¶¶ 10-15 (ADD 072-74). These members’ “desire
to use or observe an animal species, even for purely esthetic purposes, is
undeniably a cognizable interest for purpose of standing.” Lujan, 504 U.S. at 562-
63. EPA’s registration of Enlist Duo is likely to exacerbate milkweed and monarch
decline. For these reasons, the registration harms these members’ interests in
monarch butterflies and impairs their enjoyment of the outdoors. Gruber Decl.
¶¶ 10-12 (ADD 061); Bristol ¶¶ 10-14 (ADD 053-54); Wetzel Decl. ¶¶ 10-15
(ADD 072-74).
The injuries to NRDC members’ health and enjoyment of monarch
butterflies are fairly traceable to EPA’s order registering Enlist Duo. EPA’s
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 59 of 139
52
registration order enables the sale and distribution of Enlist Duo, thereby allowing
Enlist Duo to be used in ways that may expose NRDC members to the herbicide
and making it possible for Enlist Duo to harm milkweed and monarchs.
Finally, the injuries to NRDC members are likely to be redressed, at least in
part, by an order vacating Enlist Duo’s registration. If the Court vacates the
registration, Enlist Duo will no longer be authorized for sale or distribution in the
United States. As a result, vacatur would prevent NRDC members from being
exposed to Enlist Duo, ameliorating their concerns and eliminating the health risks
from that exposure. Vacatur would also help to safeguard NRDC members’
interests in observing and interacting with monarch butterflies. Enlist Duo’s
registration is expected to increase 2,4-D use and bolster glyphosate use, which is
likely to harm milkweed. See supra Statement of the Case I; Argument II.B.
Vacating the registration would prevent this adverse effect, thereby benefiting
monarch butterflies and NRDC’s members. NRDC therefore has standing to
challenge EPA’s registration of Enlist Duo.
CONCLUSION
For the foregoing reasons, the Court should grant the petition for review and
vacate EPA’s registration of Enlist Duo. Vacatur should extend not only to EPA’s
2017 registration order, but also to the superseded 2014 and 2015 registration
orders if those orders would otherwise be reinstated.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 60 of 139
53
Dated: April 11, 2018 Respectfully submitted, /s/ Margaret T. Hsieh Margaret T. Hsieh Mitchell S. Bernard Kaitlin Morrison Natural Resources Defense Council 40 West 20th Street New York, NY 10011 Telephone: (212) 727-2700 Facsimile: (415) 795-4799 [email protected] [email protected] [email protected] Peter J. DeMarco Natural Resources Defense Council 1152 15th Street NW Suite 300 Washington, DC 20005 Telephone: (202) 289-6868 Facsimile: (415) 795-4799 [email protected] Counsel for Petitioner NRDC
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 61 of 139
54
STATEMENT OF RELATED CASES
There are no known related cases pending in this Court.
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 62 of 139
55
CERTIFICATE OF COMPLIANCE
This brief complies with the type-volume limitation of Cir. R. 32-1(a)
because it contains 12,007 words, excluding the parts of the brief exempted by Cir.
R. 32-1(c) and Fed. R. App. P. 32(f).
This brief complies with the typeface requirements of Fed. R. App. P.
32(a)(5) and the type style requirements of Fed. R. App. P. 32(a)(6) because it has
been prepared in a proportionally spaced typeface using 14-point Times New
Roman font.
Dated: April 11, 2018 /s/ Margaret T. Hsieh
Counsel for Petitioner NRDC
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 63 of 139
56
CERTIFICATE OF SERVICE
I hereby certify that on April 11, 2018, I electronically filed the foregoing
brief and the accompanying declarations of Joan Bristol, LeRoy Gruber, Gina
Trujillo, and Diane Wetzel with the Clerk of the Court for the United States Court
of Appeals for the Ninth Circuit using the appellate CM/ECF system.
I certify that all participants in the case are registered CM/ECF users and
that service will be accomplished by the appellate CM/ECF system.
Dated: April 11, 2018 /s/ Margaret T. Hsieh
Counsel for Petitioner NRDC
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 64 of 139
ADDENDUM OF STATUTES AND REGULATIONS
Table of Contents
7 U.S.C. § 136 .................................................................................................. ADD 2
7 U.S.C. § 136a .............................................................................................. ADD 14
7 U.S.C. § 136n .............................................................................................. ADD 36
40 C.F.R. § 152.44 ......................................................................................... ADD 38
40 C.F.R. § 152.112 ....................................................................................... ADD 40
40 C.F.R. § 155.40 ......................................................................................... ADD 42
40 C.F.R. § 155.42 ......................................................................................... ADD 44
40 C.F.R. § 155.53 ......................................................................................... ADD 46
40 C.F.R. § 158.75 ......................................................................................... ADD 48
ADD 001
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 65 of 139
����������� ����������������
���������������� !"#!$�%�&��'()*��#���$*+*�)(�,%-%�.�/!$��!�#�0�$1�% �
234567�85956:�;<76�=33<59567>45?6�@A�=BC4DE?5EC6�FG6H:�I�=33<:J;K9L56C�MA�N3:6D54D476:�937�O3P4C<3Q6359?�R6:54D476�;<35C<?�FG6H:�I�=33<:J8ESDK9L56C�NNA�O3P4C<3Q6359?�R6:54D476�;<35C<?�FG6H:�I�=33<:J@�2A8A;A=A�T�UVMT�UVMA�W6H43454<3:OHH6D54P6X�=EBE:5�VY�UZZM;ECC63536::[\]�_]\a�\b�cde�_fgdhca]iijkl�mnopqr�psturvprsowda�ca]x�yhgceza�e{|]a}ea{c~�xah{iij�l�e{�cda�gha�\b�h�acege}a�\cda]�cdh{�h��h{c�]a|_�hc\]��}ab\�eh{c��}aeggh{c��\]�{ec]\|a{�chfe�e�a]��h{�e{|]a}ea{c�degd��e���]aza{c��}ac]\���]aa���\]�xece|hca�h{��ac�j�l�e{�cda�gha�\b�h��h{c�]a|_�hc\]��h{�e{|]a}ea{c��degd��cd]\_|d�d�e\�\|egh��hgce\{���e���hgga�a]hca�\]�]ach]}�cda�]hca\b�|]\�cd�\]�]hca�\b�xhc_]hce\{�\]�\cda]�ea�h�ca]�cda�fadhze\]�\b�\]{hxa{ch��\]�g]\��h{c�\]�cda�]\}_gc�cda]a\b�j�l�e{�cda�gha�\b�h�}ab\�eh{c��h{�e{|]a}ea{c��degd��e���gh_a�cda��ahza�\]�b\�eh|a�c\�}]\�b]\x�h��h{c�j�l�e{�cda�gha�\b�h�}aeggh{c��h{�e{|]a}ea{c��degd��e���h]cebegeh����hgga�a]hca�cda�}]�e{|�\b��h{c�ce_a��h{}j�l�e{�cda�gha�\b�h�{ec]\|a{�chfe�e�a]��h{�e{|]a}ea{c��degd��e���]aza{c�\]�de{}a]�cda�]\ga�\b�{ec]ebeghce\{�}a{ec]ebeghce\{��hxx\{eh�z\�hce�e�hce\{��\]�_]aha�]\}_gce\{�cd]\_|d�hgce\{�hbbagce{|�\e��fhgca]eh�j�l�mv�psp�ouko�uwda�ca]x�y�}xe{ec]hc\]~�xah{�cda��}xe{ec]hc\]�\b�cda��{ze]\{xa{ch���]\cagce\{��|a{g��jnl�mv��orukorvwda�ca]x�yh}_�ca]hca}~�h �ea�c\�h{��acege}a�ebiij�l�ec�c]a{|cd�\]�_]ec��bh���fa�\��cda�]\baa}�ch{}h]}�\b��_h�ec��h�a�]aa}�\{�ec��hfa�e{|�_{}a]��degd�ec�e�\�}�ADD 002
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 66 of 139
����������� ����������������
���������������� !"#!$�%�&��'()*��#���$*+*�)(�,%-%�.�/!$��!�#�0�$1�% �
234�567�89:8;56<=�>58�:==6�89:8;?;9;=@�A>BCC7�BD�?6�E5D;�FBD�;>=�E=8;?<?@=G�BD2H4�567�I5C95:C=�<B68;?;9=6;�BF�;>=�E=8;?<?@=�>58�:==6�A>BCC7�BD�?6�E5D;�5:8;D5<;=@J2K4�LMNOPQR>=�;=DS�T56?S5CU�S=568�5CC�I=D;=:D5;=�56@�?6I=D;=:D5;=�8E=<?=8V�?6<C9@?6W�:9;�6B;�C?S?;=@�;B�S56�56@�B;>=D�S5SS5C8V:?D@8V�F?8>V�56@�8>=CCF?8>J2X4�YXZ[N\NXK�P]]QNP[_Z�X[a2b4�YXZ[N\NXK�P]]QNP[_ZR>=�;=DS�T<=D;?F?=@�5EEC?<5;BDU�S=568�567�?6@?I?@95C�A>B�?8�<=D;?F?=@�96@=D�8=<;?B6�cde?�BF�;>?8�;?;C=�58�59;>BD?f=@�;B98=�BD�89E=DI?8=�;>=�98=�BF�567�E=8;?<?@=�A>?<>�?8�<C588?F?=@�FBD�D=8;D?<;=@�98=J�g67�5EEC?<5;BD�A>B�>BC@8�BD�5EEC?=8D=W?8;=D=@�E=8;?<?@=8V�BD�98=8�@?C9;?B68�BF�D=W?8;=D=@�E=8;?<?@=8�<B68?8;=6;�A?;>�89:8=<;?B6�h==iV�B6C7�;B�EDBI?@=�5�8=DI?<=BF�<B6;DBCC?6W�E=8;8�A?;>B9;�@=C?I=D?6W�567�965EEC?=@�E=8;?<?@=�;B�567�E=D8B6�8B�8=DI=@�?8�6B;�@==S=@�;B�:=�5�8=CC=D�BD@?8;D?:9;BD�BF�E=8;?<?@=8�96@=D�;>?8�89:<>5E;=DJ234�jZNkP[X�P]]QNP[_ZR>=�;=DS�TED?I5;=�5EEC?<5;BDU�S=568�5�<=D;?F?=@�5EEC?<5;BD�A>B�98=8�BD�89E=DI?8=8�;>=�98=�BF�567�E=8;?<?@=�A>?<>�?8<C588?F?=@�FBD�D=8;D?<;=@�98=�FBD�E9DEB8=8�BF�EDB@9<?6W�567�5WD?<9C;9D5C�<BSSB@?;7�B6�EDBE=D;7�BA6=@�BD�D=6;=@�:7�;>=5EEC?<5;BD�BD�;>=�5EEC?<5;BDl8�=SECB7=D�BD�h?F�5EEC?=@�A?;>B9;�<BSE=685;?B6�B;>=D�;>56�;D5@?6W�BF�E=D8B65C�8=DI?<=8:=;A==6�EDB@9<=D8�BF�5WD?<9C;9D5C�<BSSB@?;?=8i�B6�;>=�EDBE=D;7�BF�56B;>=D�E=D8B6J2H4�Y_OOXZNPQ�P]]QNP[_ZR>=�;=DS�T<BSS=D<?5C�5EEC?<5;BDU�S=568�56�5EEC?<5;BD�hA>=;>=D�BD�6B;�;>=�5EEC?<5;BD�?8�5�ED?I5;=�5EEC?<5;BD�A?;>D=8E=<;�;B�8BS=�98=8i�A>B�98=8�BD�89E=DI?8=8�;>=�98=�BF�567�E=8;?<?@=�A>?<>�?8�<C588?F?=@�FBD�D=8;D?<;=@�98=�FBD�567�E9DEB8=BD�B6�567�EDBE=D;7�B;>=D�;>56�58�EDBI?@=@�:7�E5D5WD5E>�hmiJ2n4�oMKXZ�[pX�KNZX[�qr]XZkNqN_M�_\�P�XZ[N\NXK�P]]QNP[_Zs6C=88�B;>=DA?8=�ED=8<D?:=@�:7�?;8�C5:=C?6WV�5�E=8;?<?@=�8>5CC�:=�<B68?@=D=@�;B�:=�5EEC?=@�96@=D�;>=�@?D=<;�89E=DI?8?B6BF�5�<=D;?F?=@�5EEC?<5;BD�?F�?;�?8�5EEC?=@�:7�5�<BSE=;=6;�E=D8B6�5<;?6W�96@=D�;>=�?68;D9<;?B68�56@�<B6;DBC�BF�5�<=D;?F?=@5EEC?<5;BD�A>B�?8�5I5?C5:C=�?F�56@�A>=6�6==@=@V�=I=6�;>B9W>�89<>�<=D;?F?=@�5EEC?<5;BD�?8�6B;�E>78?<5CC7�ED=8=6;�5;�;>=;?S=�56@�EC5<=�;>=�E=8;?<?@=�?8�5EEC?=@J2\4�tX\_QNPM[R>=�;=DS�T@=FBC?56;U�S=568�567�89:8;56<=�BD�S?u;9D=�BF�89:8;56<=8�?6;=6@=@�FBD�<598?6W�;>=�C=5I=8�BD�FBC?5W=�;B�@DBEFDBS�5�EC56;V�A?;>�BD�A?;>B9;�<598?6W�5:8<?88?B6JADD 003
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 67 of 139
����������� ����������������
���������������� !"#!$�%�&��'()*��#���$*+*�)(�,%-%�.�/!$��!�#�0�$1�% 2
345�6789::;<=>?@�A@BC�DE@FGHHIJAK�C@IJF�IJL�FMNFAIJH@�OB�CGPAMB@�OQ�FMNFAIJH@F�GJA@JE@E�QOB�IBAGQGHGIRRL�IHH@R@BIAGJS�A?@�EBLGJS�OQTRIJA�AGFFM@U3V5�67W9:7>?@�A@BC�DE@XGH@K�C@IJF�IJL�GJFABMC@JA�OB�HOJABGXIJH@�YOA?@B�A?IJ�I�QGB@IBCZ�[?GH?�GF�GJA@JE@E�QOB�ABITTGJS\�E@FABOLGJS\B@T@RRGJS\�OB�CGAGSIAGJS�IJL�T@FA�OB�IJL�OA?@B�QOBC�OQ�TRIJA�OB�IJGCIR�RGQ@�YOA?@B�A?IJ�CIJ�IJE�OA?@B�A?IJ�NIHA@BGI\XGBMF\�OB�OA?@B�CGHBOOBSIJGFC�OJ�OB�GJ�RGXGJS�CIJ�OB�OA?@B�RGXGJS�IJGCIRFZ]�NMA�JOA�GJHRMEGJS�@MGTC@JA�MF@E�QOB�A?@ITTRGHIAGOJ�OQ�T@FAGHGE@F�[?@J�FORE�F@TIBIA@RL�A?@B@QBOCU395�698=_9:=�:a_=>?@�A@BC�DEGFABGHA�HOMBAK�C@IJF�I�bJGA@E�cAIA@F�EGFABGHA�HOMBA\�A?@�dGFABGHA�eOMBA�OQ�fMIC\�A?@�dGFABGHA�eOMBA�OQ�A?@gGBSGJ�hFRIJEF\�IJE�A?@�?GS?@FA�HOMBA�OQ�iC@BGHIJ�cICOIU3j5�k<W9_<l7<=>?@�A@BC�D@JXGBOJC@JAK�GJHRME@F�[IA@B\�IGB\�RIJE\�IJE�IRR�TRIJAF�IJE�CIJ�IJE�OA?@B�IJGCIRF�RGXGJS�A?@B@GJ\�IJE�A?@GJA@BB@RIAGOJF?GTF�[?GH?�@PGFA�ICOJS�A?@F@U3m5�na<4a8>?@�A@BC�DQMJSMFK�C@IJF�IJL�JOJoH?ROBOT?LRRoN@IBGJS�A?IRROT?LA@�YA?IA�GF\�IJL�JOJoH?ROBOT?LRRoN@IBGJS�TRIJA�OQ�I�RO[@BOBE@B�A?IJ�COFF@F�IJE�RGX@B[OBAFZ\�IF�QOB�@PICTR@\�BMFA\�FCMA\�CGRE@[\�CORE\�L@IFA\�IJE�NIHA@BGI\�@PH@TA�A?OF@�OJ�OB�GJRGXGJS�CIJ�OB�OA?@B�IJGCIRF�IJE�A?OF@�OJ�OB�GJ�TBOH@FF@E�QOOE\�N@X@BIS@F\�OB�T?IBCIH@MAGHIRFU3p5�qll9<7<=�V;r;_s>?@�A@BC�DGCCGJ@JA�?ItIBEK�C@IJF�I�FGAMIAGOJ�[?GH?�@PGFAF�[?@J�A?@�HOJAGJM@E�MF@�OQ�I�T@FAGHGE@�EMBGJS�A?@�AGC@B@MGB@E�QOB�HIJH@RRIAGOJ�TBOH@@EGJS�[OMRE�N@�RGu@RL�AO�B@FMRA�GJ�MJB@IFOJINR@�IEX@BF@�@QQ@HAF�OJ�A?@�@JXGBOJC@JA�OB�[GRRGJXORX@�MJB@IFOJINR@�?ItIBE�AO�A?@�FMBXGXIR�OQ�I�FT@HG@F�E@HRIB@E�@JEIJS@B@E�OB�A?B@IA@J@E�NL�A?@�c@HB@AIBL�TMBFMIJAAO�A?@�vJEIJS@B@E�cT@HG@F�iHA�OQ�wxyzU3l5�q<7_=�9<4_7s97<=>?@�A@BC�DGJ@BA�GJSB@EG@JAK�C@IJF�IJ�GJSB@EG@JA�[?GH?�GF�JOA�IHAGX@U3<5�q<4_7s97<=�8=;=7l7<=>?@�A@BC�DGJSB@EG@JA�FAIA@C@JAK�C@IJF�I�FAIA@C@JA�[?GH?�HOJAIGJFooADD 004
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 68 of 139
����������� ����������������
���������������� !"#!$�%�&��'()*��#���$*+*�)(�,%-%�.�/!$��!�#�0�$1�% 2
345�678�9:;8�:9<�=8>?896:@8�AB�8:?7�:?6CD8�C9@>8<C896E�:9<�678�6A6:F�=8>?896:@8�AB�:FF�C98>6�C9@>8<C896GE�C9�678�=8G6C?C<8H:9<3I5�CB�678�=8G6C?C<8�?A96:C9G�:>G89C?�C9�:9J�BA>;E�:�G6:68;896�AB�678�=8>?896:@8G�AB�6A6:F�:9<�K:68>�GAFLMF8�:>G89C?E?:F?LF:68<�:G�8F8;896:>J�:>G89C?N3O5�PQRSTUV78�68>;�WC9G8?6X�;8:9G�:9J�AB�678�9L;8>ALG�G;:FF�C9D8>68M>:68�:9C;:FG�@898>:FFJ�7:DC9@�678�MA<J�;A>8�A>�F8GG�AMDCALGFJG8@;8968<E�BA>�678�;AG6�=:>6�M8FA9@C9@�6A�678�?F:GG�C9G8?6:E�?A;=>CGC9@�GCYZF8@@8<E�LGL:FFJ�KC9@8<�BA>;GE�:G�BA>�8Y:;=F8EM886F8GE�ML@GE�M88GE�BFC8GE�:9<�6A�A678>�:FFC8<�?F:GG8G�AB�:>67>A=A<G�K7AG8�;8;M8>G�:>8�KC9@F8GG�:9<�LGL:FFJ�7:D8�;A>867:9�GCY�F8@GE�:G�BA>�8Y:;=F8E�G=C<8>GE�;C68GE�6C?[GE�?896C=8<8GE�:9<�KAA<�FC?8N3\5�]_S�Qa�_SbQc345�]_SV78�68>;�WF:M8FX�;8:9G�678�K>C6689E�=>C968<E�A>�@>:=7C?�;:668>�A9E�A>�:66:?78<�6AE�678�=8G6C?C<8�A>�<8DC?8�A>�:9J�ABC6G�?A96:C98>G�A>�K>:==8>GN3I5�]_SbQcV78�68>;�WF:M8FC9@X�;8:9G�:FF�F:M8FG�:9<�:FF�A678>�K>C6689E�=>C968<E�A>�@>:=7C?�;:668>ZZ3d5�:??A;=:9JC9@�678�=8G6C?C<8�A>�<8DC?8�:6�:9J�6C;8H�A>3e5�6A�K7C?7�>8B8>89?8�CG�;:<8�A9�678�F:M8F�A>�C9�FC68>:6L>8�:??A;=:9JC9@�678�=8G6C?C<8�A>�<8DC?8E�8Y?8=6�6A�?L>>896ABBC?C:F�=LMFC?:6CA9G�AB�678�f9DC>A9;896:F�g>A68?6CA9�h@89?JE�678�i9C68<�j6:68G�k8=:>6;896G�AB�h@>C?LF6L>8�:9<l968>CA>E�678�k8=:>6;896�AB�m8:F67�:9<�mL;:9�j8>DC?8GE�j6:68�8Y=8>C;896�G6:6CA9GE�j6:68�:@>C?LF6L>:F�?AFF8@8GE�:9<A678>�GC;CF:>�n8<8>:F�A>�j6:68�C9G6C6L6CA9G�A>�:@89?C8G�:L67A>Co8<�MJ�F:K�6A�?A9<L?6�>8G8:>?7�C9�678�BC8F<�AB�=8G6C?C<8GN3p5�qbR_rQaSa345�h�=8G6C?C<8�CG�;CGM>:9<8<�CBZZ3d5�C6G�F:M8FC9@�M8:>G�:9J�G6:68;896E�<8GC@9E�A>�@>:=7C?�>8=>8G896:6CA9�>8F:6CD8�678>86A�A>�6A�C6G�C9@>8<C896G�K7C?7�CGB:FG8�A>�;CGF8:<C9@�C9�:9J�=:>6C?LF:>H3e5�C6�CG�?A96:C98<�C9�:�=:?[:@8�A>�A678>�?A96:C98>�A>�K>:==C9@�K7C?7�<A8G�9A6�?A9BA>;�6A�678�G6:9<:><G�8G6:MFCG78<MJ�678�h<;C9CG6>:6A>�=L>GL:96�6A�G8?6CA9�stuKv?wvtw�AB�67CG�6C6F8HADD 005
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 69 of 139
����������� ����������������
���������������� !"#!$�%�&��'()*��#���$*+*�)(�,%-%�.�/!$��!�#�0�$1�% 2
345�67�68�9:�6;67976<:�<=>�<?�68�<==@?@A�=<?�89B@�C:A@?�7D@�:9;@�<=>�9:<7D@?�E@876F6A@G3H5�678�B9I@B�A<@8�:<7�I@9?�7D@�?@J687?976<:�:C;I@?�9886J:@A�C:A@?�8@F76<:�KLM@�<=�7D68�767B@�7<�@9FD�@879IB68D;@:76:�ND6FD�67�N98�E?<ACF@AG3O5�9:P�N<?A>�8797@;@:7>�<?�<7D@?�6:=<?;976<:�?@QC6?@A�IP�<?�C:A@?�9C7D<?67P�<=�7D68�8CIFD9E7@?�7<�9EE@9?�<:�7D@B9I@B�<?�B9I@B6:J�68�:<7�E?<;6:@:7BP�EB9F@A�7D@?@<:�N67D�8CFD�F<:8E6FC<C8:@88�R98�F<;E9?@A�N67D�<7D@?�N<?A8>8797@;@:78>�A@86J:8>�<?�J?9ED6F�;977@?�6:�7D@�B9I@B6:JS�9:A�6:�8CFD�7@?;8�98�7<�?@:A@?�67�B6T@BP�7<�I@�?@9A�9:AC:A@?87<<A�IP�7D@�<?A6:9?P�6:A6U6AC9B�C:A@?�FC87<;9?P�F<:A676<:8�<=�EC?FD98@�9:A�C8@G3V5�7D@�B9I@B6:J�9FF<;E9:P6:J�67�A<@8�:<7�F<:796:�A6?@F76<:8�=<?�C8@�ND6FD�9?@�:@F@889?P�=<?�@==@F76:J�7D@�EC?E<8@�=<?ND6FD�7D@�E?<ACF7�68�6:7@:A@A�9:A�6=�F<;EB6@A�N67D>�7<J@7D@?�N67D�9:P�?@QC6?@;@:78�6;E<8@A�C:A@?�8@F76<:�KLM9RAS<=�7D68�767B@>�9?@�9A@QC97@�7<�E?<7@F7�D@9B7D�9:A�7D@�@:U6?<:;@:7G3W5�7D@�B9I@B�A<@8�:<7�F<:796:�9�N9?:6:J�<?�F9C76<:�8797@;@:7�ND6FD�;9P�I@�:@F@889?P�9:A�6=�F<;EB6@A�N67D>�7<J@7D@?N67D�9:P�?@QC6?@;@:78�6;E<8@A�C:A@?�8@F76<:�KLM9RAS�<=�7D68�767B@>�68�9A@QC97@�7<�E?<7@F7�D@9B7D�9:A�7D@�@:U6?<:;@:7G<?3X5�6:�7D@�F98@�<=�9�E@876F6A@�:<7�?@J687@?@A�6:�9FF<?A9:F@�N67D�8@F76<:�KLM9�<=�7D68�767B@�9:A�6:7@:A@A�=<?�@YE<?7>�7D@B9I@B�A<@8�:<7�F<:796:>�6:�N<?A8�E?<;6:@:7BP�EB9F@A�7D@?@<:�N67D�8CFD�F<:8E6FC<C8:@88�R98�F<;E9?@A�N67D�<7D@?N<?A8>�8797@;@:78>�A@86J:8>�<?�J?9ED6F�;977@?�6:�7D@�B9I@B6:JS�98�7<�?@:A@?�67�B6T@BP�7<�I@�:<7@A�IP�7D@�<?A6:9?P6:A6U6AC9B�C:A@?�FC87<;9?P�F<:A676<:8�<=�EC?FD98@�9:A�C8@>�7D@�=<BB<N6:JZ�[\<7�]@J687@?@A�=<?�8@�6:�7D@�:67@A_797@8�<=�;@?6F9ab3c5��E@876F6A@�68�;68I?9:A@A�6=dd3e5�7D@�B9I@B�A<@8�:<7�I@9?�9:�6:J?@A6@:7�8797@;@:7�<:�7D97�E9?7�<=�7D@�6;;@A697@�F<:796:@?�R9:A�<:�7D@�<C786A@F<:796:@?�<?�N?9EE@?�<=�7D@�?@796B�E9FT9J@>�6=�7D@?@�I@�<:@>�7D?<CJD�ND6FD�7D@�6:J?@A6@:7�8797@;@:7�<:�7D@�6;;@A697@F<:796:@?�F9::<7�I@�FB@9?BP�?@9AS�ND6FD�68�E?@8@:7@A�<?�A68EB9P@A�C:A@?�FC87<;9?P�F<:A676<:8�<=�EC?FD98@>�@YF@E77D97�9�E@876F6A@�68�:<7�;68I?9:A@A�C:A@?�7D68�8CIE9?9J?9ED�6=dd3f5�7D@�86g@�<?�=<?;�<=�7D@�6;;@A697@�F<:796:@?>�<?�7D@�<C786A@�F<:796:@?�<?�N?9EE@?�<=�7D@�?@796B�E9FT9J@>�;9T@867�6;E?9F76F9IB@�7<�EB9F@�7D@�6:J?@A6@:7�8797@;@:7�<:�7D@�E9?7�ND6FD�68�E?@8@:7@A�<?�A68EB9P@A�C:A@?�FC87<;9?PF<:A676<:8�<=�EC?FD98@G�9:A3ff5�7D@�6:J?@A6@:7�8797@;@:7�9EE@9?8�E?<;6:@:7BP�<:�9:<7D@?�E9?7�<=�7D@�6;;@A697@�F<:796:@?>�<?�<C786A@�F<:796:@?<?�N?9EE@?>�E@?;677@A�IP�7D@�A;6:687?97<?G3h5�7D@�B9I@B6:J�A<@8�:<7�F<:796:�9�8797@;@:7�<=�7D@�C8@�FB9886=6F976<:�C:A@?�ND6FD�7D@�E?<ACF7�68�?@J687@?@AGADD 006
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 70 of 139
����������� ����������������
���������������� !"#!$�%�&��'()*��#���$*+*�)(�,%-%�.�/!$��!�#�0�$1�% 2
345�67898�:;�<=6�>??:@8A�6=�:6;�B=<6>:<89C�><A�6=�678�=D6;:A8�B=<6>:<89�=9�E9>FF89�=?�678�986>:G�F>BH>I8C�:?�67898�J8=<8C�679=DI7�E7:B7�678�98KD:98A�:<?=9L>6:=<�=<�678�:LL8A:>68�B=<6>:<89�B><<=6�J8�BG8>9GM�98>AC�>�G>J8G�J8>9:<INN3O5�678�<>L8�><A�>AA98;;�=?�678�F9=ADB89C�98I:;69><6C�=9�F89;=<�?=9�E7=L�F9=ADB8AP3OO5�678�<>L8C�J9><AC�=9�69>A8L>9H�D<A89�E7:B7�678�F8;6:B:A8�:;�;=GAP3OOO5�678�<86�E8:I76�=9�L8>;D98�=?�678�B=<68<6C�8@B8F6�67>6�678�QAL:<:;69>6=9�L>M�F89L:6�98>;=<>JG8�R>9:>6:=<;P�><A3OS5�E78<�98KD:98A�JM�98IDG>6:=<�=?�678�QAL:<:;69>6=9�6=�8??8B6D>68�678�FD9F=;8;�=?�67:;�;DJB7>F689C�678�98I:;69>6:=<<DLJ89�>;;:I<8A�6=�678�F8;6:B:A8�D<A89�67:;�;DJB7>F689C�><A�678�D;8�BG>;;:?:B>6:=<P�><A3T5�678�F8;6:B:A8�B=<6>:<;�><M�;DJ;6><B8�=9�;DJ;6><B8;�:<�KD><6:6:8;�7:I7GM�6=@:B�6=�L><C�D<G8;;�678�G>J8G�;7>GG�J8>9C:<�>AA:6:=<�6=�><M�=6789�L>6689�98KD:98A�JM�67:;�;DJB7>F689NN3O5�678�;HDGG�><A�B9=;;J=<8;P3OO5�678�E=9A�UF=:;=<V�F9=L:<8<6GM�:<�98A�=<�>�J>BHI9=D<A�=?�A:;6:<B6GM�B=<69>;6:<I�B=G=9P�><A3OOO5�>�;6>68L8<6�=?�>�F9>B6:B>G�698>6L8<6�W?:9;6�>:A�=9�=6789E:;8X�:<�B>;8�=?�F=:;=<:<I�JM�678�F8;6:B:A8Y3Z5�[\] _a\b78�689L�U<8L>6=A8V�L8><;�:<R8968J9>68�><:L>G;�=?�678�F7MGDL�<8L>678GL:<678;�><A�BG>;;�<8L>6=A>C�67>6�:;CD<;8IL8<68A�9=D<A�E=9L;�E:67�8G=<I>68AC�?D;:?=9LC�=9�;>BG:H8�J=A:8;�B=R898A�E:67�BD6:BG8C�><A�:<7>J:6:<I�;=:GC�E>689CFG><6;C�=9�FG><6�F>96;P�L>M�>G;=�J8�B>GG8A�<8L>;�=9�88GE=9L;Y3c5�d\Zceb78�689L�UF89;=<V�L8><;�><M�:<A:R:AD>GC�F>96<89;7:FC�>;;=B:>6:=<C�B=9F=9>6:=<C�=9�><M�=9I><:f8A�I9=DF�=?�F89;=<;E786789�:<B=9F=9>68A�=9�<=6Y3_5�d\c_b78�689L�UF8;6V�L8><;�WgX�><M�:<;8B6C�9=A8<6C�<8L>6=A8C�?D<ID;C�E88AC�=9�WhX�><M�=6789�?=9L�=?�68998;69:>G�=9�>KD>6:BFG><6�=9�><:L>G�G:?8�=9�R:9D;C�J>B689:>C�=9�=6789�L:B9=N=9I><:;L�W8@B8F6�R:9D;8;C�J>B689:>C�=9�=6789�L:B9=N=9I><:;L;�=<�=9:<�G:R:<I�L><�=9�=6789�G:R:<I�><:L>G;X�E7:B7�678�QAL:<:;69>6=9�A8BG>98;�6=�J8�>�F8;6�D<A89�;8B6:=<�gijEWBXWgX�=?�67:;�6:6G8Y3k5�d\c_OlOa\ADD 007
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 71 of 139
����������� ����������������
���������������� !"#!$�%�&��'()*��#���$*+*�)(�,%-%�.�/!$��!�#�0�$1�% 2
345�6578�9:5;6<=<>5?�85@A;�BCD�@AE�;FG;6@A=5�H7�8<I6F75�HJ�;FG;6@A=5;�<A65A>5>�JH7�:75K5A6<ALM�>5;67HE<ALM�75:5NN<ALMH7�8<6<L@6<AL�@AE�:5;6M�BOD�@AE�;FG;6@A=5�H7�8<I6F75�HJ�;FG;6@A=5;�<A65A>5>�JH7�F;5�@;�@�:N@A6�75LFN@6H7M�>5JHN<@A6M�H7>5;<==@A6M�@A>�BPD�@AE�A<67HL5A�;6@G<N<Q57M�5I=5:6�64@6�645�6578�9:5;6<=<>5?�;4@NN�AH6�<A=NF>5�@AE�@76<=N5�64@6�<;�@�9A5R@A<8@N�>7FL?�R<64<A�645�85@A<AL�HJ�;5=6<HA�POCBRD�HJ�3<6N5�OCM�64@6�4@;�G55A�>56578<A5>�GE�645�S5=756@7E�HJ�T5@N64@A>�TF8@A�S57K<=5;�AH6�6H�G5�@�A5R�@A<8@N�>7FL�GE�@�75LFN@6<HA�5;6@GN<;4<AL�=HA><6<HA;�HJ�F;5�JH7�645�@76<=N5M�H7�64@6<;�@A�@A<8@N�J55>�R<64<A�645�85@A<AL�HJ�;5=6<HA�POCBID�HJ�3<6N5�OC�G5@7<AL�H7�=HA6@<A<AL�@�A5R�@A<8@N�>7FLU�345�65789:5;6<=<>5?�>H5;�AH6�<A=NF>5�N<VF<>�=458<=@N�;657<N@A6�:7H>F=6;�B<A=NF><AL�@AE�;657<N@A6�H7�;FGH7><A@65�><;<AJ5=6@A6�=N@<8;HA�;F=4�:7H>F=6;D�JH7�F;5�HA�@�=7<6<=@N�H7�;58<W=7<6<=@N�>5K<=5M�@;�>5J<A5>�<A�;5=6<HA�POC�HJ�3<6N5�OCU�XH7�:F7:H;5;�HJ�645:75=5><AL�;5A65A=5M�645�6578�9=7<6<=@N�>5K<=5?�<A=NF>5;�@AE�>5K<=5�R4<=4�<;�<A67H>F=5>�><75=6NE�<A6H�645�4F8@A�GH>EM5<6457�<A6H�H7�<A�=HA6@=6�R<64�645�GNHH>;675@8�H7�AH78@NNE�;657<N5�@75@;�HJ�645�GH>E�@A>�645�6578�9;58<W=7<6<=@N�>5K<=5?<A=NF>5;�@AE�>5K<=5�R4<=4�=HA6@=6;�<A6@=6�8F=HF;�858G7@A5;�GF6�R4<=4�>H5;�AH6�H7><A@7<NE�:5A567@65�645�GNHH>�G@77<57H7�H6457R<;5�5A657�AH78@NNE�;657<N5�@75@;�HJ�645�GH>EUYZ[�\]_�abcd]ea345�6578�9:N@A6�75LFN@6H7?�85@A;�@AE�;FG;6@A=5�H7�8<I6F75�HJ�;FG;6@A=5;�<A65A>5>M�647HFL4�:4E;<HNHL<=@N�@=6<HAM�JH7@==5N57@6<AL�H7�756@7><AL�645�7@65�HJ�L7HR64�H7�7@65�HJ�8@6F7@6<HAM�H7�JH7�H6457R<;5�@N657<AL�645�G54@K<H7�HJ�:N@A6;�H7�645:7H>F=5�64575HJM�GF6�;4@NN�AH6�<A=NF>5�;FG;6@A=5;�6H�645�5I65A6�64@6�645E�@75�<A65A>5>�@;�:N@A6�AF67<5A6;M�67@=5�5N585A6;MAF67<6<HA@N�=458<=@N;M�:N@A6�<AH=FN@A6;M�@A>�;H<N�@85A>85A6;U�fN;HM�645�6578�9:N@A6�75LFN@6H7?�;4@NN�AH6�G5�75VF<75>6H�<A=NF>5�@AE�HJ�;F=4�HJ�64H;5�AF67<5A6�8<I6F75;�H7�;H<N�@85A>85A6;�@;�@75�=H88HANE�gAHRA�@;�K<6@8<AW4H78HA54H76<=FN6F7@N�:7H>F=6;M�<A65A>5>�JH7�<8:7HK585A6M�8@<A65A@A=5M�;F7K<K@NM�45@N64M�@A>�:7H:@L@6<HA�HJ�:N@A6;M�@A>�@;�@75AH6�JH7�:5;6�>5;67F=6<HA�@A>�@75�AHA6HI<=M�AHA:H<;HAHF;�<A�645�FA><NF65>�:@=g@L5>�=HA=5A67@6<HAUYh[�\aeidjba�_i�kaeidjb345�6578�9:7H>F=57?�85@A;�645�:57;HA�R4H�8@AFJ@=6F75;M�:75:@75;M�=H8:HFA>;M�:7H:@L@65;M�H7�:7H=5;;5;�@AE�:5;6<=<>5H7�>5K<=5�H7�@=6<K5�<AL75><5A6�F;5>�<A�:7H>F=<AL�@�:5;6<=<>5U�345�6578�9:7H>F=5?�85@A;�6H�8@AFJ@=6F75M�:75:@75M=H8:HFA>M�:7H:@L@65M�H7�:7H=5;;�@AE�:5;6<=<>5�H7�>5K<=5�H7�@=6<K5�<AL75><5A6�F;5>�<A�:7H>F=<AL�@�:5;6<=<>5U�345�><NF6<HAGE�<A><K<>F@N;�HJ�JH78FN@65>�:5;6<=<>5;�JH7�645<7�HRA�F;5�@A>�@==H7><AL�6H�645�><75=6<HA;�HA�75L<;6575>�N@G5N;�;4@NN�AH6�HJ<6;5NJ�75;FN6�<A�;F=4�<A><K<>F@N;�G5<AL�<A=NF>5>�<A�645�>5J<A<6<HA�HJ�9:7H>F=57?�JH7�645�:F7:H;5;�HJ�64<;�;FG=4@:657UYl[�\aebj�mb]m�_i�mb�b_Znae_ob_345�6578;�9:7H65=6�45@N64�@A>�645�5AK<7HA85A6?�@A>�9:7H65=6<HA�HJ�45@N64�@A>�645�5AK<7HA85A6?�85@A�:7H65=6<HA�@L@<A;6@AE�FA75@;HA@GN5�@>K57;5�5JJ5=6;�HA�645�5AK<7HA85A6UYp[�qbcnra_345�6578�975L<;67@A6?�85@A;�@�:57;HA�R4H�4@;�75L<;6575>�@AE�:5;6<=<>5�:F7;F@A6�6H�645�:7HK<;<HA;�HJ�64<;�;FG=4@:657UYs[�qbcnra ne_345�6578�975L<;67@6<HA?�<A=NF>5;�7575L<;67@6<HAUY [�t^bADD 008
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 72 of 139
����������� ����������������
���������������� !"#!$�%�&��'()*��#���$*+*�)(�,%-%�.�/!$��!�#�0�$1�% �
234�5467�895:54;�74:<=�:�95:54>�534�?@=56@A5�BC�DBEF7G@:>�534�DB77B<H4:E53�BC�IF465B�J@AB>�534�K@6L@<�M=E:<N=>�OF:7>534�26F=5�2466@5B6P�BC�534�I:A@C@A�M=E:<N=>�:<N�Q746@A:<�9:7B:RSTTU�VWXYZ[\WZT]Y�Z_YX[Y�YYab[�\W�bcY�YW_dX\WeYWb234�5467�8F<64:=B<:GE4�:Nf46=4�4CC4A5=�B<�534�4<f@6B<74<5;�74:<=�ghi�:<P�F<64:=B<:GE4�6@=j�5B�7:<�B6�534�4<f@6B<74<5>5:j@<L�@<5B�:AABF<5�534�4AB<B7@A>�=BA@:E>�:<N�4<f@6B<74<5:E�AB=5=�:<N�G4<4C@5=�BC�534�F=4�BC�:<P�k4=5@A@N4>�B6�gli�:�3F7:<N@45:6P�6@=j�C6B7�64=@NF4=�53:5�64=FE5�C6B7�:�F=4�BC�:�k4=5@A@N4�@<�B6�B<�:<P�CBBN�@<AB<=@=54<5�H@53�534�=5:<N:6N�F<N46=4A5@B<�mno:�BC�2@5E4�lhR�234�QN7@<@=56:5B6�=3:EE�AB<=@N46�534�6@=j=�:<N�G4<4C@5=�BC�kFGE@A�34:E53�k4=5@A@N4=�=4k:6:54�C6B7534�6@=j=�:<N�G4<4C@5=�BC�B5346�k4=5@A@N4=R�M<�H4@L3@<L�:<P�64LFE:5B6P�:A5@B<�AB<A46<@<L�:�kFGE@A�34:E53�k4=5@A@N4�F<N4653@=�=FGA3:k546>�534�QN7@<@=56:5B6�=3:EE�H4@L3�:<P�6@=j=�BC�534�k4=5@A@N4�:L:@<=5�534�34:E53�6@=j=�=FA3�:=�534�N@=4:=4=56:<=7@554N�GP�534�f4A5B6�5B�G4�AB<56BEE4N�GP�534�k4=5@A@N4RSaaU�pYY234�5467�8H44N;�74:<=�:<P�kE:<5�H3@A3�L6BH=�H3464�<B5�H:<54NRS U�q[bZT]d[ceYWb234�5467�84=5:GE@=374<5;�74:<=�:<P�kE:A4�H3464�:�k4=5@A@N4�B6�N4f@A4�B6�:A5@f4�@<L64N@4<5�F=4N�@<�k6BNFA@<L�:�k4=5@A@N4@=�k6BNFA4N>�B6�34EN>�CB6�N@=56@GF5@B<�B6�=:E4RSYYU�r\�s[Y�ZWt�XYud[bYXY�vY[bdadY�dW�Z�eZWWYX�dWa\W[d[bYWb�wdbc�db[�]ZTY]dWu234�5467�85B�F=4�:<P�64L@=5464N�k4=5@A@N4�@<�:�7:<<46�@<AB<=@=54<5�H@53�@5=�E:G4E@<L;�74:<=�5B�F=4�:<P�64L@=5464N�k4=5@A@N4@<�:�7:<<46�<B5�k467@554N�GP�534�E:G4E@<L>�4xA4k5�53:5�534�5467�=3:EE�<B5�@<AEFN4�ghi�:kkEP@<L�:�k4=5@A@N4�:5�:<P�NB=:L4>AB<A4<56:5@B<>�B6�C64yF4<AP�E4==�53:<�53:5�=k4A@C@4N�B<�534�E:G4E@<L�F<E4==�534�E:G4E@<L�=k4A@C@A:EEP�k6B3@G@5=�N4f@:5@B<C6B7�534�=k4A@C@4N�NB=:L4>�AB<A4<56:5@B<>�B6�C64yF4<AP>�gli�:kkEP@<L�:�k4=5@A@N4�:L:@<=5�:<P�5:6L45�k4=5�<B5�=k4A@C@4NB<�534�E:G4E@<L�@C�534�:kkE@A:5@B<�@=�5B�534�A6Bk>�:<@7:E>�B6�=@54�=k4A@C@4N�B<�534�E:G4E@<L>�F<E4==�534�QN7@<@=56:5B6�3:=64yF@64N�53:5�534�E:G4E@<L�=k4A@C@A:EEP�=5:54�53:5�534�k4=5@A@N4�7:P�G4�F=4N�B<EP�CB6�534�k4=5=�=k4A@C@4N�B<�534�E:G4E@<L�:C546534�QN7@<@=56:5B6�3:=�N45467@<4N�53:5�534�F=4�BC�534�k4=5@A@N4�:L:@<=5�B5346�k4=5=�HBFEN�A:F=4�:<�F<64:=B<:GE4�:Nf46=44CC4A5�B<�534�4<f@6B<74<5>�gmi�47kEBP@<L�:<P�7453BN�BC�:kkE@A:5@B<�<B5�k6B3@G@54N�GP�534�E:G4E@<L�F<E4==�534�E:G4E@<L=k4A@C@A:EEP�=5:54=�53:5�534�k6BNFA5�7:P�G4�:kkE@4N�B<EP�GP�534�7453BN=�=k4A@C@4N�B<�534�E:G4E@<L>�gni�7@x@<L�:�k4=5@A@N4�B6k4=5@A@N4=�H@53�:�C465@E@z46�H34<�=FA3�7@x5F64�@=�<B5�k6B3@G@54N�GP�534�E:G4E@<L>�g{i�:<P�F=4�BC�:�k4=5@A@N4�@<�AB<CB67:<A4H@53�=4A5@B<�hmoA>�hmok>�B6�hmof�BC�53@=�5@5E4>�B6�goi�:<P�F=4�BC�:�k4=5@A@N4�@<�:�7:<<46�53:5�534�QN7@<@=56:5B6�N45467@<4=�5BG4�AB<=@=54<5�H@53�534�kF6kB=4=�BC�53@=�=FGA3:k546R�QC546�|:6A3�mh>�h}~}>�534�5467�=3:EE�<B5�@<AEFN4�534�F=4�BC�:�k4=5@A@N4CB6�:L6@AFE5F6:E�B6�CB64=56P�kF6kB=4=�:5�:�N@EF5@B<�E4==�53:<�E:G4E�NB=:L4�F<E4==�G4CB64�B6�:C546�53:5�N:54�534�QN7@<@=56:5B6@==F4=�:�64LFE:5@B<�B6�:Nf@=B6P�Bk@<@B<�AB<=@=54<5�H@53�534�=5FNP�k6Bf@N4N�CB6�@<�=4A5@B<�l~gGi�BC�534��4N46:E�I4=5@A@N4QA5�BC�h}~�>�H3@A3�64LFE:5@B<�B6�:Nf@=B6P�Bk@<@B<�=k4A@C@A:EEP�64yF@64=�534�F=4�BC�N4C@<@54�:7BF<5=�BC�N@EF5@B<RSU��sb[bZWdWu�ZbZ�XY�sdXYeYWbS�U��W�uYWYXZ]ADD 009
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 73 of 139
����������� ����������������
���������������� !"#!$�%�&��'()*��#���$*+*�)(�,%-%�.�/!$��!�#�0�$1�% 2
345�6578�9:;6<6=>?@>A�?=6=�75B;@7585>6C�85=><�=�75B;@7585>6�D:7�=>E�<6;?EF�@>D:78=6@:>F�:7�?=6=�64=6�@<�>5G5<<=7E6:�8=H5�=�?56578@>=6@:>�;>?57�<5G6@:>�IJK=LGMLNM�:D�64@<�6@6O5�=>?�P4@G4�<6;?EF�@>D:78=6@:>F�:7�?=6=QQRST�4=<�>:6�U55>�<;U8@665?�6:�645�V?8@>@<67=6:7W�:7RXT�@D�<;U8@665?�6:�645�V?8@>@<67=6:7F�645�V?8@>@<67=6:7�4=<�?56578@>5?�8;<6�U5�75<;U8@665?�U5G=;<5�@6�@<�>:6Y=O@?F�G:8ZO565F�:7�=?5B;=65�6:�8=H5�=�?56578@>=6@:>�;>?57�<5G6@:>�IJK=LGMLNM�:D�64@<�6@6O5�=>?�645�75A;O=6@:><�=>?A;@?5O@>5<�@<<;5?�;>?57�<;G4�<5G6@:>[R\T�]_abcd>�8=H@>A�=�?56578@>=6@:>�;>?57�Z=7=A7=Z4�LIMLeM�75<Z5G6@>A�=�<6;?EF�645�V?8@>@<67=6:7�<4=OO�5f=8@>5F�=6�=�8@>@8;8F75O5Y=>6�Z7:6:G:O<F�?:G;85>6=6@:>�:D�645�G:>?;G6�=>?�=>=OE<@<�:D�645�<6;?EF�=>?�645�75<;O6<�:D�645�<6;?E�6:�?56578@>5P456457�645�<6;?E�=>?�645�75<;O6<�:D�645�<6;?E�D;OD@OO�645�?=6=�75B;@7585>6�D:7�P4@G4�645�<6;?E�P=<�<;U8@665?�6:�645V?8@>@<67=6:7[RggT�ha�ijcbjklm�ab�cmnn345�6578�96:�?@<67@U;65�:7�<5OOC�85=><�6:�?@<67@U;65F�<5OOF�:DD57�D:7�<=O5F�4:O?�D:7�?@<67@U;6@:>F�4:O?�D:7�<=O5F�4:O?�D:7<4@Z85>6F�<4@ZF�?5O@Y57�D:7�<4@Z85>6F�75O5=<5�D:7�<4@Z85>6F�:7�75G5@Y5�=>?�L4=Y@>A�<:�75G5@Y5?M�?5O@Y57�:7�:DD57�6:�?5O@Y57[345�6578�?:5<�>:6�@>GO;?5�645�4:O?@>A�:7�=ZZO@G=6@:>�:D�75A@<6575?�Z5<6@G@?5<�:7�;<5�?@O;6@:><�64575:D�UE�=>E�=ZZO@G=6:7P4:�Z7:Y@?5<�=�<57Y@G5�:D�G:>67:OO@>A�Z5<6<�P@64:;6�?5O@Y57@>A�=>E�;>=ZZO@5?�Z5<6@G@?5�6:�=>E�Z57<:>�<:�<57Y5?[RooT�pjbagmq�ckjnjrmb345�6578�9>@67:A5>�<6=U@O@s57C�85=><�=>E�<;U<6=>G5�:7�8@f6;75�:D�<;U<6=>G5<�@>65>?5?�D:7�Z75Y5>6@>A�:7�4@>?57@>A�645Z7:G5<<�:D�>@67@D@G=6@:>F�?5>@67@D@G=6@:>F�=88:>@=�Y:O=6@O@s=6@:>F�:7�;75=<5�Z7:?;G6@:>�647:;A4�=G6@:>�;Z:>�<:@O�U=G657@=[t;G4�6578�<4=OO�>:6�@>GO;?5QQRuT�?@GE=>?@=8@?5WR\T�=88:>@;8�64@:<;OD=65W�:7RvT�=>E�<;U<6=>G5�:7�8@f6;75�:D�<;U<6=>G5<[IQQRST�64=6�P=<�>:6�75A@<6575?�Z;7<;=>6�6:�<5G6@:>�IJK=�:D�64@<�6@6O5�Z7@:7�6:�w=>;=7E�IF�IxxyW�=>?RXT�64=6�P=<�@>�G:8857G@=O�=A7:>:8@G�;<5�Z7@:7�6:�w=>;=7E�IF�IxxyF�P@64�75<Z5G6�6:�P4@G4�=D657�w=>;=7E�IF�IxxyF�645?@<67@U;6:7�:7�<5OO57�:D�645�<;U<6=>G5�:7�8@f6;75�4=<�8=?5�>:�<Z5G@D@G�GO=@8�:D�Z75Y5>6@:>�:7�4@>?57@>A�:D�645�Z7:G5<<:D�>@67@D@G=6@:>F�?5>@67@D@G=6@:>F�=88:>@=�Y:O=6@O@s=6@:>y�;75=<5�Z7:?;G6@:>�75A=7?O5<<�:D�645�=G6;=O�;<5�:7�Z;7Z:<5D:7F�:7�D;6;75�;<5�:7�Z;7Z:<5�D:7F�645�<;U<6=>G5�:7�8@f6;75[ADD 010
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 74 of 139
����������� ����������������
���������������� !"#!$�%�&��'()*��#���$*+*�)(�,%-%�.�/!$��!�#�0�$1�% ��
2343565738�6495�:7�6435;:4<8�;5=>:;59�3?�@5�8>@6:3359�3?�47A�23435�<5B:8<43:C5�?;�;5B><43?;A�4>3D?;:3AE�?;�;5=>:;59�@A8>FD�4>3D?;:3A�3?�@5�:7F<>959�:7�3D5�<4@5<:7B�?;�?3D5;�<:35;43>;5�4FF?6G47A:7B�47A�8>FD�8>@8347F5�?;�6:H3>;5�8D4<<�7?3@5�955659�4�8G5F:I:F�F<4:6�J:3D:7�3D5�6547:7B�?I�3D:8�8>@85F3:?7KLMMNO�PQRSTUSQSVU�QWWXRVQTYZ[D5�35;6�\64:735747F5�4GG<:F43?;]�65478�47A�:79:C:9>4<�JD?E�:7�3D5�G;:7F:G4<�F?>;85�?I�8>FD�:79:C:9>4<8�56G<?A6573E>858E�?;�8>G5;C:858�3D5�>85�?IE�4�G583:F:95�7?3�F<488:I:59�I?;�;583;:F359�>85�_?3D5;�3D47�4�;549A�3?�>85�F?78>65;G;?9>F38�G583:F:95a�I?;�3D5�G>;G?85�?I�G;?C:9:7B�83;>F3>;4<�G583�F?73;?<�?;�<4J7�G583�F?73;?<�:7F<>9:7B�b47:3?;8E�B575;4<64:735747F5�G5;8?775<E�847:343:?7�G5;8?775<E�479�B;?>798�64:735747F5�G5;8?775<K�[D5�35;6�\64:735747F5�4GG<:F43?;]9?58�7?3�:7F<>95�G;:C435�4GG<:F43?;8�48�95I:759�:7�8>@85F3:?7�_5_ca�:79:C:9>4<8�JD?�>85�473:6:F;?@:4<�G583:F:958E�847:3:d5;8?;�9:8:7I5F34738a�:79:C:9>4<8�56G<?A59�@A�e595;4<E�23435E�479�<?F4<�B?C5;765738�?;�47A�G?<:3:F4<�8>@9:C:8:?78�3D5;5?IE?;�:79:C:9>4<8�JD?�>85�G583:F:958�7?3�F<488:I:59�I?;�;583;:F359�>85�:7�?;�4;?>79�3D5:;�D?658E�@?438E�8?9�I4;68E�7>;85;:58EB;557D?>858E�?;�?3D5;�7?7F?665;F:4<�G;?G5;3AKLffN�gUZhRVU�TUViSRVRQS[D5�35;6�\85;C:F5�35FD7:F:47]�65478�47A�:79:C:9>4<�JD?�>858�?;�8>G5;C:858�3D5�>85�?I�G583:F:958�_?3D5;�3D47�4�;549A�3?�>85F?78>65;�G;?9>F38�G583:F:95�I?;�3D5�G>;G?85�?I�G;?C:9:7B�83;>F3>;4<�G583�F?73;?<�?;�<4J7�G583�F?73;?<�?7�3D5�G;?G5;3A�?I47?3D5;�I?;�4�I55K�[D5�35;6�\85;C:F5�35FD7:F:47]�9?58�7?3�:7F<>95�:79:C:9>4<8�JD?�>85�473:6:F;?@:4<�G583:F:958E�847:3:d5;8?;�9:8:7I5F34738a�?;�JD?�?3D5;J:85�4GG<A�;549A�3?�>85�F?78>65;�G;?9>F38�G583:F:958KLXXN�PRSYZ�jkU[D5�35;6�\6:7?;�>85]�65478�3D5�>85�?I�4�G583:F:95�?7�47�47:64<E�?7�4�F?665;F:4<�4B;:F><3>;4<�F;?G�?;�8:35E�?;�I?;�3D5G;?35F3:?7�?I�G>@<:F�D54<3D�JD5;5llLmN�3D5�3?34<�n7:359�234358�4F;54B5�I?;�3D5�F;?G�:8�<588�3D47�OooEooo�4F;58E�48�9535;6:759�@A�3D5�25F;534;A�?I�pB;:F><3>;5a?;LqN�3D5�p96:7:83;43?;E�:7�F?78><343:?7�J:3D�3D5�25F;534;A�?I�pB;:F><3>;5E�9535;6:758�3D43E�@4859�?7�:7I?;643:?7G;?C:959�@A�47�4GG<:F473�I?;�;5B:83;43:?7�?;�4�;5B:83;473E�3D5�>85�9?58�7?3�G;?C:95�8>II:F:573�5F?7?6:F�:7F573:C5�3?8>GG?;3�3D5�:7:3:4<�;5B:83;43:?7�?;�F?73:7>:7B�;5B:83;43:?7�?I�4�G583:F:95�I?;�8>FD�>85�479llLrN�3D5;5�4;5�:78>II:F:573�5II:F4F:?>8�4<35;743:C5�;5B:835;59�G583:F:958�4C4:<4@<5�I?;�3D5�>85aLsN�3D5�4<35;743:C58�3?�3D5�G583:F:95�>85�G?85�B;5435;�;:8t8�3?�3D5�57C:;?76573�?;�D>647�D54<3DaLuN�3D5�6:7?;�>85�G583:F:95�G<4A8�?;�J:<<�G<4A�4�8:B7:I:F473�G4;3�:7�6474B:7B�G583�;58:8347F5a�?;LvN�3D5�6:7?;�>85�G583:F:95�G<4A8�?;�J:<<�G<4A�4�8:B7:I:F473�G4;3�:7�47�:735B;4359�G583�6474B56573�G;?B;46KADD 011
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 75 of 139
����������� ����������������
���������������� !"#!$�%�&��'()*��#���$*+*�)(�,%-%�.�/!$��!�#�0�$1�% ��
234�567685�75�7�9:;<=�854�8;>4=�63:5�58?54@6:<;�537AA�@<;6:;84�75�A<;B�75�634�C>9:;:56=76<=�375�;<6�>464=9:;4>�6376D?754>�<;�4E:56:;B�>767D�58@3�854�97F�@7854�7;�8;=475<;7?A4�7>G4=54�4HH4@6�<;�634�4;G:=<;94;6�7;>�634�854�<634=I:54J87A:H:45�H<=�58@3�567685KLMMN�OPQRMRSTUVRWX�YZ[QRSR\ZL]N�P�_ZPZTWX234�64=9�7;6:9:@=<?:7A�a456:@:>4b�947;5�7�a456:@:>4�6376ccLON�:5�:;64;>4>�6<ccLRN�>:5:;H4@6D�57;:6:d4D�=4>8@4D�<=�9:6:B764�B=<I63�<=�>4G4A<a94;6�<H�9:@=<?:<A<B:@7A�<=B7;:595e�<=LRRN�a=<64@6�:;7;:9764�<?f4@65D�:;>856=:7A�a=<@45545�<=�5F56495D�58=H7@45D�I764=D�<=�<634=�@349:@7A�58?567;@45�H=<9@<;679:;76:<;D�H<8A:;BD�<=�>464=:<=76:<;�@7854>�?F�?7@64=:7D�G:=8545D�H8;B:D�a=<6<d<7D�7AB74D�<=�5A:94e�7;>LgN�:;�634�:;64;>4>�854�:5�4E49a6�H=<9D�<=�<634=I:54�;<6�58?f4@6�6<D�7�6<A4=7;@4�8;>4=�54@6:<;�hij7�<H�2:6A4�kl�<=�7H<<>�7>>:6:G4�=4B8A76:<;�8;>4=�54@6:<;�him�<H�2:6A4�klKLnN�opSXq\Z\�YTU\qSQ[234�64=9�7;6:9:@=<?:7A�a456:@:>4b�><45�;<6�:;@A8>4ccLON�7�I<<>�a=454=G76:G4�<=�7;6:H<8A:;B�a7:;6�a=<>8@6�H<=�I3:@3�7�@A7:9�<H�a456:@:>7A�7@6:G:6F�<634=�637;�<=�:;�7>>:6:<;6<�7;�7@6:G:6F�>45@=:?4>�:;�a7=7B=7a3�rls�:5�97>4eLgN�7;�7B=:@8A68=7A�H8;B:@:>4�a=<>8@6e�<=LtN�7;�7J876:@�34=?:@:>4�a=<>8@6KLuN�PSXq\Z\�YTU\qSQ[234�64=9�7;6:9:@=<?:7A�a456:@:>4b�><45�:;@A8>4�7;F�<634=�@349:@7A�564=:A7;6�a=<>8@6�r<634=�637;�A:J8:>�@349:@7A564=:A7;6�a=<>8@65�4E49a6�8;>4=�58?54@6:<;�r8ssD�7;F�<634=�>:5:;H4@67;6�a=<>8@6D�7;F�<634=�:;>856=:7A�9:@=<?:<@:>4a=<>8@6D�7;>�7;F�<634=�a=454=G76:G4�a=<>8@6�6376�:5�;<6�4E@A8>4>�?F�a7=7B=7a3�rksKLPPN�vqVXRS�wZWXQw�YZ[QRSR\ZADD 012
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 76 of 139
����������� ����������������
���������������� !"#!$�%�&��'()*��#���$*+*�)(�,%-%�.�/!$��!�#�0�$1�% ��
234�5467�89:;<=>�34?<53�94@5=>=A4B�74?C@�?CD�7=CE6�:@4�94@5=>=A4�96EA:>5�64F=@5464A�GE6�:@4�?CA�:@4A�964AE7=C?C5<D=C�9:;<=>�34?<53�96EF6?7@�GE6�H4>5E6�>EC56E<�E6�GE6�E5346�64>EFC=I4A�34?<53�96E54>5=EC�:@4@J�=C><:A=CF�534�964H4C5=EC�E67=5=F?5=EC�EG�H=6:@4@J�;?>546=?J�E6�E5346�7=>6EE6F?C=@7@�KE5346�53?C�H=6:@4@J�;?>546=?J�E6�E5346�7=>6EE6F?C=@7@�EC�E6�=C<=H=CF�7?C�E6�E5346�<=H=CF�?C=7?<L�53?5�9E@4�?�5364?5�5E�9:;<=>�34?<53MNOOP�QRSTOU234�5467�8H4>5E6B�74?C@�?CD�E6F?C=@7�>?9?;<4�EG�56?C@7=55=CF�534�>?:@?5=H4�?F4C5�EG�3:7?C�A=@4?@4�E6�>?9?;<4�EG96EA:>=CF�3:7?C�A=@>E7GE65�E6�=CV:6DJ�=C><:A=CF�7E@W:=5E4@J�G<=4@J�G<4?@J�>E>X6E?>34@J�E6�E5346�=C@4>5@�?CA�5=>X@J�7=54@JE6�6?5@M YZ[\]N_PK:C4�abJ�cdefJ�>M�cabJ�g�aJ�?@�?AA4A�h:;MiM�dajbckJ�g�aJ�l>5M�acJ�cdfaJ�mk�n5?5M�dfbo�?74CA4A�h:;MiM�dpjaqbJ�g�cpKGLJr4>M�amJ�cdfpJ�mf�n5?5M�dqpo�h:;MiM�dejceqJ�g�dJ�sEHM�amJ�cdfbJ�md�n5?5M�fbeo�h:;MiM�dbjpdkJ�g�cJ�n495M�pqJ�cdfmJ�da�n5?5Mmcdo�h:;MiM�cqqjbpaJ�2=5<4�tJ�g�cqcJ�2=5<4�utJ�g�kqcK?LJ�2=5<4�utttJ�g�mqcK?LJ�l>5M�abJ�cdmmJ�cqa�n5?5M�akbbJ�akffJ�akfdo�h:;MiMcqajapfJ�2=5<4�vJ�g�cqqkK?LKcLJ�KaLJ�K;LKpLKwLJ�KxLJ�r4>M�cpJ�cddcJ�cqb�n5?5M�cmdeJ�cmdbo�h:;MiM�cqejcfqJ�2=5<4�tJ�gg�cqbK?LJcaqJ�2=5<4�ttJ�gg�acqK?LJ�aacJ�apqJ�2=5<4�tttJ�g�pqeJ�w:FM�pJ�cddkJ�ccq�n5?5M�cedqJ�cedaJ�cedpJ�cbqaJ�cbqmJ�cbcaMLsE54@�EG�r4>=@=EC@�KdLyEE5CE54@c nE�=C�E6=F=C?<M�h6E;?;<D�@3E:<A�CE5�3?H4�?�946=EAMa nE�=C�E6=F=C?<M�h6E;?;<D�@3E:<A�;4�GE<<Ez4A�;D�8J�E6BMp nE�=C�E6=F=C?<M�sE�@:;@4>M�K==L�3?@�;44C�4C?>54AMf�{MnM|MwM�g�cpkJ�f�{n|w�g�cpk|:664C5�536E:F3�hMiM�ccbjceqM[}~�O��\OS��R}T ��aqcm�23E7@EC��4:546@M�sE�><?=7�5E�E6=F=C?<�{MnM��EH46C74C5��E6X@M
ADD 013
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 77 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ �
89:;<=�>;?;<@�AB=<�C99B;?;<=D:;E<�FG�CHI:JKE;KI<�LM<N@�O�C99B@PAQ?R;<I�SG�T9@<J;:J:=<@�?9=�U9V:IB9W<9;?E�X<@;:J:=<�AB9;IBE�LM<N@�O�C99B@P>KYJQ?R;<I�TTG�U9V:IB9W<9;?E�X<@;:J:=<�AB9;IBE�LM<N@�O�C99B@PF�8G>GAGCG�Z�[\S?Z�[\S?G�M<H:@;I?;:B9�BN�R<@;:J:=<@AKII<9;9<@@]_�abcdeafagh�ij�eakdlhehdigmnopqr�st�quvwxypy�z{�r|xt�t}zo|sqrpu~��v�qputv��x��s�{��rsrp��s{�yxtruxz}rp�vu�tp���rv�s�{�qputv��s�{�qptrxoxyp�r|sr�xt��vrup�xtrpupy�}�ypu�r|xt�t}zo|sqrpu���v�r|p�pnrp�r��popttsu{�rv�qupwp�r�}�upstv�sz�p�sywputp�p��port�v��r|p�p�wxuv��p�r~r|p��y�x�xtrusrvu��s{�z{�up�}�srxv���x�xr�r|p�yxtruxz}rxv�~�ts�p~�vu�}tp�x��s�{��rsrp�v��s�{�qptrxoxyp�r|sr�xt��vr�up�xtrpupy}�ypu�r|xt�t}zo|sqrpu�s�y�r|sr�xt��vr�r|p�t}z�por�v��s��pnqpux�p�rs��}tp�qpu�xr�}�ypu�tporxv�����o�v��r|xt�rxr�p�vu�s�p�pu�p�o{�pnp�qrxv��}�ypu�tporxv�����q�v��r|xt�rxr�p�]�_���af�hdigl��qptrxoxyp��|xo|�xt��vr�up�xtrpupy��xr|�r|p��y�x�xtrusrvu��s{�zp�rus�t�puupy�x���]�_�r|p�rus�t�pu�xt��uv��v�p�up�xtrpupy�ptrsz�xt|�p�r�rv�s�vr|pu�up�xtrpupy�ptrsz�xt|�p�r�vqpusrpy�z{�r|p�ts�p�quvy}oputv�p�{��vu�qso�s�x���sr�r|p�tpov�y�ptrsz�xt|�p�r�vu��vu�}tp�st�s�ov�trxr}p�r�qsur�v��s�vr|pu�qptrxoxyp�quvy}opy�sr�r|ptpov�y�ptrsz�xt|�p�r��vu]�_�r|p�rus�t�pu�xt�q}ut}s�r�rv�s�y�x��soovuys�op��xr|�r|p�up�}xup�p�rt�v��s��pnqpux�p�rs��}tp�qpu�xr�]�_��ei�a�cea�jie�eakdlhehdig]�_��hhafagh�eabcdea�mso|�sqq�xos�r��vu�up�xtrusrxv��v��s�qptrxoxyp�t|s����x�p��xr|�r|p��y�x�xtrusrvu�s�trsrp�p�r��|xo|�x�o�}ypt��]�_�r|p��s�p�s�y�syyuptt�v��r|p�sqq�xos�r�s�y�v��s�{�vr|pu�qputv���|vtp��s�p��x���sqqpsu�v��r|p��szp�x���]�_�r|p��s�p�v��r|p�qptrxoxyp�]�_�s�ov�q�prp�ovq{�v��r|p��szp�x���v��r|p�qptrxoxyp~�s�trsrp�p�r�v��s���o�sx�t�rv�zp��syp��vu�xr~�s�y�s�{�yxuporxv�t�vu�xrt�}tp�ADD 014
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 78 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ �
89:�;<=�>?@AB=;=�C?D@EBF�?C�;<=�A=G;H>HI=J8K:�F�D=LE=G;�;<F;�;<=�A=G;H>HI=�M=�>BFGGHCH=I�C?D�N=O=DFB�EG=�?D�C?D�D=G;DH>;=I�EG=P�?D�C?D�M?;<J�FOI8Q:�=R>=A;�FG�?;<=DSHG=�AD?THI=I�HO�AFDFNDFA<�UVWUXWP�HC�D=LE=G;=I�MY�;<=�ZI@HOHG;DF;?DP�F�CEBB�I=G>DHA;H?O�?C�;<=;=G;G�@FI=�FOI�;<=�D=GEB;G�;<=D=?C�EA?O�S<H><�;<=�>BFH@G�FD=�MFG=IP�?D�FB;=DOF;HT=BY�F�>H;F;H?O�;?�IF;F�;<F;�FAA=FDHO�;<=�AEMBH>�BH;=DF;ED=�?D�;<F;�AD=TH?EGBY�<FI�M==O�GEM@H;;=I�;?�;<=�ZI@HOHG;DF;?D�FOI�;<F;�;<=�ZI@HOHG;DF;?D�@FY>?OGHI=D�HO�F>>?DIFO>=�SH;<�;<=�C?BB?SHON�AD?THGH?OG[8\:�]H;<�D=GA=>;�;?�A=G;H>HI=G�>?O;FHOHON�F>;HT=�HOND=IH=O;G�;<F;�FD=�HOH;HFBBY�D=NHG;=D=I�EOI=D�;<HG�GEM><FA;=D�FC;=D=A;=@M=D�_P�abcdP�IF;F�GEM@H;;=I�;?�GEAA?D;�;<=�FAABH>F;H?O�C?D�;<=�?DHNHOFB�D=NHG;DF;H?O�?C�;<=�A=G;H>HI=P�?D�FOFAABH>F;H?O�C?D�FO�F@=OI@=O;�FIIHON�FOY�O=S�EG=�;?�;<=�D=NHG;DF;H?O�FOI�;<F;�A=D;FHOG�G?B=BY�;?�GE><�O=S�EG=PG<FBB�O?;P�SH;<?E;�;<=�SDH;;=O�A=D@HGGH?O�?C�;<=�?DHNHOFB�IF;F�GEM@H;;=DP�M=�>?OGHI=D=I�MY�;<=�ZI@HOHG;DF;?D�;?GEAA?D;�FO�FAABH>F;H?O�MY�FO?;<=D�A=DG?O�IEDHON�F�A=DH?I�?C�;=O�Y=FDG�C?BB?SHON�;<=�IF;=�;<=�ZI@HOHG;DF;?D�CHDG;D=NHG;=DG�;<=�A=G;H>HI=P�=R>=A;�;<F;�GE><�A=D@HGGH?O�G<FBB�O?;�M=�D=LEHD=I�HO�;<=�>FG=�?C�I=C=OGHT=�IF;Fe8\\:�f<=�A=DH?I�?C�=R>BEGHT=�IF;F�EG=�AD?THI=I�EOI=D�>BFEG=�UHW�G<FBB�M=�=R;=OI=I�a�FIIH;H?OFB�Y=FD�C?D�=F><�_�@HO?DEG=G�D=NHG;=D=I�FC;=D�ZENEG;�_P�abbgP�FOI�SH;<HO�c�Y=FDG�?C�;<=�>?@@=O>=@=O;�?C�;<=�=R>BEGHT=�EG=�A=DH?IP�EA�;?�F;?;FB�?C�_�FIIH;H?OFB�Y=FDG�C?D�FBB�@HO?D�EG=G�D=NHG;=D=I�MY�;<=�ZI@HOHG;DF;?D�HC�;<=�ZI@HOHG;DF;?DP�HO�>?OGEB;F;H?OSH;<�;<=�=>D=;FDY�?C�ZNDH>EB;ED=P�I=;=D@HO=G�;<F;P�MFG=I�?O�HOC?D@F;H?O�AD?THI=I�MY�FO�FAABH>FO;�C?D�D=NHG;DF;H?O?D�F�D=NHG;DFO;P�;<F;hh8i:�;<=D=�FD=�HOGECCH>H=O;�=CCH>F>H?EG�FB;=DOF;HT=�D=NHG;=D=I�A=G;H>HI=G�FTFHBFMB=�C?D�;<=�EG=J8ii:�;<=�FB;=DOF;HT=G�;?�;<=�@HO?D�EG=�A=G;H>HI=�A?G=�ND=F;=D�DHGjG�;?�;<=�=OTHD?O@=O;�?D�<E@FO�<=FB;<J8iii:�;<=�@HO?D�EG=�A=G;H>HI=�ABFYG�?D�SHBB�ABFY�F�GHNOHCH>FO;�AFD;�HO�@FOFNHON�A=G;�D=GHG;FO>=J�?D8ik:�;<=�@HO?D�EG=�A=G;H>HI=�ABFYG�?D�SHBB�ABFY�F�GHNOHCH>FO;�AFD;�HO�FO�HO;=NDF;=I�A=G;�@FOFN=@=O;�AD?NDF@ef<=�D=NHG;DF;H?O�?C�F�A=G;H>HI=�C?D�F�@HO?D�EG=�?O�F�>D?A�ND?EAHON�=G;FMBHG<=I�MY�;<=�ZI@HOHG;DF;?D�G<FBB�M=>?OGHI=D=I�C?D�AEDA?G=G�?C�;<HG�>BFEG=�a�@HO?D�EG=�C?D�=F><�D=AD=G=O;F;HT=�>D?A�C?D�S<H><�IF;F�FD=�AD?THI=IHO�;<=�>D?A�ND?EAHONe�ZOY�FIIH;H?OFB�=R>BEGHT=�EG=�A=DH?I�EOI=D�;<HG�>BFEG=�G<FBB�M=�@?IHCH=I�FG�FAAD?ADHF;=?D�;=D@HOF;=I�HC�;<=�D=NHG;DFO;�T?BEO;FDHBY�>FO>=BG�;<=�AD?IE>;�?D�I=B=;=G�CD?@�;<=�D=NHG;DF;H?O�;<=�@HO?DEG=G�S<H><�C?D@=I�;<=�MFGHG�C?D�;<=�=R;=OGH?O�?C�;<=�FIIH;H?OFB�=R>BEGHT=�EG=�A=DH?I�?D�HC�;<=�ZI@HOHG;DF;?DI=;=D@HO=G�;<F;�;<=�D=NHG;DFO;�HG�O?;�F>;EFBBY�@FDj=;HON�;<=�AD?IE>;�C?D�GE><�@HO?D�EG=Ge8\\\:�lR>=A;�FG�?;<=DSHG=�AD?THI=I�HO�>BFEG=�UHWP�SH;<�D=GA=>;�;?�IF;F�GEM@H;;=I�FC;=D�X=>=@M=D�_aP�abgbP�MY�FOFAABH>FO;�?D�D=NHG;DFO;�;?�GEAA?D;�FO�FAABH>F;H?O�C?D�D=NHG;DF;H?OP�=RA=DH@=O;FB�EG=�A=D@H;P�?D�F@=OI@=O;�FIIHONF�O=S�EG=�;?�FO�=RHG;HON�D=NHG;DF;H?OP�;?�GEAA?D;�?D�@FHO;FHO�HO�=CC=>;�FO�=RHG;HON�D=NHG;DF;H?OP�?D�C?D�D=D=NHG;DF;H?OP;<=�ZI@HOHG;DF;?D�@FYP�SH;<?E;�;<=�A=D@HGGH?O�?C�;<=�?DHNHOFB�IF;F�GEM@H;;=DP�>?OGHI=D�FOY�GE><�H;=@�?C�IF;F�HOGEAA?D;�?C�FO�FAABH>F;H?O�MY�FOY�?;<=D�A=DG?O�U<=D=HOFC;=D�HO�;<HG�GEMAFDFNDFA<�D=C=DD=I�;?�FG�;<=�mFAABH>FO;nWADD 015
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 79 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ 8
9:;<:=�;<>�?:?;>>=@A>BC�D>C:EF�?EGGE9:=H�;<>�FB;>�;<>�FB;B�9>C>�EC:H:=BGGA�IJKL:;;>F�E=GA�:?�;<>�BDDG:MB=;�<BI�LBF>B=�E??>C�;E�MELD>=IB;>�;<>�EC:H:=BG�FB;B�IJKL:;;>C�B=F�IJKL:;;>F�IJM<�E??>C�;E�;<>�NFL:=:I;CB;EC�BMMELDB=:>FKA�>O:F>=M>�E?�F>G:O>CA�;E�;<>�EC:H:=BG�FB;B�IJKL:;;>C�E?�;<>�E??>CP�Q<>�;>CLI�B=F�BLEJ=;�E?�MELD>=IB;:E=LBA�K>�?:R>F�KA�BHC>>L>=;�K>;9>>=�;<>�EC:H:=BG�FB;B�IJKL:;;>C�B=F�;<>�BDDG:MB=;S�ECS�?B:G:=H�IJM<�BHC>>L>=;SK:=F:=H�BCK:;CB;:E=�J=F>C�;<:I�IJKDBCBHCBD<P�T?S�B;�;<>�>=F�E?�=:=>;A�FBAI�B?;>C�;<>�FB;>�E?�F>G:O>CA�;E�;<>�EC:H:=BGFB;B�IJKL:;;>C�E?�;<>�E??>C�;E�MELD>=IB;>S�;<>�EC:H:=BG�FB;B�IJKL:;;>C�B=F�;<>�BDDG:MB=;�<BO>�=>:;<>C�BHC>>FE=�;<>�BLEJ=;�B=F�;>CLI�E?�MELD>=IB;:E=�=EC�E=�B�DCEM>FJC>�?EC�C>BM<:=H�B=�BHC>>L>=;�E=�;<>�BLEJ=;�B=F;>CLI�E?�MELD>=IB;:E=S�>:;<>C�D>CIE=�LBA�:=:;:B;>�K:=F:=H�BCK:;CB;:E=�DCEM>>F:=HI�KA�C>UJ>I;:=H�;<>�V>F>CBGW>F:B;:E=�B=F�XE=M:G:B;:E=�Y>CO:M>�;E�BDDE:=;�B=�BCK:;CB;EC�?CEL�;<>�CEI;>C�E?�BCK:;CB;ECI�LB:=;B:=>F�KA�IJM<Y>CO:M>P�Q<>�DCEM>FJC>�B=F�CJG>I�E?�;<>�Y>CO:M>�I<BGG�K>�BDDG:MBKG>�;E�;<>�I>G>M;:E=�E?�IJM<�BCK:;CB;EC�B=F�;EIJM<�BCK:;CB;:E=�DCEM>>F:=HIS�B=F�;<>�?:=F:=HI�B=F�F>;>CL:=B;:E=�E?�;<>�BCK:;CB;EC�I<BGG�K>�?:=BG�B=F�ME=MGJI:O>SB=F�=E�E??:M:BG�EC�MEJC;�E?�;<>�Z=:;>F�Y;B;>I�I<BGG�<BO>�DE9>C�EC�[JC:IF:M;:E=�;E�C>O:>9�B=A�IJM<�?:=F:=HI�B=FF>;>CL:=B;:E=S�>RM>D;�?EC�?CBJFS�L:IC>DC>I>=;B;:E=S�EC�E;<>C�L:IME=FJM;�KA�E=>�E?�;<>�DBC;:>I�;E�;<>�BCK:;CB;:E=EC�;<>�BCK:;CB;EC�9<>C>�;<>C>�:I�B�O>C:?:>F�MELDGB:=;�9:;<�IJDDEC;:=H�B??:FBO:;I�B;;>I;:=H�;E�ID>M:?:M�:=I;B=M>IE?�IJM<�?CBJFS�L:IC>DC>I>=;B;:E=S�EC�E;<>C�L:IME=FJM;P�Q<>�DBC;:>I�;E�;<>�BCK:;CB;:E=�I<BGG�I<BC>�>UJBGGA�:=�;<>DBAL>=;�E?�;<>�?>>�B=F�>RD>=I>I�E?�;<>�BCK:;CB;ECP�T?�;<>�NFL:=:I;CB;EC�F>;>CL:=>I�;<B;�B=�EC:H:=BG�FB;B�IJKL:;;>C<BI�?B:G>F�;E�DBC;:M:DB;>�:=�B�DCEM>FJC>�?EC�C>BM<:=H�B=�BHC>>L>=;�EC�:=�B=�BCK:;CB;:E=�DCEM>>F:=H�BI�C>UJ:C>FKA�;<:I�IJKDBCBHCBD<S�EC�?B:G>F�;E�MELDGA�9:;<�;<>�;>CLI�E?�B=�BHC>>L>=;�EC�BCK:;CB;:E=�F>M:I:E=�ME=M>C=:=HMELD>=IB;:E=�J=F>C�;<:I�IJKDBCBHCBD<S�;<>�EC:H:=BG�FB;B�IJKL:;;>C�I<BGG�?EC?>:;�;<>�C:H<;�;E�MELD>=IB;:E=�?EC;<>�JI>�E?�;<>�FB;B�:=�IJDDEC;�E?�;<>�BDDG:MB;:E=P�\E;9:;<I;B=F:=H�B=A�E;<>C�DCEO:I:E=�E?�;<:I�IJKM<BD;>CS�:?�;<>NFL:=:I;CB;EC�F>;>CL:=>I�;<B;�B=�BDDG:MB=;�<BI�?B:G>F�;E�DBC;:M:DB;>�:=�B�DCEM>FJC>�?EC�C>BM<:=H�B=�BHC>>L>=;�EC:=�B=�BCK:;CB;:E=�DCEM>>F:=H�BI�C>UJ:C>F�KA�;<:I�IJKDBCBHCBD<S�EC�?B:G>F�;E�MELDGA�9:;<�;<>�;>CLI�E?�B=�BHC>>L>=;EC�BCK:;CB;:E=�F>M:I:E=�ME=M>C=:=H�MELD>=IB;:E=�J=F>C�;<:I�IJKDBCBHCBD<S�;<>�NFL:=:I;CB;EC�I<BGG�F>=A�;<>BDDG:MB;:E=�EC�MB=M>G�;<>�C>H:I;CB;:E=�E?�;<>�D>I;:M:F>�:=�IJDDEC;�E?�9<:M<�;<>�FB;B�9>C>�JI>F�9:;<EJ;�?JC;<>C<>BC:=HP�]>?EC>�;<>�NFL:=:I;CB;EC�;B>I�BM;:E=�J=F>C�>:;<>C�E?�;<>�DC>M>F:=H�;9E�I>=;>=M>IS�;<>�NFL:=:I;CB;ECI<BGG�?JC=:I<�;E�;<>�B??>M;>F�D>CIE=S�KA�M>C;:?:>F�LB:GS�=E;:M>�E?�:=;>=;�;E�;B>�BM;:E=�B=F�BGGE9�?:?;>>=�FBAI�?CEL;<>�FB;>�E?�F>G:O>CA�E?�;<>�=E;:M>�?EC�;<>�B??>M;>F�D>CIE=�;E�C>IDE=FP�T?�B�C>H:I;CB;:E=�:I�F>=:>F�EC�MB=M>G>F�J=F>C;<:I�IJKDBCBHCBD<S�;<>�NFL:=:I;CB;EC�LBA�LB>�IJM<�ECF>C�BI�;<>�NFL:=:I;CB;EC�F>>LI�BDDCEDC:B;>�ME=M>C=:=H;<>�ME=;:=J>F�IBG>�B=F�JI>�E?�>R:I;:=H�I;EMI�E?�IJM<�D>I;:M:F>P�_>H:I;CB;:E=�BM;:E=�KA�;<>�NFL:=:I;CB;EC�I<BGG�=E;K>�F>GBA>F�D>=F:=H�;<>�?:R:=H�E?�MELD>=IB;:E=Pabc�N?;>C�>RD:CB;:E=�E?�B=A�D>C:EF�E?�>RMGJI:O>�JI>�B=F�B=A�D>C:EF�?EC�9<:M<�MELD>=IB;:E=�:I�C>UJ:C>F�?EC�;<>�JI>E?�B=�:;>L�E?�FB;B�J=F>C�MGBJI>I�d:eS�d::eS�B=F�d:::eS�;<>�NFL:=:I;CB;EC�LBA�ME=I:F>C�IJM<�:;>L�E?�FB;B�:=�IJDDEC;�E?B=�BDDG:MB;:E=�KA�B=A�E;<>C�BDDG:MB=;�9:;<EJ;�;<>�D>CL:II:E=�E?�;<>�EC:H:=BG�FB;B�IJKL:;;>C�B=F�9:;<EJ;�B=�E??>C<BO:=H�K>>=�C>M>:O>F�;E�MELD>=IB;>�;<>�EC:H:=BG�FB;B�IJKL:;;>C�?EC�;<>�JI>�E?�IJM<�:;>L�E?�FB;BPbc�Q<>�D>C:EF�E?�>RMGJI:O>�JI>�DCEO:F>F�J=F>C�MGBJI>�d::e�I<BGG�=E;�;B>�>??>M;�J=;:G�f�A>BC�B?;>C�NJHJI;�gS�fhhiS>RM>D;�9<>C>�B=�BDDG:MB=;�EC�C>H:I;CB=;�:I�BDDGA:=H�?EC�;<>�C>H:I;CB;:E=�E?�B�D>I;:M:F>�ME=;B:=:=H�B=�BM;:O>�:=HC>F:>=;=E;�DC>O:EJIGA�C>H:I;>C>FPbac�j:;<�C>ID>M;�;E�FB;B�IJKL:;;>F�B?;>C�NJHJI;�gS�fhhiS�KA�B=�BDDG:MB=;�EC�C>H:I;CB=;�;E�IJDDEC;�B=�BL>=FL>=;BFF:=H�B�=>9�JI>�;E�B=�>R:I;:=H�C>H:I;CB;:E=�;<B;�FE>I�=E;�C>;B:=�B=A�D>C:EF�E?�>RMGJI:O>�JI>S�:?�IJM<�FB;B�C>GB;>IIEG>GA�;E�B�L:=EC�JI>�E?�B�D>I;:M:F>S�IJM<�FB;B�I<BGG�=E;S�9:;<EJ;�;<>�9C:;;>=�D>CL:II:E=�E?�;<>�EC:H:=BG�FB;BIJKL:;;>CS�K>�ME=I:F>C>F�KA�;<>�NFL:=:I;CB;EC�;E�IJDDEC;�B=�BDDG:MB;:E=�?EC�B�L:=EC�JI>�KA�B=E;<>C�D>CIE=�FJC:=H;<>�D>C:EF�E?�fk�A>BCI�?EGGE9:=H�;<>�FB;>�E?�IJKL:II:E=�E?�IJM<�FB;BP�Q<>�BDDG:MB=;�EC�C>H:I;CB=;�B;�;<>�;:L>�;<>=>9�L:=EC�JI>�:I�C>UJ>I;>F�I<BGG�=E;:?A�;<>�NFL:=:I;CB;EC�;<B;�;E�;<>�K>I;�E?�;<>:C�=E9G>FH>�;<>�>RMGJI:O>�JI>D>C:EF�?EC�;<>�D>I;:M:F>�<BI�>RD:C>F�B=F�;<B;�;<>�FB;B�D>C;B:=:=H�IEG>GA�;E�;<>�L:=EC�JI>�E?�B�D>I;:M:F>�:I�>G:H:KG>ADD 016
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 80 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ 8
9:;�<=>�?;:@ABA:CB�:9�<=AB�?D;DE;D?=F�G9�<=>�HAC:;�IB>�;>EAB<;D<A:C�J=AK=�AB�BI??:;<>L�MN�LD<D�BIMHA<<>L�?I;BIDC<<:�<=AB�BIMB>K<A:C�AB�@:OIC<D;AON�KDCK>O>L�:;�A9�BIK=�LD<D�D;>�BIMB>PI>C<ON�IB>L�<:�BI??:;<�D�C:CHAC:;�IB>Q�<=>LD<D�B=DOO�C:�O:CE>;�M>�BIMR>K<�<:�<=>�>SKOIBA@>�IB>�?;:@ABA:CB�:9�<=AB�KODIB>�MI<�B=DOO�ACB<>DL�M>�K:CBAL>;>L�MN�<=>TLHACAB<;D<:;�AC�DKK:;LDCK>�JA<=�<=>�?;:@ABA:CB�:9�KODIB>�UAVQ�DB�D??;:?;AD<>FWXY�G9�<=>�D??OAKDC<�AB�;>PI>B<ACE�<=D<�<=>�;>EAB<;D<A:C�:;�DH>CLH>C<�<:�<=>�;>EAB<;D<A:C�:9�D�?>B<AKAL>�M>�>S?>LA<>LQDC�>S?ODCD<A:C�:9�<=>�MDBAB�9:;�<=>�;>PI>B<�HIB<�M>�BIMHA<<>LQ�AC�DKK:;LDCK>�JA<=�?D;DE;D?=�UZ[V�:9�<=AB�BIMB>K<A:CFW\Y�] _�a�bcddef_�eg�fhib_f_eaWjY�ka�ihahflm=>�TLHACAB<;D<:;�B=DOO�?IMOAB=�EIAL>OAC>B�B?>KA9NACE�<=>�nACLB�:9�AC9:;HD<A:C�J=AK=�JAOO�M>�;>PIA;>L�<:�BI??:;<<=>�;>EAB<;D<A:C�:9�D�?>B<AKAL>�DCL�B=DOO�;>@AB>�BIK=�EIAL>OAC>B�9;:H�<AH>�<:�<AH>F�G9�<=>;>D9<>;�<=>�TLHACAB<;D<:;;>PIA;>B�DCN�DLLA<A:CDO�nACL�:9�AC9:;HD<A:C�ICL>;�BIM?D;DE;D?=�UoV�:9�<=AB�?D;DE;D?=Q�<=>�TLHACAB<;D<:;�B=DOO?>;HA<�BI99AKA>C<�<AH>�9:;�D??OAKDC<B�<:�:M<DAC�BIK=�DLLA<A:CDO�AC9:;HD<A:CF�m=>�TLHACAB<;D<:;Q�AC�>B<DMOAB=ACEB<DCLD;LB�9:;�LD<D�;>PIA;>H>C<B�9:;�<=>�;>EAB<;D<A:C�:9�?>B<AKAL>B�JA<=�;>B?>K<�<:�HAC:;�IB>BQ�B=DOO�HDn>�BIK=B<DCLD;LB�K:HH>CBI;D<>�JA<=�<=>�DC<AKA?D<>L�>S<>C<�:9�IB>Q�?D<<>;C�:9�IB>Q�<=>�?IMOAK�=>DO<=�DCL�DE;AKIO<I;DO�C>>L9:;�BIK=�HAC:;�IB>Q�DCL�<=>�O>@>O�DCL�L>E;>>�:9�?:<>C<ADO�M>C>9AKADO�:;�DL@>;B>�>99>K<B�:C�HDC�DCL�<=>�>C@A;:CH>C<Fm=>�TLHACAB<;D<:;�B=DOO�C:<�;>PIA;>�D�?>;B:C�<:�BIMHA<Q�AC�;>OD<A:C�<:�D�;>EAB<;D<A:C�:;�;>;>EAB<;D<A:C�:9�D�?>B<AKAL>9:;�HAC:;�DE;AKIO<I;DO�IB>�ICL>;�<=AB�BIMK=D?<>;Q�DCN�9A>OL�;>BALI>�LD<D�9;:H�D�E>:E;D?=AK�D;>D�J=>;>�<=>�?>B<AKAL>JAOO�C:<�M>�;>EAB<>;>L�9:;�BIK=�IB>F�GC�<=>�L>@>O:?H>C<�:9�<=>B>�B<DCLD;LBQ�<=>�TLHACAB<;D<:;�B=DOO�K:CBAL>;�<=>>K:C:HAK�9DK<:;B�:9�?:<>C<ADO�CD<A:CDO�@:OIH>�:9�IB>Q�>S<>C<�:9�LAB<;AMI<A:CQ�DCL�<=>�AH?DK<�:9�<=>�K:B<�:9�H>><ACE<=>�;>PIA;>H>C<B�:C�<=>�ACK>C<A@>B�9:;�DCN�?:<>C<ADO�;>EAB<;DC<�<:�ICL>;<Dn>�<=>�L>@>O:?H>C<�:9�<=>�;>PIA;>L�LD<DFpSK>?<�DB�?;:@AL>L�MN�B>K<A:C�Zqr=�:9�<=AB�<A<O>Q�JA<=AC�q[�LDNB�D9<>;�<=>�TLHACAB<;D<:;�;>EAB<>;B�D�?>B<AKAL>�ICL>;<=AB�BIMK=D?<>;�<=>�TLHACAB<;D<:;�B=DOO�HDn>�D@DAODMO>�<:�<=>�?IMOAK�<=>�LD<D�KDOO>L�9:;�AC�<=>�;>EAB<;D<A:C�B<D<>H>C<<:E><=>;�JA<=�BIK=�:<=>;�BKA>C<A9AK�AC9:;HD<A:C�DB�<=>�TLHACAB<;D<:;�L>>HB�;>O>@DC<�<:�<=>�TLHACAB<;D<:;sB�L>KABA:CFWtY�juu_eal�u_WY�G9�<=>�TLHACAB<;D<:;�L><>;HAC>B�<=D<�DLLA<A:CDO�LD<D�D;>�;>PIA;>L�<:�HDAC<DAC�AC�>99>K<�DC�>SAB<ACE�;>EAB<;D<A:C�:9D�?>B<AKAL>Q�<=>�TLHACAB<;D<:;�B=DOO�C:<A9N�DOO�>SAB<ACE�;>EAB<;DC<B�:9�<=>�?>B<AKAL>�<:�J=AK=�<=>�L><>;HACD<A:C�;>OD<>BDCL�?;:@AL>�D�OAB<�:9�BIK=�;>EAB<;DC<B�<:�DCN�AC<>;>B<>L�?>;B:CFWY�pDK=�;>EAB<;DC<�:9�BIK=�?>B<AKAL>�B=DOO�?;:@AL>�>@AL>CK>�JA<=AC�CAC><N�LDNB�D9<>;�;>K>A?<�:9�C:<A9AKD<A:C�<=D<�A<AB�<DnACE�D??;:?;AD<>�B<>?B�<:�B>KI;>�<=>�DLLA<A:CDO�LD<D�<=D<�D;>�;>PIA;>LF�mJ:�:;�H:;>�;>EAB<;DC<B�HDN�DE;>>�<:L>@>O:?�R:AC<ONQ�:;�<:�B=D;>�AC�<=>�K:B<�:9�L>@>O:?ACEQ�BIK=�LD<D�A9�<=>N�DE;>>�DCL�DL@AB>�<=>�TLHACAB<;D<:;�:9�<=>A;AC<>C<�JA<=AC�CAC><N�LDNB�D9<>;�C:<A9AKD<A:CF�TCN�;>EAB<;DC<�J=:�DE;>>B�<:�B=D;>�AC�<=>�K:B<�:9�?;:LIKACE�<=>�LD<D�B=DOOM>�>C<A<O>L�<:�>SDHAC>�DCL�;>ON�I?:C�BIK=�LD<D�AC�BI??:;<�:9�HDAC<>CDCK>�:9�BIK=�;>EAB<;D<A:CF�m=>�TLHACAB<;D<:;B=DOO�ABBI>�D�C:<AK>�:9�AC<>C<�<:�BIB?>CL�<=>�;>EAB<;D<A:C�:9�D�?>B<AKAL>�AC�DKK:;LDCK>�JA<=�<=>�?;:K>LI;>B�?;>BK;AM>LMN�KODIB>�UA@V�A9�D�;>EAB<;DC<�9DAOB�<:�K:H?ON�JA<=�<=AB�KODIB>FWY�G9Q�D<�<=>�>CL�:9�BAS<N�LDNB�D9<>;�DL@ABACE�<=>�TLHACAB<;D<:;�:9�<=>A;�DE;>>H>C<�<:�L>@>O:?�R:AC<ONQ�:;�B=D;>�AC�<=>K:B<�:9�L>@>O:?ACEQ�LD<DQ�<=>�;>EAB<;DC<B�=D@>�C:<�9I;<=>;�DE;>>L�:C�<=>�<>;HB�:9�<=>�LD<D�L>@>O:?H>C<�D;;DCE>H>C<ADD 017
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 81 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ 8
9:�9;�<�=:9>?@A:?�B9:�:?<>CD;E�FA>C�<E:??G?;HI�<;J�9B�FA>C�:?EDFH:<;HF�G<J�D;DHD<H?�KD;@D;E�<:KDH:<HD9;�=:9>??@D;EFKJ�:?LA?FHD;E�HC?�M?@?:<N�O?@D<HD9;�<;@�P9;>DND<HD9;�Q?:RD>?�H9�<==9D;H�<;�<:KDH:<H9:�B:9G�HC?�:9FH?:�9B�<:KDH:<H9:FG<D;H<D;?@�KJ�FA>C�Q?:RD>?S�TC?�=:9>?@A:?�<;@�:AN?F�9B�HC?�Q?:RD>?�FC<NN�K?�<==ND><KN?�H9�HC?�F?N?>HD9;�9B�FA>C<:KDH:<H9:�<;@�H9�FA>C�<:KDH:<HD9;�=:9>??@D;EFI�<;@�HC?�BD;@D;EF�<;@�@?H?:GD;<HD9;�9B�HC?�<:KDH:<H9:�FC<NN�K?�BD;<N�<;@>9;>NAFDR?I�<;@�;9�9BBD>D<N�9:�>9A:H�9B�HC?�U;DH?@�QH<H?F�FC<NN�C<R?�=9V?:�9:�WA:DF@D>HD9;�H9�:?RD?V�<;J�FA>C�BD;@D;EF<;@�@?H?:GD;<HD9;I�?X>?=H�B9:�B:<A@I�GDF:?=:?F?;H<HD9;I�9:�9HC?:�GDF>9;@A>H�KJ�9;?�9B�HC?�=<:HD?F�H9�HC?�<:KDH:<HD9;9:�HC?�<:KDH:<H9:�VC?:?�HC?:?�DF�<�R?:DBD?@�>9G=N<D;H�VDHC�FA==9:HD;E�<BBD@<RDHF�<HH?FHD;E�H9�F=?>DBD>�D;FH<;>?F�9B�FA>CB:<A@I�GDF:?=:?F?;H<HD9;I�9:�9HC?:�GDF>9;@A>HS�YNN�=<:HD?F�H9�HC?�<:KDH:<HD9;�FC<NN�FC<:?�?LA<NNJ�D;�HC?�=<JG?;H�9BHC?�B??�<;@�?X=?;F?F�9B�HC?�<:KDH:<H9:S�TC?�Y@GD;DFH:<H9:�FC<NN�DFFA?�<�;9HD>?�9B�D;H?;H�H9�FAF=?;@�HC?�:?EDFH:<HD9;�9B<�=?FHD>D@?�D;�<>>9:@<;>?�VDHC�HC?�=:9>?@A:?F�=:?F>:DK?@�KJ�>N<AF?�ZDR[�DB�<�:?EDFH:<;H�B<DNF�H9�>9G=NJ�VDHC�HCDF�>N<AF?S\]_�9HVDHCFH<;@D;E�<;J�9HC?:�=:9RDFD9;�9B�HCDF�FAK>C<=H?:I�DB�HC?�Y@GD;DFH:<H9:�@?H?:GD;?F�HC<H�<�:?EDFH:<;HIVDHCD;�HC?�HDG?�:?LAD:?@�KJ�HC?�Y@GD;DFH:<H9:I�C<F�B<DN?@�H9�H<a?�<==:9=:D<H?�FH?=F�H9�F?>A:?�HC?�@<H<�:?LAD:?@A;@?:�HCDF�FAK=<:<E:<=CI�H9�=<:HD>D=<H?�D;�<�=:9>?@A:?�B9:�:?<>CD;E�<E:??G?;H�>9;>?:;D;E�<�W9D;H�@<H<�@?R?N9=G?;H<::<;E?G?;H�A;@?:�HCDF�FAK=<:<E:<=C�9:�D;�<;�<:KDH:<HD9;�=:9>??@D;E�<F�:?LAD:?@�KJ�HCDF�FAK=<:<E:<=CI�9:�H9�>9G=NJVDHC�HC?�H?:GF�9B�<;�<E:??G?;H�9:�<:KDH:<HD9;�@?>DFD9;�>9;>?:;D;E�<�W9D;H�@<H<�@?R?N9=G?;H�<::<;E?G?;H�A;@?:HCDF�FAK=<:<E:<=CI�HC?�Y@GD;DFH:<H9:�G<J�DFFA?�<�;9HD>?�9B�D;H?;H�H9�FAF=?;@�FA>C�:?EDFH:<;HbF�:?EDFH:<HD9;�9B�HC?=?FHD>D@?�B9:�VCD>C�<@@DHD9;<N�@<H<�DF�:?LAD:?@S�TC?�Y@GD;DFH:<H9:�G<J�D;>NA@?�D;�HC?�;9HD>?�9B�D;H?;H�H9�FAF=?;@FA>C�=:9RDFD9;F�<F�HC?�Y@GD;DFH:<H9:�@??GF�<==:9=:D<H?�>9;>?:;D;E�HC?�>9;HD;A?@�F<N?�<;@�AF?�9B�?XDFHD;E�FH9>aF9B�FA>C�=?FHD>D@?S�Y;J�FAF=?;FD9;�=:9=9F?@�A;@?:�HCDF�FAK=<:<E:<=C�FC<NN�K?>9G?�BD;<N�<;@�?BB?>HDR?�<H�HC?�?;@�9BHCD:HJ�@<JF�B:9G�:?>?D=H�KJ�HC?�:?EDFH:<;H�9B�HC?�;9HD>?�9B�D;H?;H�H9�FAF=?;@I�A;N?FF�@A:D;E�HC<H�HDG?�<�:?LA?FH�B9:C?<:D;E�DF�G<@?�KJ�<�=?:F9;�<@R?:F?NJ�<BB?>H?@�KJ�HC?�;9HD>?�9:�HC?�:?EDFH:<;H�C<F�F<HDFBD?@�HC?�Y@GD;DFH:<H9:�HC<HHC?�:?EDFH:<;H�C<F�>9G=ND?@�BANNJ�VDHC�HC?�:?LAD:?G?;HF�HC<H�F?:R?@�<F�<�K<FDF�B9:�HC?�;9HD>?�9B�D;H?;H�H9�FAF=?;@ScB�<�C?<:D;E�DF�:?LA?FH?@I�<�C?<:D;E�FC<NN�K?�>9;@A>H?@�A;@?:�F?>HD9;�def@Z@[�9B�HCDF�HDHN?S�TC?�9;NJ�G<HH?:F�B9::?F9NAHD9;�<H�HC<H�C?<:D;E�FC<NN�K?�VC?HC?:�HC?�:?EDFH:<;H�C<F�B<DN?@�H9�H<a?�HC?�<>HD9;�HC<H�F?:R?@�<F�HC?�K<FDF�B9:�HC?;9HD>?�9B�D;H?;H�H9�FAF=?;@�HC?�:?EDFH:<HD9;�9B�HC?�=?FHD>D@?�B9:�VCD>C�<@@DHD9;<N�@<H<�DF�:?LAD:?@I�<;@�VC?HC?:�HC?Y@GD;DFH:<H9:bF�@?H?:GD;<HD9;�VDHC�:?F=?>H�H9�HC?�@DF=9FDHD9;�9B�?XDFHD;E�FH9>aF�DF�>9;FDFH?;H�VDHC�HCDF�FAK>C<=H?:S�cB<�C?<:D;E�DF�C?N@I�<�@?>DFD9;�<BH?:�>9G=N?HD9;�9B�FA>C�C?<:D;E�FC<NN�K?�BD;<NS�9HVDHCFH<;@D;E�<;J�9HC?:�=:9RDFD9;�9BHCDF�FAK>C<=H?:I�<�C?<:D;E�FC<NN�K?�C?N@�<;@�<�@?H?:GD;<HD9;�G<@?�VDHCD;�F?R?;HJgBDR?�@<JF�<BH?:�:?>?D=H�9B�<�:?LA?FHB9:�FA>C�C?<:D;ES�Y;J�:?EDFH:<HD9;�FAF=?;@?@�A;@?:�HCDF�FAK=<:<E:<=C�FC<NN�K?�:?D;FH<H?@�KJ�HC?�Y@GD;DFH:<H9:�DBHC?�Y@GD;DFH:<H9:�@?H?:GD;?F�HC<H�HC?�:?EDFH:<;H�C<F�>9G=ND?@�BANNJ�VDHC�HC?�:?LAD:?G?;HF�HC<H�F?:R?@�<F�<�K<FDF�B9:HC?�FAF=?;FD9;�9B�HC?�:?EDFH:<HD9;S\_�Y;J�@<H<�FAKGDHH?@�A;@?:�HCDF�FAK=<:<E:<=C�FC<NN�K?�FAKW?>H�H9�HC?�=:9RDFD9;F�9B�=<:<E:<=C�Zd[Zh[S�iC?;?R?:FA>C�@<H<�<:?�FAKGDHH?@�W9D;HNJ�KJ�HV9�9:�G9:?�:?EDFH:<;HFI�<;�<E?;H�FC<NN�K?�<E:??@�9;�<H�HC?�HDG?�9B�HC?�W9D;HFAKGDFFD9;�H9�C<;@N?�<;J�FAKF?LA?;H�@<H<�>9G=?;F<HD9;�G<HH?:F�B9:�HC?�W9D;H�FAKGDHH?:F�9B�FA>C�@<H<S\]_�U=9;�HC?�:?LA?FH�9B�<�:?EDFH:<;H�HC?�Y@GD;DFH:<H9:�FC<NNI�D;�HC?�><F?�9B�<�GD;9:�AF?I�?XH?;@�HC?�@?<@ND;?�B9:�HC?=:9@A>HD9;�9B�:?FD@A?�>C?GDFH:J�@<H<�A;@?:�HCDF�FAK=<:<E:<=C�B9:�@<H<�:?LAD:?@�F9N?NJ�H9�FA==9:H�HC<H�GD;9:�AF?A;HDN�HC?�BD;<N�@?<@ND;?�B9:�FAKGDFFD9;�9B�@<H<�A;@?:�F?>HD9;�def<gd�9B�HCDF�HDHN?�B9:�HC?�9HC?:�AF?F�9B�HC?�=?FHD>D@??FH<KNDFC?@�<F�9B�YAEAFH�eI�djjfI�DBgg\k_�HC?�@<H<�H9�FA==9:H�9HC?:�AF?F�9B�HC?�=?FHD>D@?�9;�<�B99@�<:?�K?D;E�=:9RD@?@lADD 018
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 82 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ 8
9::;�<=>�?>@AB<?CD<E�AD�BFGHA<<AD@�C�?>IF>B<�JK?�BFL=�CD�>M<>DBAKDE�N?KOAP>B�C�BL=>PFQ>E�ADLQFPAD@�AD<>?AH�PC<>B�<KH>CBF?>�N?K@?>BBE�<K�CBBF?>�<=C<�<=>�PC<C�N?KPFL<AKD�RAQQ�G>�LKHNQ><>P�G>JK?>�<=>�>MNA?C<AKD�KJ�<=>�>M<>DBAKDN>?AKPS9:::;�<=>�TPHADAB<?C<K?�=CB�P><>?HAD>P�<=C<�BFL=�>M<>DBAKD�RAQQ�DK<�BA@DAJALCD<QU�P>QCU�<=>�TPHADAB<?C<K?VBBL=>PFQ>�JK?�ABBFAD@�C�?>?>@AB<?C<AKD�>QA@AGAQA<U�P><>?HADC<AKD�?>IFA?>P�FDP>?�B>L<AKD�WXYCZW�KJ�<=AB�<A<Q>S�CDP9:[;�<=>�TPHADAB<?C<K?�=CB�P><>?HAD>P�<=C<�GCB>P�KD�>MAB<AD@�PC<CE�BFL=�>M<>DBAKD�RKFQP�DK<�BA@DAJALCD<QU�ADL?>CB><=>�?AB\�KJ�CDU�FD?>CBKDCGQ>�CPO>?B>�>JJ>L<�KD�<=>�>DOA?KDH>D<]�J�<=>�TPHADAB<?C<K?�@?CD<B�CD�>M<>DBAKD�FDP>?<=AB�LQCFB>E�<=>�TPHADAB<?C<K?�B=CQQ�HKDA<K?�<=>�P>O>QKNH>D<�KJ�<=>�PC<C�CDP�B=CQQ�>DBF?>�<=C<�<=>�?>@AB<?CD<�ABH>><AD@�<=>�BL=>PFQ>�JK?�<=>�N?KPFL<AKD�KJ�<=>�PC<C]�J�<=>�TPHADAB<?C<K?�P><>?HAD>B�<=C<�<=>�?>@AB<?CD<�AB�DK<H>><AD@�K?�=CB�DK<�H><�<=>�BL=>PFQ>�JK?�<=>�N?KPFL<AKD�KJ�BFL=�PC<CE�<=>�TPHADAB<?C<K?�HCU�N?KL>>P�AD�CLLK?PCDL>RA<=�LQCFB>�_AO�?>@C?PAD@�<=>�LKD<ADF>P�?>@AB<?C<AKD�KJ�<=>�CJJ>L<>P�N?KPFL<B�RA<=�<=>�HADK?�FB>�CDP�B=CQQ�ADJK?H<=>�NFGQAL�KJ�BFL=�CL<AKD]�aK<RA<=B<CDPAD@�<=>�N?KOABAKDB�KJ�<=AB�LQCFB>E�<=>�TPHADAB<?C<K?�HCU�<C\>�CL<AKD�<KHKPAJU�K?�?>OK\>�<=>�>M<>DBAKD�FDP>?�<=AB�LQCFB>�AJ�<=>�TPHADAB<?C<K?�P><>?HAD>B�<=C<�<=>�>M<>DBAKD�JK?�<=>�HADK?FB>�HCU�LCFB>�CD�FD?>CBKDCGQ>�CPO>?B>�>JJ>L<�KD�<=>�>DOA?KDH>D<]�D�BFL=�LA?LFHB<CDL>E�<=>�TPHADAB<?C<K?�B=CQQN?KOAP>E�AD�R?A<AD@�<K�<=>�?>@AB<?CD<E�C�DK<AL>�?>OK\AD@�<=>�>M<>DBAKD�KJ�<AH>�JK?�BFGHABBAKD�KJ�PC<C]�bFL=�PC<CB=CQQ�ADB<>CP�G>�PF>�AD�CLLK?PCDL>�RA<=�<=>�PC<>�>B<CGQAB=>P�GU�<=>�TPHADAB<?C<K?�JK?�<=>�BFGHABBAKD�KJ�<=>�PC<C]9cdd;�J�<=>�?>@AB<?CD<�PK>B�DK<�LKHHA<�<K�BFNNK?<�C�BN>LAJAL�HADK?�FB>�KJ�<=>�N>B<ALAP>E�GF<�AB�BFNNK?<AD@�CDP�N?KOAPAD@PC<C�AD�C�<AH>QU�CDP�CP>IFC<>�JCB=AKD�<K�BFNNK?<�FB>B�KJ�<=>�N>B<ALAP>�KD�C�JKKPE�K?�AJ�CQQ�FB>B�KJ�<=>�N>B<ALAP>�C?>DKDJKKP�FB>B�CDP�<=>�?>@AB<?CD<�PK>B�DK<�LKHHA<�<K�BFNNK?<�C�BN>LAJAL�HADK?�FB>�KJ�<=>�N>B<ALAP>�GF<�AB�BFNNK?<AD@�CDPN?KOAPAD@�PC<C�AD�C�<AH>QU�CDP�CP>IFC<>�JCB=AKD�<K�BFNNK?<�K<=>?�DKDJKKP�FB>B�KJ�<=>�N>B<ALAP>E�<=>�TPHADAB<?C<K?E�C<<=>�R?A<<>D�?>IF>B<�KJ�<=>�?>@AB<?CD<E�B=CQQ�DK<�<C\>�CDU�CL<AKD�NF?BFCD<�<K�<=AB�LQCFB>�AD�?>@C?P�<K�BFL=�FDBFNNK?<>PHADK?�FB>�FD<AQ�<=>�JADCQ�P>CPQAD>�>B<CGQAB=>P�CB�KJ�TF@FB<�XE�WeeYE�JK?�<=>�BFGHABBAKD�KJ�PC<C�FDP>?�B>L<AKD�WXYCZWKJ�<=AB�<A<Q>�JK?�<=>�BFNNK?<>P�FB>B�AP>D<AJA>P�NF?BFCD<�<K�<=AB�LQCFB>�FDQ>BB�<=>�TPHADAB<?C<K?�P><>?HAD>B�<=C<�<=>CGB>DL>�KJ�<=>�PC<C�AB�BA@DAJALCD<�>DKF@=�<K�LCFB>�=FHCD�=>CQ<=�K?�>DOA?KDH>D<CQ�LKDL>?DB]�fD�<=>�GCBAB�KJ�BFL=P><>?HADC<AKDE�<=>�TPHADAB<?C<K?�HCU�?>JFB>�<=>�?>IF>B<�JK?�>M<>DBAKD�GU�<=>�?>@AB<?CD<]�gNKD�?>L>AN<�KJ�<=>�?>IF>B<J?KH�<=>�?>@AB<?CD<E�<=>�TPHADAB<?C<K?�B=CQQ�NFGQAB=�AD�<=>�h>P>?CQ�i>@AB<>?�C�DK<AL>�KJ�<=>�?>L>AN<�KJ�<=>�?>IF>B<�CDP<=>�>JJ>L<AO>�PC<>�FNKD�R=AL=�<=>�FB>B�DK<�G>AD@�BFNNK?<>P�RAQQ�G>�OKQFD<C?AQU�P>Q><>P�J?KH�<=>�?>@AB<?C<AKD�NF?BFCD<<K�B>L<AKD�WXYP_J_W�KJ�<=AB�<A<Q>]�J�<=>�TPHADAB<?C<K?�@?CD<B�CD�>M<>DBAKD�FDP>?�<=AB�LQCFB>E�<=>�TPHADAB<?C<K?�B=CQQHKDA<K?�<=>�P>O>QKNH>D<�KJ�<=>�PC<C�JK?�<=>�FB>B�G>AD@�BFNNK?<>P�CDP�B=CQQ�>DBF?>�<=C<�<=>�?>@AB<?CD<�AB�H>><AD@<=>�BL=>PFQ>�JK?�<=>�N?KPFL<AKD�KJ�BFL=�PC<C]�J�<=>�TPHADAB<?C<K?�P><>?HAD>B�<=C<�<=>�?>@AB<?CD<�AB�DK<�H>><AD@�K?=CB�DK<�H><�<=>�BL=>PFQ>�JK?�<=>�N?KPFL<AKD�KJ�BFL=�PC<CE�<=>�TPHADAB<?C<K?�HCU�N?KL>>P�AD�CLLK?PCDL>�RA<=�LQCFB>_AO�KJ�<=AB�BFGNC?C@?CN=�?>@C?PAD@�<=>�LKD<ADF>P�?>@AB<?C<AKD�KJ�<=>�CJJ>L<>P�N?KPFL<B�RA<=�<=>�HADK?�CDP�K<=>?FB>B�CDP�B=CQQ�ADJK?H�<=>�NFGQAL�KJ�BFL=�CL<AKD�AD�CLLK?PCDL>�RA<=�B>L<AKD�WXYP_J_j�KJ�<=AB�<A<Q>]�aK<RA<=B<CDPAD@<=>�N?KOABAKDB�KJ�<=AB�LQCFB>E�<=>�TPHADAB<?C<K?�HCU�P>DUE�HKPAJUE�K?�?>OK\>�<=>�<>HNK?C?U�>M<>DBAKD�FDP>?�<=ABBFGNC?C@?CN=�AJ�<=>�TPHADAB<?C<K?�P><>?HAD>B�<=C<�<=>�LKD<ADFC<AKD�KJ�<=>�HADK?�FB>�HCU�LCFB>�CD�FD?>CBKDCGQ>CPO>?B>�>JJ>L<�KD�<=>�>DOA?KDH>D<]�D�<=>�>O>D<�KJ�HKPAJALC<AKD�K?�?>OKLC<AKDE�<=>�TPHADAB<?C<K?�B=CQQ�N?KOAP>E�ADR?A<AD@E�<K�<=>�?>@AB<?CD<�C�DK<AL>�?>OK\AD@�<=>�<>HNK?C?U�>M<>DBAKD�CDP�>B<CGQAB=�C�D>R�>JJ>L<AO>�PC<>�GU�R=AL=�<=>HADK?�FB>�B=CQQ�G>�P>Q><>P�J?KH�<=>�?>@AB<?C<AKD]9cddd;9:;�J�PC<C�?>IFA?>P�<K�BFNNK?<�?>@AB<?C<AKD�KJ�C�N>B<ALAP>�FDP>?�BFGNC?C@?CN=�_T�AB�?>IF>B<>P�GU�C�h>P>?CQ�K?b<C<>�?>@FQC<K?U�CF<=K?A<UE�<=>�TPHADAB<?C<K?�B=CQQE�<K�<=>�>M<>D<�N?CL<ALCGQ>E�LKK?PADC<>�PC<C�?>IFA?>H>D<BE�<>B<N?K<KLKQBE�<AH><CGQ>BE�CDP�B<CDPC?PB�KJ�?>OA>R�CDP�?>PFL>�GF?P>DB�CDP�?>PFDPCDLU�LCFB>P�<K�<=>�?>@AB<?CD<�GUHFQ<ANQ>�?>IFA?>H>D<B�KD�<=>�?>@AB<?CD<]ADD 019
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 83 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ 8
9::;�<=>�?@ABCBDEFGEHF�AGI�>CE>F�BCEH�G�JHHK>FGEBL>�GMF>>A>CE�NBE=�G�OEGE>�EH�JGFFI�HPE�DPQJRGPD>�STUV9:::;�WHE�RGE>F�E=GC�X�I>GF�GYE>F�?PMPDE�Z[�X\\][�E=>�?@ABCBDEFGEHF�D=GRR�@>L>RHK�G�KFHJ>DD�EH�B@>CEBYI�GC@�GDDBDE�BCGRR>LBGEBCM�YPEPF>�@BDKGFBEB>D�Q>EN>>C�>@>FGR�GC@�OEGE>�@GEG�F>_PBF>A>CEDV9;�abcdebfbgh�dijkghligmnBE=BC�CBC>�AHCE=D�GYE>F�O>KE>AQ>F�Zo[�X\pq[�E=>�?@ABCBDEFGEHF�D=GRR[�QI�F>MPRGEBHC[�KF>DJFBQ>�DBAKRBYB>@KFHJ>@PF>D�YHF�E=>�F>MBDEFGEBHC�HY�K>DEBJB@>D[�N=BJ=�D=GRR�BCJRP@>�E=>�KFHLBDBHCD�HY�DPQKGFGMFGK=�SrU�HY�E=BDKGFGMFGK=V9s;�tugcdvbjwWH�GKKRBJGCE�YHF�F>MBDEFGEBHC�HY�G�K>DEBJB@>�N=H�KFHKHD>D�EH�KPFJ=GD>�G�F>MBDE>F>@�K>DEBJB@>�YFHA�GCHE=>F�KFH@PJ>F�BCHF@>F�EH�YHFAPRGE>�DPJ=�KPFJ=GD>@�K>DEBJB@>�BCEH�E=>�K>DEBJB@>�E=GE�BD�E=>�DPQx>JE�HY�E=>�GKKRBJGEBHC�D=GRR�Q>�F>_PBF>@EHyy9b;�DPQABE�HF�JBE>�@GEG�K>FEGBCBCM�EH�DPJ=�KPFJ=GD>@�KFH@PJEz�HF9bb;�HYY>F�EH�KGI�F>GDHCGQR>�JHAK>CDGEBHC�HE=>FNBD>�F>_PBF>@�QI�KGFGMFGK=�SXUSrU�HY�E=BD�DPQD>JEBHC�YHF�E=>�PD>HY�GCI�DPJ=�@GEGV9t;�{bwji�lmg�|}b~giTC�=GC@RBCM�E=>�F>MBDEFGEBHC�HY�G�K>DEBJB@>�YHF�G�ABCHF�PD>[�E=>�?@ABCBDEFGEHF�AGI�NGBL>�HE=>FNBD>�GKKRBJGQR>�@GEGF>_PBF>A>CED�BY�E=>�?@ABCBDEFGEHF�@>E>FABC>D�E=GE�E=>�GQD>CJ>�HY�DPJ=�@GEG�NBRR�CHE�KF>L>CE�E=>�?@ABCBDEFGEHF�YFHA@>E>FABCBCMyy9b;�E=>�BCJF>A>CEGR�FBD��KF>D>CE>@�QI�E=>�ABCHF�PD>�HY�E=>�K>DEBJB@>z�GC@9bb;�E=GE�DPJ=�FBD�[�BY�GCI[�NHPR@�CHE�Q>�GC�PCF>GDHCGQR>�G@L>FD>�>YY>JE�HC�E=>�>CLBFHCA>CEV9�;��ddebk}vbjw9�;�:w��gwgi}e<=>�?@ABCBDEFGEHF�D=GRR�F>LB>N�E=>�@GEG�GYE>F�F>J>BKE�HY�E=>�GKKRBJGEBHC�GC@�D=GRR[�GD�>�K>@BEBHPDRI�GD�KHDDBQR>[�>BE=>FF>MBDE>F�E=>�K>DEBJB@>�BC�GJJHF@GCJ>�NBE=�KGFGMFGK=�S�U[�HF�CHEBYI�E=>�GKKRBJGCE�HY�E=>�?@ABCBDEFGEHF�D�@>E>FABCGEBHCE=GE�BE�@H>D�CHE�JHAKRI�NBE=�E=>�KFHLBDBHCD�HY�E=>�DPQJ=GKE>F�BC�GJJHF@GCJ>�NBE=�KGFGMFGK=�S]UVADD 020
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 84 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ �
89:�;<=>?@ABC�DE�FGHF?B>?@BCCI�F@J@CBE8@:�KLM�NOPQRQSTUVTWU�SLVXXY�VS�MZ[MOQTQW\SX]�VS�[WSSQXMY�UM_QM�VRO�VaT�WR�VR]�V[[XQaVTQWR�UMaMQ_MO�]�TLMNOPQRQSTUVTWU�TLVTbb8;:�[UW[WSMS�TLM�QRQTQVX�WU�VPMROMO�UMcQSTUVTQWR�Wd�VR�MROb\SM�[MSTQaQOM�TLVTY�Qd�UMcQSTMUMO�VS�[UW[WSMOY�W\XO�MQOMRTQaVX�WU�S\STVRTQVXX]�SQPQXVU�QR�aWP[WSQTQWR�VRO�XVMXQRc�TW�V�a\UUMRTX]bUMcQSTMUMO�[MSTQaQOM�QOMRTQdQMO�QR�TLMV[[XQaVTQWRY�WU�TLVT�W\XO�OQddMU�QR�aWP[WSQTQWR�VRO�XVMXQRc�dUWP�S\aL�a\UUMRTX]bUMcQSTMUMO�[MSTQaQOM�WRX]�QR�V]STLVT�W\XO�RWT�SQcRQdQaVRTX]�QRaUMVSM�TLM�UQSe�Wd�\RUMVSWRVXM�VO_MUSM�MddMaTS�WR�TLM�MR_QUWRPMRTf�WU8;;:�[UW[WSMS�VR�VPMROPMRT�TW�TLM�UMcQSTUVTQWR�Wd�V�UMcQSTMUMO�[MSTQaQOM�TLVT�OWMS�RWT�UMg\QUM�SaQMRTQdQa�UM_QMWd�OVTVh8@@:�iR�MZ[MOQTQRc�TLM�UM_QM�Wd�VR�V[[XQaVTQWR�dWU�VR�VaTQWR�OMSaUQMO�QR�aXV\SM�jQkY�TLM�NOPQRQSTUVTWU�SLVXXbb8;:�UM_QM�TLM�V[[XQaVTQWR�QR�VaaWUOVRaM�QTL�SMaTQWR�lmnbojdkjpkjqk�Wd�TLQS�TQTXM�VROY�Qd�TLM�V[[XQaVTQWR�QS�dW\ROTW�M�QRaWP[XMTMY�UMrMaT�TLM�V[[XQaVTQWRf8;;:�RWT�XVTMU�TLVR�TLM�V[[XQaVXM�OMaQSQWR�UM_QM�TQPM�MSTVXQSLMO�[\US\VRT�TW�SMaTQWR�lmnbojdkjpkjqk�Wd�TLQSTQTXMY�WUY�Qd�RW�UM_QM�TQPM�QS�MSTVXQSLMOY�RWT�XVTMU�TLVR�st�OV]S�VdTMU�UMaMQ_QRc�V�aWP[XMTM�V[[XQaVTQWRY�RWTQd]�TLMUMcQSTUVRT�Qd�TLM�V[[XQaVTQWR�LVS�MMR�cUVRTMO�WU�OMRQMOf�VRO8;;;:�Qd�TLM�V[[XQaVTQWR�QS�OMRQMOY�RWTQd]�TLM�UMcQSTUVRT�QR�UQTQRc�Wd�TLM�S[MaQdQa�UMVSWRS�dWU�TLM�OMRQVX�Wd�TLMV[[XQaVTQWRh8u:�v@>DE�GF=�E=w@F?EB?@D>8@:�KLM�NOPQRQSTUVTWU�SLVXXY�VS�MZ[MOQTQW\SX]�VS�[WSSQXMY�UM_QM�VRO�VaT�WR�VR]�aWP[XMTM�V[[XQaVTQWRbb8;:�TLVT�[UW[WSMS�TLM�QRQTQVX�UMcQSTUVTQWR�Wd�V�RM�[MSTQaQOM�VaTQ_M�QRcUMOQMRT�Qd�TLM�VaTQ_M�QRcUMOQMRT�QS�[UW[WSMOTW�M�UMcQSTMUMO�SWXMX]�dWU�PQRWU�\SMSY�WU�[UW[WSMS�V�UMcQSTUVTQWR�VPMROPMRT�SWXMX]�dWU�PQRWU�\SMS�TW�VR�MZQSTQRcUMcQSTUVTQWRf�WU8;;:�dWU�V�UMcQSTUVTQWR�WU�V�UMcQSTUVTQWR�VPMROPMRT�TLVT�[UW[WSMS�SQcRQdQaVRT�PQRWU�\SMSh8@@:�xWU�TLM�[\U[WSMS�Wd�aXV\SM�jQkbb8;:�TLM�TMUP�yVS�MZ[MOQTQW\SX]�VS�[WSSQXMz�PMVRS�TLVT�TLM�NOPQRQSTUVTWU�SLVXXY�TW�TLM�cUMVTMST�MZTMRT�[UVaTQaVXMYaWP[XMTM�V�UM_QM�VRO�M_VX\VTQWR�Wd�VXX�OVTVY�S\PQTTMO�QTL�V�aWP[XMTM�V[[XQaVTQWRY�QTLQR�l{�PWRTLS�VdTMUADD 021
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 85 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ 8
9:;�<=>?@<<@AB�AC�9:;�DA?EF;9;�GEEF@DG9@ABH�GBI�9:;�CG@F=J;�AC�9:;�KI?@B@<9JG9AJ�9A�DA?EF;9;�<=D:�G�J;L@;M�GBI;LGF=G9@AB�=BI;J�DFG=<;�N@O�<:GFF�BA9�>;�<=>P;D9�9A�P=I@D@GF�J;L@;MQ�GBIRSST�9:;�9;J?�U<@VB@C@DGB9�?@BAJ�=<;<W�?;GB<�X�AJ�?AJ;�?@BAJ�=<;<�EJAEA<;I�CAJ�;L;JY�BAB?@BAJ�=<;H�G�?@BAJ�=<;9:G9�MA=FIH�@B�9:;�P=IV?;B9�AC�9:;�KI?@B@<9JG9AJH�<;JL;�G<�G�J;EFGD;?;B9�CAJ�GBY�=<;�M:@D:�:G<�>;;B�DGBD;F;I�@B9:;�Z�Y;GJ<�EJ;D;I@BV�9:;�J;D;@E9�AC�9:;�GEEF@DG9@ABH�AJ�G�?@BAJ�=<;�9:G9�@B�9:;�AE@B@AB�AC�9:;�KI?@B@<9JG9AJ�MA=FIGLA@I�9:;�J;@<<=GBD;�AC�GB�;?;JV;BDY�;[;?E9@AB�=BI;J�<;D9@AB�\X]E�AC�9:@<�9@9F;�CAJ�9:G9�?@BAJ�=<;R_T�abcdefb�fghb�ijk�ldmhgllgjn�ji�hgnjk�dlb�aefeoC�G�J;V@<9JGB9�?Gp;<�G�J;q=;<9�CAJ�G�?@BAJ�=<;�MG@L;JH�J;VGJI@BV�IG9G�J;q=@J;I�>Y�9:;�KI?@B@<9JG9AJH�E=J<=GB9�9AEGJGVJGE:�NrONsOH�GBI�@C�9:;�KI?@B@<9JG9AJ�I;B@;<�@B�M:AF;�AJ�@B�EGJ9�<=D:�IG9G�MG@L;J�J;q=;<9H�9:;�J;V@<9JGB9�<:GFF:GL;�G�C=FFt9@?;�E;J@AI�CAJ�EJAL@I@BV�<=D:�IG9G�uAJ�E=JEA<;<�AC�9:@<�<=>EGJGVJGE:H�9:;�9;J?�UC=FFt9@?;�E;J@AIW?;GB<�9:;�9@?;�E;J@AI�AJ@V@BGFFY�;<9G>F@<:;I�>Y�9:;�KI?@B@<9JG9AJ�CAJ�<=>?@<<@AB�AC�<=D:�IG9GH�>;V@BB@BV�M@9:�9:;IG9;�AC�J;D;@E9�>Y�9:;�J;V@<9JGB9�AC�9:;�KI?@B@<9JG9AJv<�BA9@D;�AC�I;B@GFRwT�xjfgyb�ji�ezz{gyefgjn|:;�KI?@B@<9JG9AJ�<:GFF�E=>F@<:�@B�9:;�u;I;JGF�};V@<9;JH�EJA?E9FY�GC9;J�J;D;@E9�AC�9:;�<9G9;?;B9�GBI�A9:;J�IG9G�J;q=@J;IE=J<=GB9�9A�EGJGVJGE:<�N\O�GBI�NrOH�G�BA9@D;�AC�;GD:�GEEF@DG9@AB�CAJ�J;V@<9JG9@AB�AC�GBY�E;<9@D@I;�@C�@9�DAB9G@B<�GBY�B;MGD9@L;�@BVJ;I@;B9�AJ�@C�@9�MA=FI�;B9G@F�G�D:GBV;I�=<;�EG99;JB�|:;�BA9@D;�<:GFF�EJAL@I;�CAJ�G�E;J@AI�AC�X~�IGY<�@B�M:@D:GBY�u;I;JGF�GV;BDY�AJ�GBY�A9:;J�@B9;J;<9;I�E;J<AB�?GY�DA??;B9R�T�zzkj�e{�ji�kb�glfkefgjn|:;�KI?@B@<9JG9AJ�<:GFF�J;V@<9;J�G�E;<9@D@I;�@C�9:;�KI?@B@<9JG9AJ�I;9;J?@B;<�9:G9H�M:;B�DAB<@I;J;I�M@9:�GBY�J;<9J@D9@AB<@?EA<;I�=BI;J�<=><;D9@AB�NIOttRT�@9<�DA?EA<@9@AB�@<�<=D:�G<�9A�MGJJGB9�9:;�EJAEA<;I�DFG@?<�CAJ�@9QR�T�@9<�FG>;F@BV�GBI�A9:;J�?G9;J@GF�J;q=@J;I�9A�>;�<=>?@99;I�DA?EFY�M@9:�9:;�J;q=@J;?;B9<�AC�9:@<�<=>D:GE9;JQR�T�@9�M@FF�E;JCAJ?�@9<�@B9;BI;I�C=BD9@AB�M@9:A=9�=BJ;G<ABG>F;�GIL;J<;�;CC;D9<�AB�9:;�;BL@JAB?;B9Q�GBIR_T�M:;B�=<;I�@B�GDDAJIGBD;�M@9:�M@I;<EJ;GI�GBI�DA??ABFY�J;DAVB@�;I�EJGD9@D;�@9�M@FF�BA9�V;B;JGFFY�DG=<;=BJ;G<ABG>F;�GIL;J<;�;CC;D9<�AB�9:;�;BL@JAB?;B9|:;�KI?@B@<9JG9AJ�<:GFF�BA9�?Gp;�GBY�FGDp�AC�;<<;B9@GF@9Y�G�DJ@9;J@AB�CAJ�I;BY@BV�J;V@<9JG9@AB�AC�GBY�E;<9@D@I;��:;J;9MA�E;<9@D@I;<�?;;9�9:;�J;q=@J;?;B9<�AC�9:@<�EGJGVJGE:H�AB;�<:A=FI�BA9�>;�J;V@<9;J;I�@B�EJ;C;J;BD;�9A�9:;�A9:;JoB�DAB<@I;J@BV�GB�GEEF@DG9@AB�CAJ�9:;�J;V@<9JG9@AB�AC�G�E;<9@D@I;H�9:;�KI?@B@<9JG9AJ�?GY�MG@L;�IG9G�J;q=@J;?;B9<E;J9G@B@BV�9A�;CC@DGDYH�@B�M:@D:�;L;B9�9:;�KI?@B@<9JG9AJ�?GY�J;V@<9;J�9:;�E;<9@D@I;�M@9:A=9�I;9;J?@B@BV�9:G9�9:;E;<9@D@I;v<�DA?EA<@9@AB�@<�<=D:�G<�9A�MGJJGB9�EJAEA<;I�DFG@?<�AC�;CC@DGDY�oC�G�E;<9@D@I;�@<�CA=BI�9A�>;�;CC@DGD@A=<�>YADD 022
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 86 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ ��
89:�;<8<=�>9?=@�A=B<CD9�EFGHIBJ�DK�<LCA�<C<M=N�8�O@=A>PO<CD9�CA�=A<8QMCAL=?�<L8<�<L=�R?PC9CA<@8<D@�AL8MM�S8CH=�?8<8@=T>C@=P=9<A�O=@<8C9C9U�<D�=KKCB8B:�KD@�>A=�DK�<L=�O=A<CBC?=�C9�A>BL�;<8<=VWXY�Z[\]_�a�b[c]debe]\fK�<L=�R?PC9CA<@8<D@�?=<=@PC9=A�<L8<�<L=�@=T>C@=P=9<A�DK�O8@8U@8OL�IgJ�KD@�@=UCA<@8<CD9�8@=�9D<�A8<CAKC=?N<L=�R?PC9CA<@8<D@�AL8MM�9D<CK:�<L=�8OOMCB89<�KD@�@=UCA<@8<CD9�DK�<L=�R?PC9CA<@8<D@hA�?=<=@PC98<CD9�89?�DK�<L=R?PC9CA<@8<D@hA�@=8AD9A�IC9BM>?C9U�<L=�K8B<>8M�Q8ACAJ�<L=@=KD@N�89?�<L8<N�>9M=AA�<L=�8OOMCB89<�BD@@=B<A�<L=�BD9?C<CD9A89?�9D<CKC=A�<L=�R?PC9CA<@8<D@�<L=@=DK�?>@C9U�<L=�Fij?8:�O=@CD?�Q=UC99C9U�SC<L�<L=�?8:�8K<=@�<L=�?8<=�D9�SLCBL�<L=8OOMCB89<�@=B=CH=A�<L=�9D<CB=N�<L=�R?PC9CA<@8<D@�P8:�@=K>A=�<D�@=UCA<=@�<L=�O=A<CBC?=V�kL=9=H=@�<L=�R?PC9CA<@8<D@@=K>A=A�<D�@=UCA<=@�8�O=A<CBC?=N�<L=�R?PC9CA<@8<D@�AL8MM�9D<CK:�<L=�8OOMCB89<�DK�<L=�R?PC9CA<@8<D@hA�?=BCACD9�89?�DK�<L=R?PC9CA<@8<D@hA�@=8AD9A�IC9BM>?C9U�<L=�K8B<>8M�Q8ACAJ�<L=@=KD@V�lL=�R?PC9CA<@8<D@�AL8MM�O@DPO<M:�O>QMCAL�C9�<L=�m=?=@8Mn=UCA<=@�9D<CB=�DK�A>BL�?=9C8M�DK�@=UCA<@8<CD9�89?�<L=�@=8AD9A�<L=@=KD@V�oOD9�A>BL�9D<CKCB8<CD9N�<L=�8OOMCB89<�KD@@=UCA<@8<CD9�D@�D<L=@�C9<=@=A<=?�O=@AD9�SC<L�<L=�BD9B>@@=9B=�DK�<L=�8OOMCB89<�AL8MM�L8H=�<L=�A8P=�@=P=?C=A�8A�O@DHC?=?KD@�C9�A=B<CD9�EFG?�DK�<LCA�<C<M=VWpY�q[c]debe]\�r\s[b�dt[u]_�u]burvde\u[dwD<SC<LA<89?C9U�<L=�O@DHCACD9A�DK�O8@8U@8OL�IgJjjWxY�lL=�R?PC9CA<@8<D@�P8:�BD9?C<CD98MM:�@=UCA<=@�D@�8P=9?�<L=�@=UCA<@8<CD9�DK�8�O=A<CBC?=�CK�<L=�R?PC9CA<@8<D@?=<=@PC9=A�<L8<�ICJ�<L=�O=A<CBC?=�89?�O@DODA=?�>A=�8@=�C?=9<CB8M�D@�A>QA<89<C8MM:�ACPCM8@�<D�89:�B>@@=9<M:�@=UCA<=@=?O=A<CBC?=�89?�>A=�<L=@=DKN�D@�?CKK=@�D9M:�C9�S8:A�<L8<�SD>M?�9D<�ACU9CKCB89<M:�C9B@=8A=�<L=�@CAy�DK�>9@=8AD98QM=8?H=@A=�=KK=B<A�D9�<L=�=9HC@D9P=9<N�89?�ICCJ�8OO@DHC9U�<L=�@=UCA<@8<CD9�D@�8P=9?P=9<�C9�<L=�P899=@�O@DODA=?�Q:<L=�8OOMCB89<�SD>M?�9D<�ACU9CKCB89<M:�C9B@=8A=�<L=�@CAy�DK�89:�>9@=8AD98QM=�8?H=@A=�=KK=B<�D9�<L=�=9HC@D9P=9<V�R98OOMCB89<�A==yC9U�BD9?C<CD98M�@=UCA<@8<CD9�D@�8P=9?=?�@=UCA<@8<CD9�>9?=@�<LCA�A>QO8@8U@8OL�AL8MM�A>QPC<�A>BL�?8<88A�SD>M?�Q=�@=T>C@=?�<D�DQ<8C9�@=UCA<@8<CD9�DK�8�ACPCM8@�O=A<CBC?=�>9?=@�O8@8U@8OL�IgJV�fK�<L=�8OOMCB89<�CA�>98QM=<D�A>QPC<�89�C<=P�DK�?8<8�Q=B8>A=�C<�L8A�9D<�:=<�Q==9�U=9=@8<=?N�<L=�R?PC9CA<@8<D@�P8:�@=UCA<=@�D@�8P=9?�<L=@=UCA<@8<CD9�DK�<L=�O=A<CBC?=�>9?=@�A>BL�BD9?C<CD9A�8A�SCMM�@=T>C@=�<L=�A>QPCAACD9�DK�A>BL�?8<8�9D<�M8<=@�<L89�<L=�<CP=A>BL�?8<8�8@=�@=T>C@=?�<D�Q=�A>QPC<<=?�SC<L�@=AO=B<�<D�ACPCM8@�O=A<CBC?=A�8M@=8?:�@=UCA<=@=?�>9?=@�<LCA�A>QBL8O<=@VWzY�lL=�R?PC9CA<@8<D@�P8:�BD9?C<CD98MM:�8P=9?�<L=�@=UCA<@8<CD9�DK�8�O=A<CBC?=�<D�O=@PC<�8??C<CD98M�>A=A�DK�A>BLO=A<CBC?=�9D<SC<LA<89?C9U�<L8<�?8<8�BD9B=@9C9U�<L=�O=A<CBC?=�P8:�Q=�C9A>KKCBC=9<�<D�A>OOD@<�89�>9BD9?C<CD98M8P=9?P=9<N�CK�<L=�R?PC9CA<@8<D@�?=<=@PC9=A�<L8<�ICJ�<L=�8OOMCB89<�L8A�A>QPC<<=?�A8<CAK8B<D@:�?8<8�O=@<8C9C9U�<D�<L=O@DODA=?�8??C<CD98M�>A=N�89?�ICCJ�8P=9?C9U�<L=�@=UCA<@8<CD9�C9�<L=�P899=@�O@DODA=?�Q:�<L=�8OOMCB89<�SD>M?�9D<ACU9CKCB89<M:�C9B@=8A=�<L=�@CAy�DK�89:�>9@=8AD98QM=�8?H=@A=�=KK=B<�D9�<L=�=9HC@D9P=9<V�wD<SC<LA<89?C9U�<L=�KD@=UDC9UO@DHCACD9A�DK�<LCA�A>QO8@8U@8OLN�9D�@=UCA<@8<CD9�DK�8�O=A<CBC?=�P8:�Q=�8P=9?=?�<D�O=@PC<�89�8??C<CD98M�>A=�DK�A>BLO=A<CBC?=�CK�<L=�R?PC9CA<@8<D@�L8A�CAA>=?�8�9D<CB=�A<8<C9U�<L8<�A>BL�O=A<CBC?=N�D@�89:�C9U@=?C=9<�<L=@=DKN�P==<A�D@={B==?A�@CAy�B@C<=@C8�8AADBC8<=?�C9�SLDM=�D@�C9�O8@<�SC<L�L>P89�?C=<8@:�={ODA>@=�=9>P=@8<=?�C9�@=U>M8<CD9A�CAA>=?>9?=@�<LCA�A>QBL8O<=@N�89?�?>@C9U�<L=�O=9?=9B:�DK�89:�@CAyjQ=9=KC<�=H8M>8<CD9�C9C<C8<=?�Q:�A>BL�9D<CB=N�CK�IfJ�<L=8??C<CD98M�>A=�DK�A>BL�O=A<CBC?=�C9HDMH=A�8�P8|D@�KDD?�D@�K==?�B@DON�D@�IffJ�<L=�8??C<CD98M�>A=�DK�A>BL�O=A<CBC?=C9HDMH=A�8�PC9D@�KDD?�D@�K==?�B@DO�89?�<L=�R?PC9CA<@8<D@�?=<=@PC9=AN�SC<L�<L=�BD9B>@@=9B=�DK�<L=�;=B@=<8@:�DKRU@CB>M<>@=N�<L=@=�CA�8H8CM8QM=�89�=KK=B<CH=�8M<=@98<CH=�O=A<CBC?=�<L8<�?D=A�9D<�P==<�D@�={B==?�A>BL�@CAy�B@C<=@C8V�R98OOMCB89<�A==yC9U�8P=9?=?�@=UCA<@8<CD9�>9?=@�<LCA�A>QO8@8U@8OL�AL8MM�A>QPC<�A>BL�?8<8�8A�SD>M?�Q=�@=T>C@=?�<DDQ<8C9�@=UCA<@8<CD9�DK�8�ACPCM8@�O=A<CBC?=�>9?=@�O8@8U@8OL�IgJV�fK�<L=�8OOMCB89<�CA�>98QM=�<D�A>QPC<�89�C<=P�DK�?8<8ID<L=@�<L89�?8<8�O=@<8C9C9U�<D�<L=�O@DODA=?�8??C<CD98M�>A=J�Q=B8>A=�C<�L8A�9D<�:=<�Q==9�U=9=@8<=?N�<L=�R?PC9CA<@8<D@ADD 023
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 87 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ ��
89:�98;<=�>?;�@;ABC>@9>BD<�E<=;@�CEF?�FD<=B>BD<C�9C�GBHH�@;IEB@;�>?;�CEJ8BCCBD<�DK�CEF?�=9>9�<D>�H9>;@�>?9<�>?;�>B8;CEF?�=9>9�9@;�@;IEB@;=�>D�J;�CEJ8B>>;=�GB>?�@;CL;F>�>D�CB8BH9@�L;C>BFB=;C�9H@;9=:�@;ABC>;@;=�E<=;@�>?BC�CEJF?9L>;@MNOP�Q?;�R=8B<BC>@9>D@�89:�FD<=B>BD<9HH:�@;ABC>;@�9�L;C>BFB=;�FD<>9B<B<A�9<�9F>BS;�B<A@;=B;<>�<D>�FD<>9B<;=�B<�9<:FE@@;<>H:�@;ABC>;@;=�L;C>BFB=;�KD@�9�L;@BD=�@;9CD<9JH:�CEKKBFB;<>�KD@�>?;�A;<;@9>BD<�9<=�CEJ8BCCBD<�DK�@;IEB@;=�=9>9TG?BF?�9@;�H9FUB<A�J;F9EC;�9�L;@BD=�@;9CD<9JH:�CEKKBFB;<>�KD@�A;<;@9>BD<�DK�>?;�=9>9�?9C�<D>�;H9LC;=�CB<F;�>?;R=8B<BC>@9>D@�KB@C>�B8LDC;=�>?;�=9>9�@;IEB@;8;<>V�D<�>?;�FD<=B>BD<�>?9>�J:�>?;�;<=�DK�CEF?�L;@BD=�>?;�R=8B<BC>@9>D@@;F;BS;C�CEF?�=9>9�9<=�>?;�=9>9�=D�<D>�8;;>�D@�;WF;;=�@BCU�F@B>;@B9�;<E8;@9>;=�B<�@;AEH9>BD<C�BCCE;=�E<=;@�>?BCCEJF?9L>;@X�9<=�D<�CEF?�D>?;@�FD<=B>BD<C�9C�>?;�R=8B<BC>@9>D@�89:�L@;CF@BJ;M�R�FD<=B>BD<9H�@;ABC>@9>BD<�E<=;@�>?BCCEJL9@9A@9L?�C?9HH�J;�A@9<>;=�D<H:�BK�>?;�R=8B<BC>@9>D@�=;>;@8B<;C�>?9>�EC;�DK�>?;�L;C>BFB=;�=E@B<A�CEF?�L;@BD=�GBHH<D>�F9EC;�9<:�E<@;9CD<9JH;�9=S;@C;�;KK;F>�D<�>?;�;<SB@D<8;<>X�9<=�>?9>�EC;�DK�>?;�L;C>BFB=;�BC�B<�>?;�LEJHBF�B<>;@;C>MNYP�Z[\]_�ab _[_c\a\_d]�]d_]efD>GB>?C>9<=B<A�9<:�D>?;@�L@DSBCBD<�DK�>?BC�CEJF?9L>;@X�>?;�R=8B<BC>@9>D@�89:�<D>�B<B>B9>;�9�LEJHBF�B<>;@B89=8B<BC>@9>BS;�@;SB;G�L@DF;CC�>D�=;S;HDL�9�@BCUgJ;<;KB>�;S9HE9>BD<�DK�>?;�B<A@;=B;<>C�DK�9�L;C>BFB=;�D@�9<:�DK�B>C�EC;C�L@BD@>D�B<B>B9>B<A�9�KD@89H�9F>BD<�>D�F9<F;HX�CECL;<=X�D@�=;<:�@;ABC>@9>BD<�DK�CEF?�L;C>BFB=;X�@;IEB@;=�E<=;@�>?BC�CEJF?9L>;@XE<H;CC�CEF?�B<>;@B8�9=8B<BC>@9>BS;�L@DF;CC�BC�J9C;=�D<�9�S9HB=9>;=�>;C>�D@�D>?;@�CBA<BKBF9<>�;SB=;<F;�@9BCB<A�L@E=;<>FD<F;@<C�DK�E<@;9CD<9JH;�9=S;@C;�@BCU�>D�89<�D@�>D�>?;�;<SB@D<8;<>M�fD>BF;�DK�>?;�=;KB<B>BD<�DK�>?;�>;@8C�hS9HB=9>;=>;C>i�9<=�hD>?;@�CBA<BKBF9<>�;SB=;<F;i�9C�EC;=�?;@;B<�C?9HH�J;�LEJHBC?;=�J:�>?;�R=8B<BC>@9>D@�B<�>?;�j;=;@9H�k;ABC>;@MNlP�man]o_[pNqP�qbb_\_r[ao�c\a\]][\csEJt;F>�>D�CEJL9@9A@9L?C�TuV�9<=�TvVX�B>�C?9HH�<D>�J;�9�SBDH9>BD<�DK�>?BC�CEJF?9L>;@�KD@�9�@;ABC>@9<>�>D�8D=BK:>?;�H9J;HB<A�DK�9<�9<>B8BF@DJB9H�L;C>BFB=;�L@D=EF>�>D�B<FHE=;�@;H;S9<>�B<KD@89>BD<�D<�L@D=EF>�;KKBF9F:X�L@D=EF>FD8LDCB>BD<X�FD<>9B<;@�FD8LDCB>BD<�D@�=;CBA<X�D@�D>?;@�F?9@9F>;@BC>BFC�>?9>�=D�<D>�@;H9>;�>D�9<:�L;C>BFB=9H�FH9B8�D@L;C>BFB=9H�9F>BSB>:MNwP�x]yz_]][\c{@DLDC;=�H9J;HB<A�B<KD@89>BD<�E<=;@�CEJL9@9A@9L?�TRV�C?9HH�<D>�J;�K9HC;�D@�8BCH;9=B<AX�C?9HH�<D>�FD<KHBF>�GB>?D@�=;>@9F>�K@D8�9<:�C>9>;8;<>�@;IEB@;=�J:�H9G�D@�>?;�R=8B<BC>@9>D@�9C�9�FD<=B>BD<�DK�@;ABC>@9>BD<X�9<=�C?9HH�J;CEJC>9<>B9>;=�D<�>?;�@;IE;C>�DK�>?;�R=8B<BC>@9>D@MNOP�|r\_}_~a\_r[�a[b�b_ca��rdaoN_P�|r\_}_~a\_r[R�@;ABC>@9>BD<�89:�J;�8D=BKB;=�E<=;@�CEJL9@9A@9L?�TRV�BKggADD 024
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 88 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ ��
89:�;<=�>=?@A;>BC;�CD;@E@=A�;<=�FGH@C@A;>B;D>�@C�I>@;@C?�CD;�JB;=>�;<BC�KL�GBMA�N>@D>�;D�G@A;>@OP;@DC�D>�ABJ=�DE�BN>DGPQ;�O=B>@C?�;<=�HDG@E@=G�JBO=J@C?R�BCG899:�;<=�FGH@C@A;>B;D>�GD=A�CD;�G@ABNN>DS=�DE�;<=�HDG@E@QB;@DC�PCG=>�QJBPA=�T@@UV8WW:�XWYZ[[\]Z_D;�JB;=>�;<BC�aL�GBMA�BE;=>�>=Q=@N;�DE�B�CD;@E@QB;@DC�PCG=>�QJBPA=�T@Ub�;<=�FGH@C@A;>B;D>�HBM�G@ABNN>DS=�;<=HDG@E@QB;@DC�OM�A=CG@C?�;<=�>=?@A;>BC;�CD;@E@QB;@DC�@C�I>@;@C?�A;B;@C?�;<B;�;<=�N>DNDA=G�JBC?PB?=�@A�CD;�BQQ=N;BOJ=BCG�A;B;@C?�;<=�>=BADCA�I<M�;<=�FGH@C@A;>B;D>�E@CGA�;<=�N>DNDA=G�HDG@E@QB;@DC�PCBQQ=N;BOJ=V8WWW:�cdYe\WfeW]g�]g�YZ_dF�>=?@A;>BC;�HBM�CD;�A=JJ�D>�G@A;>@OP;=�B�N>DGPQ;�O=B>@C?�B�G@ABNN>DS=G�HDG@E@QB;@DCV8W:�hijdfeW]gF�>=?@A;>BC;�HBM�E@J=�BC�DOk=Q;@DC�@C�I>@;@C?�;D�B�G@ABNN>DSBJ�PCG=>�QJBPA=�T@@U�CD;�JB;=>�;<BC�aL�GBMA�BE;=>�>=Q=@N;DE�CD;@E@QB;@DC�DE�;<=�G@ABNN>DSBJV8:�lWgZ_�ZfeW]gF�G=Q@A@DC�OM�;<=�FGH@C@A;>B;D>�EDJJDI@C?�>=Q=@N;�BCG�QDCA@G=>B;@DC�DE�BC�DOk=Q;@DC�E@J=G�PCG=>�QJBPA=�T@SU�A<BJJO=�QDCA@G=>=G�B�E@CBJ�B?=CQM�BQ;@DCV8X:�mYd�nW_oeW]gp<=�JBO=J�D>�JBO=J@C?�>=qP@>=G�PCG=>�;<@A�APOQ<BN;=>�ED>�BC�BC;@H@Q>DO@BJ�N=A;@Q@G=�;<B;�@A�D>�HBM�O=�G@JP;=G�ED>�PA=HBM�<BS=�B�G@EE=>=C;�A;B;=H=C;�DE�QBP;@DC�D>�N>D;=Q;@S=�H=BAP>=A�ED>�PA=�DE�;<=�>=QDHH=CG=G�G@JP;=G�ADJP;@DC�DE;<=�N=A;@Q@G=�;<BC�ED>�PA=�DE�B�QDCQ=C;>B;=�DE�;<=�N=A;@Q@G=�@E�;<=�FGH@C@A;>B;D>�G=;=>H@C=A�;<B;rr8W:�BG=qPB;=�GB;B�<BS=�O==C�APOH@;;=G�;D�APNND>;�;<=�A;B;=H=C;�N>DNDA=G�ED>�;<=�G@JP;=G�ADJP;@DC�PA=AR�BCG8WW:�;<=�JBO=J�D>�JBO=J@C?�N>DS@G=A�BG=qPB;=�N>D;=Q;@DC�ED>�=sNDAP>=�;D�;<=�G@JP;=G�ADJP;@DC�DE�;<=�N=A;@Q@G=V8tu:�vw[dnWedn�\dxWYe\ZeW]g�]y�[dYeWfWndY8z:�D;�JB;=>�;<BC�{�M=B>�BE;=>�FP?PA;�ab�{||Kb�;<=�FGH@C@A;>B;D>�A<BJJb�P;@J@}@C?�NPOJ@Q�QDHH=C;b�G=S=JDN�N>DQ=GP>=ABCG�?P@G=J@C=Ab�BCG�=sN=G@;=�;<=�>=S@=I�DE�BC�BNNJ@QB;@DC�ED>�>=?@A;>B;@DC�DE�B�N=A;@Q@G=�D>�BC�BH=CGH=C;�;D�B>=?@A;>B;@DC�;<B;�AB;@AE@=A�APQ<�?P@G=J@C=AVADD 025
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 89 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ �8
9:;�<=>�?@@ABC?DBE=�FEG�GHIBJDG?DBE=�EG�?=�?KH=LKH=DM�B=CANLB=I�OBEAEIBC?A�?=L�CE=PH=DBE=?A�@HJDBCBLHJM�QBAA�OHCE=JBLHGHL�FEG�HR@HLBDHL�GHPBHQ�N=LHG�DSBJ�@?G?IG?@ST�<=�?@@ABC?DBE=�FEG�GHIBJDG?DBE=�EG�?=�?KH=LKH=D�JS?AA�UN?ABF>FEG�HR@HLBDHL�GHPBHQ�BF�NJH�EF�DSH�@HJDBCBLH�@GE@EJHL�O>�DSH�?@@ABC?DBE=�K?>�GH?JE=?OA>�OH�HR@HCDHL�DE�?CCEK@ABJS�VEG�KEGH�EF�DSH�FEAAEQB=IW9X;�YHLNCH�DSH�GBJZJ�EF�@HJDBCBLHJ�DE�SNK?=�SH?ADST9XX;�YHLNCH�DSH�GBJZJ�EF�@HJDBCBLHJ�DE�=E=D?GIHD�EGI?=BJKJT9XXX;�YHLNCH�DSH�@EDH=DB?A�FEG�CE=D?KB=?DBE=�EF�IGEN=LQ?DHGM�JNGF?CH�Q?DHGM�EG�EDSHG�P?ANHL�H=PBGE=KH=D?A�GHJENGCHJT9X[;�\GE?LH=�DSH�?LE@DBE=�EF�B=DHIG?DHL�@HJD�K?=?IHKH=D�JDG?DHIBHJM�EG�K?ZH�JNCS�JDG?DHIBHJ�KEGH�?P?BA?OAH�EG�KEGHHFFHCDBPHT9];�SH�<LKB=BJDG?DEGM�=ED�A?DHG�DS?=�_�L?>J�?FDHG�GHCHB@D�EF�?=�?@@ABC?DBE=�FEG�HR@HLBDHL�GHPBHQM�JS?AA�=EDBF>�DSH?@@ABC?=D�QSHDSHG�DSH�?@@ABC?DBE=�BJ�CEK@AHDHT�aF�BD�BJ�FEN=L�DE�OH�B=CEK@AHDHM�DSH�<LKB=BJDG?DEG�K?>�HBDSHG�GHbHCD�DSHGHUNHJD�FEG�HR@HLBDHL�GHPBHQ�EG�?JZ�DSH�?@@ABC?=D�FEG�?LLBDBE=?A�B=FEGK?DBE=�DE�J?DBJF>�DSH�INBLHAB=HJ�LHPHAE@HL�N=LHGJNO@?G?IG?@S�c<dT9e;�]fghhXiXjgkXlm�li�nohkXjXeoh9p;�]fghhXiXjgkXlm�ilq�romoqgf�shot�qohkqXjkoe�shot�lq�ulkv9w;�<J�?�@?GD�EF�DSH�GHIBJDG?DBE=�EF�?�@HJDBCBLH�DSH�<LKB=BJDG?DEG�JS?AA�CA?JJBF>�BD�?J�OHB=I�FEG�IH=HG?A�NJH�EG�FEG�GHJDGBCDHLNJHT�aF�DSH�<LKB=BJDG?DEG�LHDHGKB=HJ�DS?D�JEKH�EF�DSH�NJHJ�FEG�QSBCS�DSH�@HJDBCBLH�BJ�GHIBJDHGHL�JSENAL�OH�FEG�IH=HG?ANJH�?=L�DS?D�EDSHG�NJHJ�FEG�QSBCS�BD�BJ�GHIBJDHGHL�JSENAL�OH�FEG�GHJDGBCDHL�NJHM�DSH�<LKB=BJDG?DEG�JS?AA�CA?JJBF>�BD�FEG�OEDSIH=HG?A�NJH�?=L�GHJDGBCDHL�NJHT�xHJDBCBLH�NJHJ�K?>�OH�CA?JJBFBHL�O>�GHINA?DBE=�E=�DSH�B=BDB?A�CA?JJBFBC?DBE=M�?=L�GHIBJDHGHL@HJDBCBLHJ�K?>�OH�CA?JJBFBHL�@GBEG�DE�GHGHIBJDG?DBE=T�aF�JEKH�EF�DSH�NJHJ�EF�DSH�@HJDBCBLH�?GH�CA?JJBFBHL�FEG�IH=HG?A�NJHM?=L�EDSHG�NJHJ�?GH�CA?JJBFBHL�FEG�GHJDGBCDHL�NJHM�DSH�LBGHCDBE=J�GHA?DB=I�DE�BDJ�IH=HG?A�NJHJ�JS?AA�OH�CAH?GA>�JH@?G?DHL�?=LLBJDB=INBJSHL�FGEK�DSEJH�LBGHCDBE=J�GHA?DB=I�DE�BDJ�GHJDGBCDHL�NJHJT�SH�<LKB=BJDG?DEG�K?>�GHUNBGH�DS?D�BDJ�@?CZ?IB=I?=L�A?OHAB=I�FEG�GHJDGBCDHL�NJHJ�JS?AA�OH�CAH?GA>�LBJDB=INBJS?OAH�FGEK�BDJ�@?CZ?IB=I�?=L�A?OHAB=I�FEG�IH=HG?A�NJHJT9:;�aF�DSH�<LKB=BJDG?DEG�LHDHGKB=HJ�DS?D�DSH�@HJDBCBLHM�QSH=�?@@ABHL�B=�?CCEGL?=CH�QBDS�BDJ�LBGHCDBE=J�FEG�NJHMQ?G=B=IJ�?=L�C?NDBE=J�?=L�FEG�DSH�NJHJ�FEG�QSBCS�BD�BJ�GHIBJDHGHLM�EG�FEG�E=H�EG�KEGH�EF�JNCS�NJHJM�EG�B=�?CCEGL?=CHQBDS�?�QBLHJ@GH?L�?=L�CEKKE=A>�GHCEI=ByHL�@G?CDBCHM�QBAA�=ED�IH=HG?AA>�C?NJH�N=GH?JE=?OAH�?LPHGJH�HFFHCDJ�E=�DSHH=PBGE=KH=DM�DSH�<LKB=BJDG?DEG�QBAA�CA?JJBF>�DSH�@HJDBCBLHM�EG�DSH�@?GDBCNA?G�NJH�EG�NJHJ�EF�DSH�@HJDBCBLH�DE�QSBCS�DSHLHDHGKB=?DBE=�?@@ABHJM�FEG�IH=HG?A�NJHT9];�aF�DSH�<LKB=BJDG?DEG�LHDHGKB=HJ�DS?D�DSH�@HJDBCBLHM�QSH=�?@@ABHL�B=�?CCEGL?=CH�QBDS�BDJ�LBGHCDBE=J�FEG�NJHM�Q?G=B=IJ?=L�C?NDBE=J�?=L�FEG�DSH�NJHJ�FEG�QSBCS�BD�BJ�GHIBJDHGHLM�EG�FEG�E=H�EG�KEGH�EF�JNCS�NJHJM�EG�B=�?CCEGL?=CH�QBDS?�QBLHJ@GH?L�?=L�CEKKE=A>�GHCEI=ByHL�@G?CDBCHM�K?>�IH=HG?AA>�C?NJHM�QBDSEND�?LLBDBE=?A�GHINA?DEG>�GHJDGBCDBE=JMADD 026
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 90 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ �8
9:;<=>?:=@A<�=BC<;><�<DD<EF>�?:�FG<�<:CH;?:I<:FJ�H:EA9BH:K�H:L9;M�F?�FG<�=NNAHE=F?;J�FG<�OBIH:H>F;=F?;�>G=AA�EA=>>HDMFG<�N<>FHEHB<J�?;�FG<�N=;FHE9A=;�9><�?;�9><>�F?�PGHEG�FG<�B<F<;IH:=FH?:�=NNAH<>J�D?;�;<>F;HEF<B�9><QRST�UD�FG<�OBIH:H>F;=F?;�EA=>>HDH<>�=�N<>FHEHB<J�?;�?:<�?;�I?;<�9><>�?D�>9EG�N<>FHEHB<J�D?;�;<>F;HEF<B�9><�@<E=9><�?D�=B<F<;IH:=FH?:�FG=F�FG<�=E9F<�B<;I=A�?;�H:G=A=FH?:�F?VHEHFM�?D�FG<�N<>FHEHB<�N;<><:F>�=�G=W=;B�F?�FG<�=NNAHE=F?;�?;?FG<;�N<;>?:>J�FG<�N<>FHEHB<�>G=AA�@<�=NNAH<B�D?;�=:M�9><�F?�PGHEG�FG<�;<>F;HEF<B�EA=>>HDHE=FH?:�=NNAH<>�?:AM�@M�?;�9:B<;FG<�BH;<EF�>9N<;CH>H?:�?D�=�E<;FHDH<B�=NNAHE=F?;XRSST�UD�FG<�OBIH:H>F;=F?;�EA=>>HDH<>�=�N<>FHEHB<J�?;�?:<�?;�I?;<�9><>�?D�>9EG�N<>FHEHB<J�D?;�;<>F;HEF<B�9><�@<E=9><�?D=�B<F<;IH:=FH?:�FG=F�HF>�9><�PHFG?9F�=BBHFH?:=A�;<K9A=F?;M�;<>F;HEFH?:�I=M�E=9><�9:;<=>?:=@A<�=BC<;><�<DD<EF>�?:FG<�<:CH;?:I<:FJ�FG<�N<>FHEHB<�>G=AA�@<�=NNAH<B�D?;�=:M�9><�F?�PGHEG�FG<�B<F<;IH:=FH?:�=NNAH<>�?:AM�@M�?;�9:B<;�FG<BH;<EF�>9N<;CH>H?:�?D�=�E<;FHDH<B�=NNAHE=F?;J�?;�>9@L<EF�F?�>9EG�?FG<;�;<>F;HEFH?:>�=>�FG<�OBIH:H>F;=F?;�I=M�N;?CHB<@M�;<K9A=FH?:X�O:M�>9EG�;<K9A=FH?:�>G=AA�@<�;<CH<P=@A<�H:�FG<�=NN;?N;H=F<�E?9;F�?D�=NN<=A>�9N?:�N<FHFH?:�?D�=�N<;>?:=BC<;><AM�=DD<EF<B�DHA<B�PHFGH:�YZ�B=M>�?D�FG<�N9@AHE=FH?:�?D�FG<�;<K9A=FH?:�H:�DH:=A�D?;IXR[T�\]_a�S_�bcddSeSbfSg_UD�FG<�OBIH:H>F;=F?;�B<F<;IH:<>�FG=F�=�EG=:K<�H:�FG<�EA=>>HDHE=FH?:�?D�=:M�9><�?D�=�N<>FHEHB<�D;?I�K<:<;=A�9><�F?;<>F;HEF<B�9><�H>�:<E<>>=;M�F?�N;<C<:F�9:;<=>?:=@A<�=BC<;><�<DD<EF>�?:�FG<�<:CH;?:I<:FJ�FG<�OBIH:H>F;=F?;�>G=AA�:?FHDMFG<�;<KH>F;=:F�?D�>9EG�N<>FHEHB<�?D�>9EG�B<F<;IH:=FH?:�=F�A<=>F�D?;FMhDHC<�B=M>�@<D?;<�I=iH:K�FG<�EG=:K<�=:B�>G=AAN9@AH>G�FG<�N;?N?><B�EG=:K<�H:�FG<�j<B<;=A�k<KH>F<;X�lG<�;<KH>F;=:FJ�?;�?FG<;�H:F<;<>F<B�N<;>?:�PHFG�FG<�E?:E9;;<:E<?D�FG<�;<KH>F;=:FJ�I=M�><<i�;<AH<D�D;?I�>9EG�B<F<;IH:=FH?:�9:B<;�><EFH?:�mnYBo@p�?D�FGH>�FHFA<XRqT�\]_a�S_�bcddSeSbfSg_�ergs�radfrSbfat�uda�fg�a_arc�udalG<�;<KH>F;=:F�?D�=:M�N<>FHEHB<�PHFG�?:<�?;�I?;<�9><>�EA=>>HDH<B�D?;�;<>F;HEF<B�9><�I=M�N<FHFH?:�FG<�OBIH:H>F;=F?;�F?EG=:K<�=:M�>9EG�EA=>>HDHE=FH?:�D;?I�;<>F;HEF<B�F?�K<:<;=A�9><X�v9EG�N<FHFH?:�>G=AA�><F�?9F�FG<�@=>H>�D?;�FG<�;<KH>F;=:Fw>N?>HFH?:�FG=F�;<>F;HEF<B�9><�EA=>>HDHE=FH?:�H>�9::<E<>>=;M�@<E=9><�EA=>>HDHE=FH?:�?D�FG<�N<>FHEHB<�D?;�K<:<;=A�9><�P?9AB:?F�E=9><�9:;<=>?:=@A<�=BC<;><�<DD<EF>�?:�FG<�<:CH;?:I<:FX�lG<�OBIH:H>F;=F?;J�PHFGH:�>HVFM�B=M>�=DF<;�;<E<HCH:K�>9EGN<FHFH?:J�>G=AA�:?FHDM�FG<�;<KH>F;=:F�PG<FG<;�FG<�N<FHFH?:�G=>�@<<:�K;=:F<B�?;�B<:H<BX�O:M�B<:H=A�>G=AA�E?:F=H:�=:<VNA=:=FH?:�FG<;<D?;�=:B�=:M�>9EG�B<:H=A�>G=AA�@<�>9@L<EF�F?�L9BHEH=A�;<CH<P�9:B<;�><EFH?:�mnY:�?D�FGH>�FHFA<XRaT�xrgtubfd�ySf]�dsa�egrsucfSg_�_t�bcSsdz;?B9EF>�PGHEG�G=C<�FG<�>=I<�D?;I9A=FH?:J�=;<�I=:9D=EF9;<B�@M�FG<�>=I<�N<;>?:J�FG<�A=@<AH:K�?D�PGHEG�E?:F=H:>�FG<>=I<�EA=HI>J�=:B�FG<�A=@<A>�?D�PGHEG�@<=;�=�B<>HK:=FH?:�HB<:FHDMH:K�FG<�N;?B9EF�=>�FG<�>=I<�N<>FHEHB<�I=M�@<�;<KH>F<;<B=>�=�>H:KA<�N<>FHEHB<{�=:B�=BBHFH?:=A�:=I<>�=:B�A=@<A>�>G=AA�@<�=BB<B�F?�FG<�;<KH>F;=FH?:�@M�>9NNA<I<:F=A�>F=F<I<:F>XReT�|Sdbacc_agudR}T�~eeabf�ge�b]_a�ge�c�acS_�gr�egrsucfSg_UD�FG<�A=@<AH:K�?;�D?;I9A=FH?:�D?;�=�N<>FHEHB<�H>�EG=:K<BJ�FG<�;<KH>F;=FH?:�>G=AA�@<�=I<:B<B�F?�;<DA<EF�>9EG�EG=:K<�HD�FG<OBIH:H>F;=F?;�B<F<;IH:<>�FG=F�FG<�EG=:K<�PHAA�:?F�CH?A=F<�=:M�N;?CH>H?:�?D�FGH>�>9@EG=NF<;XADD 027
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 91 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ �8
9:;�<=>?@ABCA?DE�EDA�C�F=G=E@=HI�IJ�KLKIM�NOPQQ�RKSTNMRPMTJI�JU�PI�PRMTVQK�WK�VJINMRXKY�PN�P�YKUKINK�UJR�MOK�VJZZTNNTJI�JU�PI[�JUUKINK�XIYKR�MOTNNXWVOP\MKR]�N�QJIS�PN�IJ�VPIVKQQPMTJI�\RJVKKYTISN�PRK�TI�KUUKVM�RKSTNMRPMTJI�JU�P�\KNMTVTYK�NOPQQ�WK�\RTZP�UPVTK�KLTYKIVKMOPM�MOK�\KNMTVTYK_�TMN�QPWKQTIS�PIY�\PVPSTIS�VJZ\Q[�aTMO�MOK�RKSTNMRPMTJI�\RJLTNTJIN�JU�MOK�NXWVOP\MKR]9b;�cdAeDB?Af�AD�gDE@dhA�DAe=B�i=F=BCh�C>=Eg?=@HI�VJIIKVMTJI�aTMO�VJINTYKRPMTJI�JU�PI[�RKSTNMRPMTJI�JR�P\\QTVPMTJI�UJR�RKSTNMRPMTJI�XIYKR�MOTN�NKVMTJI_�MOKYZTITNMRPMJR�ZP[�VJINXQM�aTMO�PI[�JMOKR�jKYKRPQ�PSKIV[]9k;�l?mAdB=@�DG�E?ABD>=E�@ACn?h?o=B@�CEF�G=BA?h?o=B�pBDFdgA@I[�ZTqMXRK�JR�JMOKR�VJZWTIPMTJI�JUrr9c;�s�JR�ZJRK�ITMRJSKI�NMPWTQTtKRN�RKSTNMKRKY�XIYKR�MOTN�NXWVOP\MKRu�PIY9v;�s�JR�ZJRK�UKRMTQTtKR�\RJYXVMN_NOPQQ�IJM�WK�NXWwKVM�MJ�MOK�\RJLTNTJIN�JU�MOTN�NKVMTJI�JR�NKVMTJIN�sxyPrs_�sxyV_�sxyK_�sxyZ_�PIY�sxyz{P|{}|�JU�MOTNMTMQK�TU�MOK�ZTqMXRK�JR�JMOKR�VJZWTIPMTJI�TN�PVVJZ\PITKY�W[�MOK�QPWKQTIS�RK~XTRKY�XIYKR�MOTN�NXWVOP\MKR�UJR�MOKITMRJSKI�NMPWTQTtKR�VJIMPTIKY�TI�MOK�ZTqMXRK�JR�JMOKR�VJZWTIPMTJI_�MOK�ZTqMXRK�JR�VJZWTIPMTJI�TN�ZTqKY�JR�VJZWTIKYTI�PVVJRYPIVK�aTMO�NXVO�QPWKQTIS_�PIY�MOK�ZTqMXRK�JR�VJZWTIPMTJI�YJKN�IJM�VJIMPTI�PI[�PVMTLK�TISRKYTKIM�JMOKR�MOPIMOK�ITMRJSKI�NMPWTQTtKR]9>;�<=>?@ABCA?DE�B=�?=�9�;��=E=BCh�Bdh=9c;��=B?DF?g�B=�?=�9?;��E�>=E=BCh�OK�RKSTNMRPMTJIN�JU�\KNMTVTYKN�PRK�MJ�WK�\KRTJYTVPQQ[�RKLTKaKY]9??;�<=>dhCA?DE@HI�PVVJRYPIVK�aTMO�MOTN�NXW\PRPSRP\O_�MOK� YZTITNMRPMJR�NOPQQ�W[�RKSXQPMTJI�KNMPWQTNO�P�\RJVKYXRK�UJRPVVJZ\QTNOTIS�MOK�\KRTJYTV�RKLTKa�JU�RKSTNMRPMTJIN]ADD 028
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 92 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ �8
9:::;�<=:>:?@�ABC:D>A?>:E=�ABF:BGHIJ�KLMNONPQRSQTR�PISUU�VTMWUJQJ�QIJ�RJXNPQRSQNTO�RJYNJZ�T[�JSVI�WJPQNVNLJ�TR�WJPQNVNLJ�VSPJ\�ZINVI�MS]�JVTMWTPJL�T[�_�TR�MTRJ�SVQNYJ�NOXRJLNJOQP�SOL�QIJ�WRTLVQP�SPPTVNSQJL�ZNQI�QIJ�SVQNYJ�NOXRJLNJOQP\�OTQ�USQJR�QISOQIJ�USQJR�T[aa9<;�bVQTJR�_\�cdcce�TR9<<;�QIJ�LSQJ�QISQ�NP�_f�]JSRP�S[QJR�QIJ�LSQJ�TO�ZINVI�QIJ�[NRPQ�WJPQNVNLJ�VTOQSNONOX�S�OJZ�SVQNYJ�NOXRJLNJOQ�NPRJXNPQJRJLg9:F;�hijDBkiB=>�ABC:D>A?>:E=�ABF:BGlTQ�USQJR�QISO�_f�]JSRP�S[QJR�QIJ�LSQJ�TO�ZINVI�QIJ�NONQNSU�RJXNPQRSQNTO�RJYNJZ�NP�VTMWUJQJL�OLJR�VUSPJ�mNNNn�SOLJSVI�_f�]JSRP�QIJRJS[QJR\�QIJ�KLMNONPQRSQTR�PISUU�VTMWUJQJ�S�P PJoJOQ�RJXNPQRSQNTO�RJYNJZ�[TR�JSVI�WJPQNVNLJ�TRWJPQNVNLJ�VSPJg9F;�p?=qB@@?>:E=lT�RJXNPQRSQNTO�PISUU�J�VSOVJUJL�SP�S�RJPUQ�T[�QIJ�RJXNPQRSQNTO�RJYNJZ�WRTVJPP�OUJPP�QIJ�KLMNONPQRSQTR�[TUUTZPQIJ�WRTVJLRJP�SOL�P PQSOQNYJ�RJoNRJMJOQP�T[�PJVQNTO�_rsL�T[�QINP�QNQUJg9t;�uEqvB>:=C9:;�<=�CB=BA?@w xJVQ�QT�VUSPJ�mNNn\�S[QJR�MJJQNOX�ZNQI�_�TR�MTRJ�NOLNYNLSUP�QISQ�SRJ�OTQ�XTYJROMJOQ�JMWUT]JJP�QT�LNPVPPMSQQJRP�RJUSQNOX�QT�S�RJXNPQRSQNTO�RJYNJZ\�QIJ�KLMNONPQRSQTR�PISUU�WUSVJ�NO�QIJ�LTVyJQ�MNOQJP�T[�QIJ�MJJQNOX\�S�UNPQT[�SQQJOLJJP\�SOL�SO]�LTVMJOQP�JzVISOXJL�SQ�QIJ�MJJQNOX\�OTQ�USQJR�QISO�QIJ�JSRUNJR�T[aa9<;�QIJ�LSQJ�QISQ�NP�{f�LS]P�S[QJR�QIJ�MJJQNOXe�TR9<<;�QIJ�LSQJ�T[�NPPSOVJ�T[�QIJ�RJXNPQRSQNTO�RJYNJZ�LJVNPNTOg9::;�|AE>Bq>B}�:=~EA�?>:E=HIJ�KLMNONPQRSQTR�PISUU�NLJOQN[]\� Q�OTQ�NOVULJ�NO�QIJ�LTVyJQ\�SO]�VTO[NLJOQNSU� PNOJPP�NO[TRMSQNTO�QIJLNPVUTPRJ�T[�ZINVI�NP�WRTINNQJL�]�PJVQNTO�_rsI�T[�QINP�QNQUJg9p;��:�:>?>:E=ADD 029
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 93 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ �8
9:;<=>?�=>�;<=@�@AB@CD;=:>�@<EFF�GH:<=B=;�;<C�IJK=>=@;HE;:H�LH:K�A>JCH;EM=>?�E>N�:;<CH�HCO=CP�:L�E�GC@;=D=JCGAH@AE>;�;:�;<=@�@ABD<EG;CHQRST�UVWVRXT�YZ[\]]_�abcZ]abde<C�IJK=>=@;HE;:H�@<EFF�A@C�;<C�EA;<:H=;N�=>�@AB@CD;=:>�fDgfhgfig�;:�HCjA=HC�;<C�@ABK=@@=:>�:L�JE;E�P<C>�@AD<�JE;EEHC�>CDC@@EHN�L:H�E�HC?=@;HE;=:>�HCO=CPQRkT�UVWV�Z[\]]_l�m_\nb VW]_l�Vd�bob\nW]_p:H�GAHG:@C@�:L�;<=@�@AB@CD;=:>q�;<C�GH:O=@=:>@�:L�@AB@CD;=:>@�fDgfrgq�fDgfhgfigq�E>J�fDgfhgfsg�@<EFF�BC�A;=F=tCJ�L:H�E>JBC�EGGF=DEBFC�;:�E>N�JE;E�HCjA=HCJ�L:H�HC?=@;HE;=:>�HCO=CPQRuT�vbw]WaVW]_�abcZ]ab\bW�x_a�VW]\]ma_[]Vy�nbW]m]dbRzT�{|VyZVW]_�_x�na_mbe:�;<C�KE}=KAK�C};C>;�GHED;=DEBFC�D:>@=@;C>;�P=;<�;<C�JC?HCC@�:L�H=@M�GHC@C>;CJ�BN�E>�E>;=K=DH:B=EF�GC@;=D=JC�E>J;<C�;NGC�:L�HCO=CP�EGGH:GH=E;C�;:�COEFAE;C�;<C�H=@M@q�;<C�IJK=>=@;HE;:H�@<EFF�=JC>;=LN�E>J�COEFAE;C�HCL:HK@�;:�;<CE>;=K=DH:B=EF�HC?=@;HE;=:>�GH:DC@@�;<E;�P:AFJ�HCJADC�HCO=CP�GCH=:J@�C}=@;=>?�E@�:L�IA?A@;�~q�r���q�L:H�E>;=K=DH:B=EFGC@;=D=JC�GH:JAD;�HC?=@;HE;=:>�EGGF=DE;=:>@�E>J�EGGF=DE;=:>@�L:H�EKC>JCJ�HC?=@;HE;=:>�:L�E>;=K=DH:B=EF�GC@;=D=JCGH:JAD;@q�=>DFAJ=>?��RXT�>CP�E>;=K=DH:B=EF�ED;=OC�=>?HCJ=C>;@�RkT�>CP�E>;=K=DH:B=EF�C>J�A@C�GH:JAD;@�R�T�@AB@;E>;=EFFN�@=K=FEH�:H�=JC>;=DEF�E>;=K=DH:B=EF�GC@;=D=JC@��E>JRUT�EKC>JKC>;@�;:�E>;=K=DH:B=EF�GC@;=D=JC�HC?=@;HE;=:>@QRST�vb|]b��W]\b�nba]_d�abdZmW]_�w_Vy�ED<�HCL:HK�=JC>;=L=CJ�A>JCH�GEHE?HEG<�frg�@<EFF�BC�JC@=?>CJ�;:�ED<=COC�;<C�?:EF�:L�HCJAD=>?�;<C�HCO=CP�GCH=:J�L:FF:P=>?@ABK=@@=:>�:L�E�D:KGFC;C�EGGF=DE;=:>q�D:>@=@;C>;�P=;<�;<C�JC?HCC�:L�H=@Mq�;:�E�GCH=:J�:L�>:;�K:HC�;<E>��RXT�����JEN@�L:H�E�>CP�E>;=K=DH:B=EF�ED;=OC�=>?HCJ=C>;�GC@;=D=JC�HC?=@;HE;=:>�RkT�h���JEN@�L:H�E�>CP�E>;=K=DH:B=EF�A@C�:L�E�HC?=@;CHCJ�ED;=OC�=>?HCJ=C>;�ADD 030
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 94 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ ��
89:�;<=�>?@A�BCD�?E@�CFGHD�EHI�?EFJKJLDCMJ?N�ODC>PLFQ8R:�S=�>?@A�BCD�?�APMAF?EFJ?NN@�AJKJN?D�CD�J>HEFJL?N�?EFJKJLDCMJ?N�ODC>PLFQ8T:�S=�>?@A�BCD�?E�?KHE>KHEF�FC�?E�?EFJKJLDCMJ?N�DHUJAFD?FJCE�FG?F�>CHA�ECF�DHVPJDH�ALJHEFJBJL�DHWJHI�CB�>?F?Q�?E>8X:�;<=�>?@A�BCD�?E�?KHE>KHEF�FC�?E�?EFJKJLDCMJ?N�DHUJAFD?FJCE�FG?F�DHVPJDHA�ALJHEFJBJL�DHWJHI�CB�>?F?�?E>�FG?F�JAECF�CFGHDIJAH�>HALDJMH>�JE�FGJA�O?D?UD?OGY8Z:�[\]_\_abacd8e:�fgd]dh_i�gj_\bkcl8c:�[hhjbm_nCF�N?FHD�FG?E�<o=�>?@A�?BFHD�pPUPAF�qr�;SSsr�FGH�p>KJEJAFD?FCD�AG?NN�OPMNJAG�JE�FGH�tH>HD?N�uHUJAFHD�ODCOCAH>DHUPN?FJCEA�FC�?LLHNHD?FH�?E>�JKODCWH�FGH�DHWJHI�CB�?EFJKJLDCMJ?N�OHAFJLJ>H�ODC>PLFA�>HAJUEH>�FC�JKONHKHEFr�FCFGH�HvFHEF�OD?LFJL?MNHr�FGH�UC?NA�AHF�BCDFG�JE�O?D?UD?OG�w<xY8cc:�y_zjcg_\_ah{DCOCAH>�DHUPN?FJCEA�JAAPH>�PE>HD�LN?PAH�wJx�AG?NN||8[:�>HBJEH�FGH�W?DJCPA�LN?AAHA�CB�?EFJKJLDCMJ?N�PAH�O?FFHDEAr�JELNP>JEU�GCPAHGCN>r�JE>PAFDJ?Nr�?E>�JEAFJFPFJCE?N>JAJEBHLF?EFA�?E>�A?EJFJ}JEU�OHAFJLJ>HAr�ODHAHDW?FJWHAr�I?FHD�FDH?FKHEFr�?E>�OPNO�?E>�O?OHD�KJNN�?>>JFJWHAr?E>�CFGHD�APLG�ODC>PLFA�JEFHE>H>�FC�>JAJEBHLFr�A?EJFJ}Hr�DH>PLHr�CD�KJFJU?FH�UDCIFG�CD�>HWHNCOKHEF�CBKJLDCMJCNCUJL?N�CDU?EJAKAr�CD�ODCFHLF�JE?EJK?FH�CM~HLFAr�JE>PAFDJ?N�ODCLHAAHA�CD�A@AFHKAr�APDB?LHAr�I?FHDr�CDCFGHD�LGHKJL?N�APMAF?ELHA�BDCK�LCEF?KJE?FJCEr�BCPNJEUr�CD�>HFHDJCD?FJCE�L?PAH>�M@�M?LFHDJ?r�WJDPAHAr�BPEUJrODCFC}C?r�?NU?Hr�CD�ANJKHQ8[[:�>JBBHDHEFJ?FH�FGH�F@OHA�CB�DHWJHI�PE>HDF?�HE�BCD�?EFJKJLDCMJ?N�OHAFJLJ>HAQ8[[[:�LCEBCDK�FGH�>HUDHH�?E>�F@OH�CB�DHWJHI�FC�FGH�DJA�A�?E>�MHEHBJFA�ODHAHEFH>�M@�?EFJKJLDCMJ?N�OHAFJLJ>HA�?E>FGH�BPELFJCE�CB�DHWJHI�PE>HD�FGJA�APMLG?OFHDr�LCEAJ>HDJEU�FGH�PAH�O?FFHDEA�CB�FGH�ODC>PLFr�FCvJLJF@r�HvOHLFH>HvOCAPDHr�?E>�ODC>PLF�F@OHQ8[�:�HEAPDH�FG?F�FGH�DHUJAFD?FJCE�ODCLHAA�JA�APBBJLJHEF�FC�K?JEF?JE�?EFJKJLDCMJ?N�OHAFJLJ>H�HBBJL?L@�?E>�FG?F?EFJKJLDCMJ?N�OHAFJLJ>H�ODC>PLFA�LCEFJEPH�FC�KHHF�ODC>PLF�OHDBCDK?ELH�AF?E>?D>A�?E>�HBBHLFJWHEHAA�NHWHNA�BCDH?LG�F@OH�CB�N?MHN�LN?JK�K?>HQ�?E>ADD 031
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 95 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ �8
9:;�<=>?@=@AB�@CC@DB<E@�FAG�H@?<FI?@�G@FG?<A@J�CKH�>HKD@JJ�=FAFL@=@ABM9NNN;�OPQQRSTUVA�G@E@?K><AL�BW@�>HK>KJ@G�H@LX?FB<KAJY�BW@�ZG=<A<JBHFBKH�JWF??�JK?<D<B�BW@�E<@[J�CHK=�H@L<JBHFABJ�FAG�KBW@HFCC@DB@G�>FHB<@J�BK�=F\<=<]@�BW@�@CC@DB<E@A@JJ�KC�BW@�HX?@�G@E@?K>=@AB�>HKD@JJM9;�_NSa�bRcdaTNPSU9N;�eUUdSfRgW@�ZG=<A<JBHFBKH�JWF??�<JJX@�C<AF?�H@LX?FB<KAJ�AKB�?FB@H�BWFA�hij�GFkJ�FCB@H�BW@�D?KJ@�KC�BW@�DK==@AB�>@H<KG�CKHBW@�>HK>KJ@G�H@LX?FB<KAJM9NN;�_NadbR�TP�QRRT�cPaVC�F�LKF?�G@JDH<I@G�<A�>FHFLHF>W�lhm�<J�AKB�=@B�Ik�BW@�C<AF?�H@LX?FB<KAJY�BW@�ZG=<A<JBHFBKH�JWF??�<G@AB<Ck�BW@�LKF?Y@\>?F<A�[Wk�BW@�LKF?�[FJ�AKB�FBBF<A@GY�G@JDH<I@�BW@�@?@=@AB�KC�BW@�H@LX?FB<KAJ�<AD?XG@G�<AJB@FGY�FAG�<G@AB<Ck�CXBXH@JB@>J�BK�FBBF<A�BW@�LKF?M9NNN;�nRodNbRQRSTUVA�<JJX<AL�C<AF?�H@LX?FB<KAJY�BW@�ZG=<A<JBHFBKH�JWF??pp9e;�DKAJ<G@H�BW@�@JBFI?<JW=@AB�KC�F�D@HB<C<DFB<KA�>HKD@JJ�CKH�H@LX?FBKHk�FDB<KAJ�<AEK?E<AL�H<JqJ�BWFB�DFA�I@H@J>KAJ<I?k�=FAFL@GY�DKAJ<JB@AB�[<BW�BW@�G@LH@@�KC�H<JqY�<A�BW@�=KJB�DKJBp@CC<D<@AB�=FAA@Hr9ee;�DKAJ<G@H�BW@�@JBFI?<JW=@AB�KC�F�D@HB<C<DFB<KA�>HKD@JJ�Ik�F>>HKE@G�?FIKHFBKH<@J�FJ�FA�FGsXADB�BK�BW@�H@E<@[>HKD@JJr9eee;�XJ@�F??�F>>HK>H<FB@�FAG�DKJBp@CC@DB<E@�H@E<@[�=@DWFA<J=JY�<AD?XG<ALpp9 ;�@\>FAG@G�XJ@�KC�AKB<C<DFB<KA�FAG�AKApAKB<C<DFB<KA�>HKD@GXH@Jr9tt;�H@E<J@G�>HKD@GXH@J�CKH�F>>?<DFB<KA�H@E<@[r�FAG9ff;�F??KDFB<KA�KC�F>>HK>H<FB@�H@JKXHD@J�BK�@AJXH@�JBH@F=?<A@G�=FAFL@=@AB�KC�FAB<=<DHKI<F?�>@JB<D<G@H@L<JBHFB<KAJr�FAG9e:;�D?FH<Ck�DH<B@H<F�CKH�G@B@H=<AFB<KA�KC�BW@�DK=>?@B@A@JJ�KC�FA�F>>?<DFB<KAMADD 032
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 96 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ ��
89:�;<=>?@A>?�B>C@>DEFGH�HIJHKLMGNO�PNKH�ONM�QRRKLM�MFK�SKTIGSKUKOMH�NS�KVMKOP�MFK�PKQPWGOKH�NS�SKXGKY�ZKSGNPH�LNOMQGOKP�GO�HIJHKLMGNO[L\[]\8_:�aA>BbcA@C>�B>C@>D�=>B@d?efR�MFK�RGOQW�SKgIWQMGNOH�MN�LQSSh�NIM�MFGH�ZQSQgSQZF�QSK�ONM�KRRKLMGXK�i]j�PQhH�QRMKS�kIgIHM�]l�mnnil�IOMGW�MFK�RGOQWSKgIWQMGNOH�JKLNUK�KRRKLMGXKl�MFK�SKXGKY�ZKSGNPl�JKgGOOGOg�NO�MFK�PQMK�NR�SKLKGZM�Jh�MFK�kgKOLh�NR�Q�LNUZWKMKQZZWGLQMGNOl�HFQWW�JKoo8@:�p�hKQSH�RNS�Q�OKY�QOMGUGLSNJGQW�QLMGXK�GOgSKPGKOM�ZKHMGLGPK�SKgGHMSQMGNOq8@@:�m�hKQS�RNS�Q�OKY�QOMGUGLSNJGQW�IHK�NR�Q�SKgGHMKSKP�QLMGXK�GOgSKPGKOMq8@@@:�mrj�PQhH�RNS�QOh�NMFKS�OKY�QOMGUGLSNJGQW�ZSNPILMq8@C:�nj�PQhH�RNS�Q�HIJHMQOMGQWWh�HGUGWQS�NS�GPKOMGLQW�QOMGUGLSNJGQW�ZSNPILMq8C:�nj�PQhH�RNS�QO�QUKOPUKOM�MN�QO�QOMGUGLSNJGQW�SKgGHMSQMGNO�MFQM�PNKH�ONM�SKTIGSK�HLGKOMGRGL�SKXGKY�NR�PQMQq�QOP8C@:�mpj�PQhH�RNS�QO�QUKOPUKOM�MN�QO�QOMGUGLSNJGQW�SKgGHMSQMGNO�MFQM�SKTIGSKH�HLGKOMGRGL�SKXGKY�NR�PQMQ�QOP�MFQMGH�ONM�NMFKSYGHK�PKHLSGJKP�GO�MFGH�HIJZQSQgSQZF8;:�sdd?�=B>e>BCcA@C>ekO�QZZWGLQMGNO�RNS�MFK�SKgGHMSQMGNOl�NS�RNS�QO�QUKOPUKOM�MN�MFK�SKgGHMSQMGNOl�NR�Q�YNNP�ZSKHKSXQMGXK�ZSNPILM�RNSYFGLF�Q�LWQGU�NR�ZKHMGLGPQW�QLMGXGMh�WGHMKP�GO�HKLMGNO�m]i[UU\�NR�MFGH�MGMWK�GH�UQPK�[SKgQSPWKHH�NR�QOh�NMFKS�ZKHMGLGPQWLWQGU�MFQM�GH�UQPK�YGMF�SKHZKLM�MN�MFK�ZSNPILM\�HFQWW�JK�SKXGKYKP�Jh�MFK�kPUGOGHMSQMNS�YGMFGO�MFK�HQUK�ZKSGNP�QH�MFQMKHMQJWGHFKP�IOPKS�MFGH�ZQSQgSQZF�RNS�QO�QOMGUGLSNJGQW�ZKHMGLGPK�ZSNPILM�QZZWGLQMGNOl�LNOHGHMKOM�YGMF�MFK�PKgSKK�NRSGHt�ZNHKP�Jh�MFK�IHK�NR�MFK�YNNP�ZSKHKSXQMGXK�ZSNPILMl�GR�MFK�QZZWGLQMGNO�SKTIGSKH�MFK�QZZWGLQOM�MN�HQMGHRh�MFK�HQUKPQMQ�SKTIGSKUKOMH�QH�QSK�SKTIGSKP�MN�HIZZNSM�QO�QZZWGLQMGNO�RNS�Q�YNNP�ZSKHKSXQMGXK�ZSNPILM�MFQM�GH�QO�QOMGUGLSNJGQWZKHMGLGPK8u:�vdA@w@xcA@db8@:�yb�z>b>BcaADD 033
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 97 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ ��
89:;<=>�>?�=@A9B<�CDDDEF�>G<�HIJDKDB>LA>?L�BGA@@�K?>DMN�AK�AOO@D=AK>�PG<>G<L�AK�AOO@D=A>D?K�GAB�:<<K�QLAK><I�?LI<KD<I�K?>�@A><L�>GAK�>G<�MDKA@�IAN�?M�>G<�AOOL?OLDA><�L<RD<P�O<LD?I�9KI<L�>GDB�OALAQLAOGF�9K@<BB�>G<�AOO@D=AK>AKI�>G<�HIJDKDB>LA>?L�AQL<<�>?�A�@A><L�IA><STUUV�WUXYZ�[\]UU_XM�>G<�HIJDKDB>LA>?L�MAD@B�>?�K?>DMN�AK�AOO@D=AK>�PD>GDK�>G<�O<LD?I�?M�>DJ<�L<a9DL<I�9KI<L�=@A9B<�CDEF�>G<�MAD@9L<BGA@@�:<�=?KBDI<L<I�AK�AQ<K=N�A=>D?K�9K@APM9@@N�PD>GG<@I�?L�9KL<AB?KA:@N�I<@AN<I�M?L�O9LO?B<B�?M�;9ID=DA@�L<RD<P9KI<L�=GAO><L�b�?M�cD>@<�dSTUUUV�ef\ghiU_XcGDB�B9:OALAQLAOG�I?<B�K?>�AOO@N�>?�AK�AOO@D=A>D?K�M?L�AK�AK>DJD=L?:DA@�O<B>D=DI<�>GA>�DB�MD@<I�9KI<L�B9:B<=>D?KC=ECjECkE�OLD?L�>?�lm�IANB�AM><L�H9Q9B>�jF�nlloSTUpV�qUgUiYiU_Xr?>PD>GB>AKIDKQ�=@A9B<�CDDEF�>G<�MAD@9L<�?M�>G<�HIJDKDB>LA>?L�>?�K?>DMN�AK�AOO@D=AK>�M?L�AK�AJ<KIJ<K>�>?�AL<QDB>LA>D?K�M?L�AK�AK>DJD=L?:DA@�O<B>D=DI<�BGA@@�K?>�:<�;9ID=DA@@N�L<RD<PA:@<�DK�A�s<I<LA@�?L�8>A><�=?9L>�DM�>G<AJ<KIJ<K>�L<a9DL<B�B=D<K>DMD=�L<RD<P�?M�IA>A�PD>GDKttTuV�>G<�>DJ<�O<LD?I�BO<=DMD<I�DK�B9:OALAQLAOG�CvECRDEF�DK�>G<�A:B<K=<�?M�A�MDKA@�L<Q9@A>D?K�9KI<L�B9:OALAQLAOGCkEw�?LTuuV�>G<�>DJ<�O<LD?I�BO<=DMD<I�DK�OALAQLAOG�CxECsEF�DM�AI?O><I�DK�A�MDKA@�L<Q9@A>D?K�9KI<L�B9:OALAQLAOG�CkESTyV�zXX{YZ�|\h_|iTzV�}{~gUU_Xk<QDKKDKQ�?K�H9Q9B>�jF�nlloF�AKI�<KIDKQ�?K�>G<�IA><�>GA>�>G<�Q?A@B�9KI<L�OALAQLAOG�CxE�AL<�A=GD<R<IF�>G<HIJDKDB>LA>?L�BGA@@F�K?>�@A><L�>GAK��AL=G�n�?M�<A=G�N<ALF�OL<OAL<�AKI�B9:JD>�AK�AKK9A@�L<O?L>�>?�>G<��?JJD>><<?K�HQLD=9@>9L<�?M�>G<��?9B<�?M��<OL<B<K>A>DR<B�AKI�>G<��?JJD>><<�?K�HQLD=9@>9L<F�r9>LD>D?KF�AKI�s?L<B>LN�?M�>G<8<KA><ST�V��\�{U|\g\XiH�L<O?L>�B9:JD>><I�9KI<L�B9:OALAQLAOG�CHE�BGA@@�DK=@9I<�A�I<B=LDO>D?K�?MttTUV�J<AB9L<B�>A�<K�>?�L<I9=<�>G<�:A=�@?Q�?M�O<KIDKQ�L<QDB>LA>D?K�AOO@D=A>D?KBwTUUV�OL?QL<BB�>?PALI�A=GD<RDKQ�L<M?LJB�9KI<L�>GDB�B9:B<=>D?Kw�AKIADD 034
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 98 of 139
����������� �� ��������� ��������������������
�������� !"#$"%�&'()'*$+�,"�-./0#�)"�"*010%/.�2+3+�4"5'*%#'%)�6"*7$+ ��
8999:�;<=>??<@ABCD>@E�C>�D?F;>G<�CH<�B=CDGDCD<E�>I�CH<�JK<@=L�F<;CBD@D@K�C>�B@CD?D=;>MDBN�;<KDEC;BCD>@EOPQRSTU8V:WXY@<�Z[\�]_\�=O�]Z[\�a�b\�BE�BAA<A�cYMOdO�Ze[]f\�a�Z\�g=CO�Z]\�] Z\�hf�iCBCO� j�B?<@A<A�cYMOdO�_e]_k\�a�]Z\�l>GOZh\�] [\�h�iCBCO�[[j�cYMOdO�[ebf\�aa�ZWBm\�beh\�i<FCO�bk\�] h\�Z�iCBCO�hZk\�hZ_ehZj�cYMOdO�]kke[bZ\�nDCN<�o\�aa�]kZWMm\]kb\�nDCN<�po\�a�fk]WMmW]m\�nDCN<�pooo\�a�hk]WMm\�g=CO�Z[\�]hh\�]kZ�iCBCO�Zff\�Zf \�Zfhkj�cYMOdO�]k]efZ_\�nDCN<�qop\�a]_Z\�l>GO�Zh\�] k\�]k_�iCBCO�bfZhj�cYMOdO�]kZeZb\�nDCN<�q\�a�]kkfWBmWbm\�WMmW]m\�WZm\�W=m\�r<=O�]b\�] ]\�]k[�iCBCO�]h_C>�]hfj�cYMOdO�]k_e]k\�nDCN<�o\�aa�]k[WMm\�]kfWMm\�nDCN<�oo\�aa�Z]kWMm\�W=mW]m\�WAm\�W<m\�WImWZm\�ZZZ�C>�ZZ_\�Zb]\�Z[k\�JYKO�b\] f\�]]k�iCBCO�]_]\�]__�C>�]_ \�]_ \�][kb\�][k_\�][kh\�][]kj�cYMOdO�]khe] \�rDGO�s\�nDCN<�p\�a�[k]WMm\�XB@O�Zb\�Zkk_\]]h�iCBCO�_]j�cYMOdO�]]ke_\�aa�Z\�b\�g=CO�\�Zkk\�]Z]�iCBCO�]kkkOml>C<E�>I�r<=DED>@E�W]kkm�tOiOuOJO�a�]bfB\��tiuJ�a�]bfBuY;;<@C�CH;>YKH�cOdO�]][e]_kORvw�xy�Sxz{|}v~ ��Zk]h�nH>?E>@��<YC<;EO�l>�=NBD?�C>�>;DKD@BN�tOiO�s>G<;@?<@C��>;�EO
ADD 035
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 99 of 139
������������� �� �������������������������������������������
��� !"#�$%&'(&)�*+,-+.(/�0&�1234'�-&�&.454)32�6/7/�8&9+.)'+)-�:&.;(/ "
<=>?@A�B?C?@D�EFA@�G==F?C?@AH>?I@�JK�GLM>NOI?OM@�PQ@RD�S�G==FDTEUCV?@M�WK�X=D@N?>N>A@D�C=A�Y=Z>MF=[@=?CI�\@D?>N>A@�EF=?MFI�PQ@RD�S�G==FDTBO]NUCV?@M�XXK�Y=Z>MF=[@=?CI�\@D?>N>A@�EF=?MFI�PQ@RD�S�G==FDTJ�<KBKEKGK��_W=�_W=K�GA[>=>D?MC?>Z@�VMFN@AOM@a�bOA>N>CI�M@Z>@cEOMM@=?=@DDdef�ghijkhlj�lmnkj�kophoqrstuvw�xy�zw{u|}~yu�v|z�~�u��~��w{~y�y��t{xvwu|��w{u�|u��yx��z��w{u����~�~yw|xwz|�wz�tx�tu��z|�y�yvu���x�|u�~yw|xw~z�z|�wz�t{x��u�x�t�xyy~�~txw~z���zw��z��z}~���x�{ux|~���x���zw{u|��~�x��xtw~z�y�z��w{u����~�~yw|xwz|��zw�tz��~wwu��wz�w{u�~yt|uw~z��z��w{u����~�~yw|xwz|�����x}�x|u����~t~x����|u�~u}x��u����w{u��~yw|~tw�tz�|wy�z��w{u���~wu���wxwuy�d�f��ophoq����lmnkj�m��e��oe�i���w{u�txyu�z��xtw�x��tz�w|z�u|y��xy�wz�w{u��x�~�~w��z��x���z|�u|�~yy�u�����w{u����~�~yw|xwz|��z��z}~���x�v���~t�{ux|~���x���vu|yz��}{z�}~����u�x��u|yu���x��utwu�����y�t{�z|�u|�x���}{z�{x���uu��x�vx|w��wz�w{u�v|ztuu�~��y��x��z�wx~�����~t~x�|u�~u}�����~�~���~��w{u���~wu���wxwuy�tz�|w�z��xvvux�y��z|�w{u�t~|t�~w�}{u|u~��y�t{�vu|yz��|uy~�uy�z|�{xy�x�v�xtu�z����y~�uyy�}~w{~������x�y�x�wu|�w{u�u�w|��z��y�t{�z|�u|��x�vuw~w~z��v|x�~���w{xw�w{u�z|�u|��u�yuw�xy~�u�~��}{z�u�z|�~��vx|w����tzv��z�w{u�vuw~w~z��y{x����u��z|w{}~w{�w|x�y�~wwu�����w{u�t�u|��z��w{u�tz�|w�wz�w{u����~�~yw|xwz|�z|�x���z��~tu|��uy~��xwu�����w{u���~�~yw|xwz|��z|�w{xw�v�|vzyu��x���w{u|u�vz��w{u����~�~yw|xwz|�y{x����~�u�~��w{u�tz�|w�w{u�|utz|��z��w{u�v|ztuu�~��yz��}{~t{�w{u����~�~yw|xwz|��xyu��w{u����~�~yw|xwz|�y�z|�u|��xy�v|z�~�u��~��yutw~z�������z���~w�u������vz��w{u��~�~���z�y�t{�vuw~w~z��w{u�tz�|w�y{x���{x�u�ust��y~�u���|~y�~tw~z��wz�x��~|��z|�yuw�xy~�u�w{u�z|�u|�tz�v�x~�u��z��~��}{z�u�z|�~��vx|w��{u�tz�|w�y{x���tz�y~�u|�x���u�~�u�tu�z��|utz|����{u�z|�u|�z��w{u����~�~yw|xwz|�y{x����u�y�ywx~�u��~��~w�~y�y�vvz|wu����y��ywx�w~x��u�~�u�tu�}{u��tz�y~�u|u��z��w{u�|utz|��xy�x�}{z�u���{u������u�w�z��w{u�tz�|w�x��~|�~���z|�yuww~���xy~�u��~�}{z�u�z|�~��vx|w��x���z|�u|����u|�w{~y�yutw~z��y{x����u��~�x���y���utw�wz�|u�~u}����w{u���v|u�u��z�|w�z��w{u���~wu���wxwuy�vz��tu|w~z|x|~�z|�tu|w~�~txw~z��xy�v|z�~�u��~��yutw~z����� �z���~w�u������{u�tz��u�tu�u�w�z��v|ztuu�~��y����u|�w{~yyutw~z��y{x����zw�����uyy�yvut~�~tx����z|�u|u�����w{u�tz�|w�wz�w{u�tz�w|x|���zvu|xwu�xy�x�ywx��z��x��z|�u|�dlf�¡nkhi¢hljhm£�m��¢hijkhlj�lmnkji�{u��~yw|~tw�tz�|wy�z��w{u���~wu���wxwuy�x|u��uywu��}~w{���|~y�~tw~z��yvut~�~tx����wz�u��z|tu��x���wz�v|u�u�w�x���|uyw|x~��~z�xw~z�y�z���w{~y�y��t{xvwu|�d¢f�¤mjhlo�m��¥n¢¦§o£ji�{u����~�~yw|xwz|�y{x�������v���~txw~z��~��y�t{��x��u|�xy�w{u����~�~yw|xwz|��x��v|uyt|~�u���~�u��zw~tu�z��x��������u�wyu�wu|u��~��xtw~z�y�~�yw~w�wu�����u|�w{u�x�w{z|~w��z��w{~y�y��t{xvwu|��©gª«d¬fADD 036
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 100 of 139
������������� �� �������������������������������������������
��� !"#�$%&'(&)�*+,-+.(/�0&�1234'�-&�&.454)32�6/7/�8&9+.)'+)-�:&.;(/
<=>?@�ABC�DEFGC�HI�DABC�J�DKC�LM�LNN@N�O>PIQI�EARBDKC�J�AC�SHTI�ADC�DEGAC�UK�VTLTI�EEFW�LX@?N@N�O>PIQI�EURKAYC�Z[T\@]C�J�FYA<F_<_C�abcI�UC�DEUFC�EU�VTLTI�ddBGW�O>PIQI�DYYRBdAC�Z[T\@�]]]C�J�UYD<[_C�SHTI�ABC�DEUUC�DYA�VTLTI�AKUAW�O>PIQIDYARAdGC�Z[T\@�eC�J�DYYK<P_<D_C�<A_C�<d_<O_C�f@HI�DdC�DEEDC�DYB�VTLTI�DUEBC�DUEKI_abT@M�bg�f@H[M[b?M�<GY_G�hIVIIiI�J�DdK?C�G�hV i�J�DdK?>jj@?T�Tkjb>lk�OIQI�DDBRDFYImno�pq�rpstuvnw x�AYDU�ZkbXMb?�y@>T@jMI�ab�H\L[X�Tb�bj[l[?L\�hIVI�zbc@j?X@?T�{bj|MI
ADD 037
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 101 of 139
������������ ��������� �������������� �������������������������
����� !�"#$%&$'�()*+),&-�.$�/012%�+$�$,232'10�4-5-�6$7),'%)'+�8$,9&-
:;<=�;>�?=<=@AB�C=DEBAFG;HIJGFB=�KLM�N@;F=OFG;H�;>�PHQG@;HR=HF:SATF=@�UM�PHQG@;HR=HFAB�N@;F=OFG;H�VD=HOW�XC=>I�Y�VHH;IZ[E\OSATF=@�PM�N=IFGOG<=�N@;D@ARINA@F�]_M�N=IFGOG<=�C=DGIF@AFG;H�AH<�:BAIIG>GOAFG;H�N@;O=<E@=I�XC=>I�Y�VHH;IZ[E\TA@F�:M�C=DGIF@AFG;H�N@;O=<E@=I�XC=>I�Y�VHH;IZKL�:M?MCM��]_MKK�]_MKK�VTTBGOAFG;H�>;@�AR=H<=<�@=DGIF@AFG;HM:E@@=HFH=IIabc�defghi�bj�hklmnogo�pq�r�stuvwxy�bzq�{lon|nfbinlz�nz�i}g�fl{hljninlzy�~bpg~nz�y�lk�hbf�b�nz��l|�b�kg�njigkgo�hklo�fi{�ji�pg�j�p{niigo��ni}�bz�bhh~nfbinlz�|lk�b{gzogo�kg�njikbinlzv��}g�bhh~nfbzi�{�ji�j�p{ni�i}g�nz|lk{binlz�kg��nkgopq�r�stuvt�y�bj�bhh~nfbp~g�il�i}g�f}bz�g�kg��gjigov��|�bz�bhh~nfbinlz�|lk�b{gzogo�kg�njikbinlz�nj�kg��nkgoy�i}g�bhh~nfbinlz{�ji�pg�bhhklmgo�pq�i}g���gzfq�pg|lkg�i}g�hklo�fiy�bj�{lon|ngoy�{bq�~g�b~~q�pg�onjiknp�igo�lk�jl~ovapc��z�nij�onjfkginlzy�i}g���gzfq�{bq�asc��bnmg�i}g�kg��nkg{gzi�|lk�j�p{njjnlz�l|�bz�bhh~nfbinlz�|lk�b{gzogo�kg�njikbinlz�auc��g��nkg�i}bi�i}g�bhh~nfbzi�fgkin|q�il�i}g���gzfq�i}bi�}g�}bj�fl{h~ngo��ni}�bz���gzfq�onkgfinmg�kbi}gk�i}bz�j�p{nibz�bhh~nfbinlz�|lk�b{gzogo�kg�njikbinlz��lka�c��gk{ni�bz�bhh~nfbzi�il�{lon|q�b�kg�njikbinlz�pq�zlin|nfbinlz�lk�zlz�zlin|nfbinlz�nz�bfflkobzfg��ni}�r�stuvwxvafc���kg�njikbzi�{bq�bi�bzq�in{g�j�p{ni�nogzinfb~�{nzlk�~bpg~nz��b{gzo{gzij�b||gfinz��b�z�{pgk�l|�hklo�fij�bj�b�jnz�~gbhh~nfbinlz�n|�zl�obib�bkg�kg��nkgo�|lk�d���il�bhhklmg�i}g�b{gzo{gzi�a|lk�geb{h~gy�b�f}bz�g�nz�i}g��lkonz��l|�bjilkb�g�jibig{gzi�|lk�ogjn�zbigo�kgjnogzinb~��jg�hklo�fijcv���flzjl~nobigo�bhh~nfbinlz�{�ji�f~gbk~q�nogzin|q�i}g�~bpg~nz�{lon|nfbinlzajc�il�pg�{bog�a�}nf}�{�ji�pg�nogzinfb~�|lk�b~~�hklo�fij�nzf~�ogo�nz�i}g�bhh~nfbinlzcy�~nji�i}g�kg�njikbinlzz�{pgk�l|�gbf}�hklo�fi�|lk��}nf}�i}g�{lon|nfbinlz�nj�kg��gjigoy�bzo�hklmnog�kg��nkgo�j�hhlkinz��{bigknb~j�a|lk�geb{h~gy~bpg~nz�c�|lk�gbf}�b||gfigo�hklo�fiv��������xs�������wsy���zg�uxy�s��x��xx����xw�xwy��gfv�swy�u��s����� d��w����������y����v�sy�s�¡w��t�����sxu�wy��hkn~�uty�s�¡t��t�����wssw�y��fiv��y�s�¡t��t�����st��¡y�¢bq�wys�¡¡��t�����s�sswy�¢bq�uxy�s�¡¡��t�������w�sy����v�suy�s�¡¡��tw����ss�u�y�¢bkf}�uuy�s�¡�y��z~gjj�li}gk�njg�zligov���£����¤�����v�v v�s�x¥s�xq����phbki���nj�b~jl�njj�go��zogk��s��v�v v����svADD 038
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 102 of 139
������������ ��������� �������������� �������������������������
����� !�"#$%&$'�()*+),&-�.$�/012%�+$�$,232'10�4-5-�6$7),'%)'+�8$,9&- �
:;<<=>?�?@<A;B@�CD<E@�FGH�FIJKL�KM�NO�JMPFIQRST�UV�WUXYZ[S\ ]�FIJK�@A_A>�O=;?=<Q�aA�EbDc_�?A�A<cBc>Db�dQeQ�fAg=<>_=>?�hA<iQ
ADD 039
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 103 of 139
��������������� ���������������������������������������� �!���������������
�"�#$%&�'()*+),�-./0.1+2�3)�4567*�0)�)1787,65�92:2�;)<.1,*.,0�=)1>+2 %
?@AB�@C�DBABEFG�HBIJGFKL@MNOLKGB�PQR�SE@KBTKL@M�@C�UMVLE@MWBMK?XFYKBE�ZR�UMVLE@MWBMKFG�SE@KBTKL@M�[IBMT\�]HBCN��[MM@N_JaTXFYKBE�UR�SBNKLTLAB�SE@IEFWNSFEK�bcdR�SBNKLTLAB�HBILNKEFKL@M�FMA�?GFNNLCLTFKL@M�SE@TBAJEBN�]HBCN��[MM@N_JaYFEK�DR�[IBMT\�HBVLBe�@C�[YYGLTFKL@MN�]HBCN��[MM@N_PQ�?RDRHR�f�bcdRbbdf�bcdRbbd�[YYE@VFG�@C�EBILNKEFKL@M�JMABE�DZDH[�NBTR�g]T_]c_RUCCBTKLVBh�DBaEJFE\�bQi�dQQj?JEEBMKMBNNklm�nopp�qrrstuv�qw�qrrpoxqyotw�zw{vs�y|v�xsoyvsoq�t}�~�~�m��vx����x�����twp��o}��q���|v�m�vwx��|q��{vyvs�owv{�y|qy�y|v�qrrpoxqyotw�o��xt�rpvyv�qw{�o��qxxt�rqwov{����qpp��qyvsoqp��sv�zosv{����y|v�mxyqw{�y|o��rqsy��owxpz{ow����zy�wty�po�oyv{�yt��vuo{vwxv�t}�xt�rpoqwxv�noy|��z�rqsy�k�t}�y|o��rqsy������|v�m�vwx��|q��svuovnv{�qpp�svpvuqwy�{qyq�ow�y|v�rt��v��otw�t}�y|v�m�vwx����vv������������qw{�����������x���|v�m�vwx��|q��{vyvs�owv{�y|qy�wt�q{{oyotwqp�{qyq�qsv�wvxv��qs��yt��q�v�y|v�{vyvs�owqyotw��sv�zosv{����~�~�m�vx����x�����noy|�sv�rvxy�yt�y|v�rv�yoxo{v�rst{zxy�n|ox|�o��y|v��z��vxy�t}�y|v�qrrpoxqyotw��{���|v�m�vwx��|q��{vyvs�owv{�y|qy�y|v�xt�rt�oyotw�t}�y|v�rst{zxy�o���zx|�q��yt�nqssqwy�y|v�rstrt�v{�v}}oxqx��xpqo��}ts�oy��o}�v}}oxqx��{qyq�qsv�sv�zosv{�yt��v��z��oyyv{�}ts�y|v�rst{zxy����rqsy�����ts�rqsy�����t}�y|o��x|qryvs��q��qrrpoxq�pv��v���|v�m�vwx��|q��{vyvs�owv{�y|qy�y|v�rst{zxy�nopp�rvs}ts��oy��owyvw{v{�}zwxyotw�noy|tzy�zwsvq�twq�pv�q{uvs�v�v}}vxy�tw�y|v�vwuostw�vwy��qw{�y|qy��n|vw�z�v{�ow�qxxts{qwxv�noy|�no{v�rsvq{�qw{�xt��twp��svxt�wo�v{�rsqxyoxv��y|v�rst{zxynopp�wty��vwvsqpp��xqz�v�zwsvq�twq�pv�q{uvs�v�v}}vxy��tw�y|v�vwuostw�vwy��}���|v�m�vwx��|q��{vyvs�owv{�y|qy�y|v�rst{zxy�o��wty��o��sqw{v{�q��y|qy�yvs��o��{v}owv{�ow�~�~�m��vx�������qw{�rqsy����t}�y|o��x|qryvs��qw{�oy��pq�vpow��qw{�rqx�q�ow��xt�rp��noy|�y|v�qrrpoxq�pv�sv�zosv�vwy��t}�y|v�mxy��y|o��rqsy��qw{rqsy������qw{�����t}�y|o��x|qryvs������}�y|v�rstrt�v{�pq�vpow���vqs��{osvxyotw��}ts�z�v�tw�}tt{��qwo�qp�}vv{��ts�}tt{�ts�}vv{�xstr���ts�o}�y|v�owyvw{v{�z�vt}�y|v�rv�yoxo{v�sv�zpy��ts��q��svq�twq�p���v�v�rvxyv{�yt�sv�zpy��{osvxyp��ts�ow{osvxyp���ow�rv�yoxo{v�sv�o{zv���owxpz{ow�sv�o{zv��t}�qw��qxyouv�ts�owvsy�ow�sv{ovwy�t}�y|v�rst{zxy��ts�t}�qw���vyq�tpoyv�ts�{v�sq{qyotw�rst{zxy�y|vsvt}��ow�tstw�}tt{�ts�qwo�qp�}vv{��qpp�wvxv��qs��ytpvsqwxv���v�v�ryotw��}st��y|v�sv�zosv�vwy�t}�q�ytpvsqwxv��qw{�}tt{�q{{oyouvsv�zpqyotw��|quv��vvw�o��zv{�zw{vs�~~��m��vx�������qw{ADD 040
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 104 of 139
��������������� ���������������������������������������� �!���������������
�"�#$%&�'()*+),�-./0.1+2�3)�4567*�0)�)1787,65�92:2�;)<.1,*.,0�=)1>+2 #
?@A�BC�D@E�FGHIJKDL�MN�OIIMDMHN�DH�PEMNQ�O�FERDMKMIEL�MR�O�IGJQ�SMD@MN�D@E�TEONMNQ�HC�UUVWX�REKY�Z[\?]AL�D@E�XQENK�@ORPEEN�NHDMCMEI�P�D@E�UHHI�ONI�VGJQ�XITMNMRDGODMHN�?UVXA�D@OD�D@E�FGHIJKD�KHTF_MER�SMD@�ON�GE]JMGETENDR�MTFHREIP�UVXYabcdefghZ�Ui�j\[ZkL�lKDY�ZjL�Z[[hm�hn�Ui�hoopoL�VEKY�\ZL�Z[[kqrlsiWtu�vp�Ui�n[p[nL�XJQY�\L�\pkvm�o[�Ui�\jZnvL�XFGM_�ZoL�\pkom�o[�Ui�v\\vnL�lKDY�pL�\pkom�on�Ui�\opk[L�wO�vL\pkkm�on�Ui�\p\\vL�wO�ZjL�\pkkm�on�Ui�n[vn\L�XJQY�\ZL�\pkkm�ov�Ui�\\pZnL�wOGK@�ZZL�\pkpL�JN_ERR�HD@EGSMRE�NHDEIYXsxyliBxzu�h�sYrYWY�\nj{\njm�rJPFOGD�s�MR�O_RH�MRRJEI�JNIEG�n\�sYrYWY�ph[\Y|HDER�HC�VEKMRMHNR�?nvAWJGGEND�D@GHJQ@�wOGK@�ZpL�Z[\km�kn�Ui�\njZ[Y}~c���������b~e ��Z[\k�x@HTRHN�iEJDEGRY�|H�K_OMT�DH�HGMQMNO_�sYrY��H�EGNTEND��HG�RY
ADD 041
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 105 of 139
������������ ���������������������
������������������� �!�"�#��$%&'�� ���!'('�&%�)"*"�+�,�!���� �-�!.�" �
/012�03�4212567�829:76;<0=>?<;72�@AB�C50;2D;<0=�03�E=F<50=G2=;/H6I;25�JB�E=F<50=G2=;67�C50;2D;<0=�K92=DL�M823>�N�K==0>OP:QDH6I;25�EB�C2>;<D<12�C50956G>C65;�RSSB�829<>;56;<0=�P;6=1651>�6=1�829<>;56;<0=�82F<2T�M823>�N�K==0>OP:QI65;�/B�829<>;56;<0=�82F<2T�C50D21:52>�M823>�N�K==0>O@A�/B4B8B�U�RSSB@AU�RSSB@A�V2=2567BE332D;<F2W�42Q5:65L�RAX�YAAZ/:552=;=2>>[\]�_abcde�fgdcd�dh_i\jkblc�dcj\mikcg�abndo_dc�pb�jgd�dhkcj\jkbl�dqkdr�abh\s�dt_kdo�kl�uvuwx�cdnjkbl�y[h]ewdhkcj\jkbl�dqkdr�kc�jgd�adkbokn�dqkdr�bp�\�adcjknkodzc�dhkcj\jkbl�jb�dlc_d�jg\j�d\ng�adcjknkod�dhkcj\jkbl�nbljkl_dcjb�c\jkcp{�jgd�uvuwx�cj\lo\o�pb�dhkcj\jkble�|lod�uvuwx�cdnjkbl�y[h]}�d\ng�adcjknkod�kc�dt_kdo�jb�md�dqkdrdodqd{�~��{d\ce[~]�xsblh�bjgd�jgklhc}�uvuwx�dt_kdc�jg\j�\�adcjknkod�hdld\ii{�rkii�lbj�n\_cd�_ld\cbl\mid�\oqdcd�dppdnjc�bl�jgddlqkblsdlje�wdhkcj\jkbl�dqkdr�kc�kljdlodo�jb�dlc_d�jg\j�d\ng�adcjknkodzc�dhkcj\jkbl�kc�m\cdo�bl�n_ dlj�cnkdljkpkn\lo�bjgd��lbridohd�dh\oklh�jgd�adcjknkod}�klni_oklh�kjc�dppdnjc�bl�g_s\l�gd\ijg�\lo�jgd�dlqkblsdlje[�]�vp�\�abo_nj�p\kic�jb�c\jkcp{�jgd�uvuwx�cj\lo\o�pb�dhkcj\jkbl}�jgd�abo_njzc�dhkcj\jkbl�s\{�md�c_m�dnj�jbn\lndii\jkbl�b�bjgd�dsdokdc�_lod�uvuwxe[m]�xaaikn\mkikj{e�fgkc�c_ma\j�\aaikdc�jb�dqd{�adcjknkod�abo_nj�dhkcjddo�_lod�uvuwx�cdnjkbl�y�\c�rdii�\c�\ii�adcjknkodabo_njc�dhkcjddo�_lod�uvuwx�cdnjkbl���[n]e�vj�obdc�lbj�\aai{�jb�abo_njc�rgbcd�c\id�b�okcjkm_jkbl�kc�\_jgbk�do_lod�uvuwx�cdnjkbl���b�cdnjkbl�~�e[n]��kskj\jkblce[~]�xj�\l{�jksd}�jgd�xhdln{�s\{�_lodj\�d�\l{�bjgd�dqkdr�bp�\�adcjknkod�_lod�uvuwx}�kdcadnjkqd�bp�jgdadcjknkodzc�a\cj}�blhbklh}�cngdo_ido}�b�lbj�{dj�cngdo_ido�dhkcj\jkbl�dqkdre[�]��gdl�jgd�xhdln{�odjdskldc�jg\j�ldr�o\j\�b�klpbs\jkbl�\d�ldndcc\{�pb�\�adcjknkodzc�dhkcj\jkbl�dqkdr}�kjrkii�dt_kd�c_ng�o\j\�_lod�uvuwx�cdnjkbl�y[n][�][�]e���������y�uw������}��dne�~�}��������|w�������uw�����~}��bqe���}�~������~�uw�~��~�}��\{�~�}�~������~�uw����y�}�x_he��}��������y�uw������}��dne~�}�����}�_lidcc�bjgdrkcd�lbjdoeADD 042
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 106 of 139
������������ ���������������������
������������������� �!�"�#��$%&'�� ���!'('�&%�)"*"�+�,�!���� �-�!.�" �
/012345167�8�09:9;9�<=>?�?@A�<=>B9;CDDE@F�FGDHCIG�J?DKG�LMN�LO<PQ�P=�R4�<=>LO9STU�VW�XVYZ[\T] �LO<P�1GH_H@�4ECFED9�aH�Kb?c_�FH�HDcIc@?b�09:9�dHeED@_E@F�fHDg9
ADD 043
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 107 of 139
������������ �� ����������������������������������
���������� !" #�$%&'%(")�* �+,-.!�' � (./.#-,�0)1)�2 3%(#!%#'�4 (5") �
6789�7:�;989<=>�?9@A>=BC7DEFCB>9�GHI�J<7B9KBC7D�7:�LDMC<7DN9DB6O=PB9<�QI�LDMC<7DN9DB=>�J<7B9KBC7D�R@9DKS�T?9:E�U�RDD7EVWAXKO=PB9<�LI�J9EBCKC89�J<7@<=NEJ=<B�YZZI�?9@CEB<=BC7D�WB=D8=<8E�=D8�?9@CEB<=BC7D�?9MC9[�T?9:E�U�RDD7EVWAXP=<B�6I�?9@CEB<=BC7D�?9MC9[�J<7K98A<9E�T?9:E�U�RDD7EVGH�6I;I?I�\�YZZIG]\�YZZIG]�?9@CEB<=BC7D�<9MC9[�K=E9EIL::9KBCM9�_KB7X9<�YH�]HHa6A<<9DBD9EEbcd�efgchijfkjlm�nomjfgncgjpl�noqjor�scfoft�u�nomjfgncgjpl�noqjor�scfo�rjii�ho�spvwpfox�py�plo�pn�vpno�csgjqo�jlmnoxjolgfclx�cii�gko�wnpxzsgf�splgcjljlm�fzsk�jlmnoxjolgbfdt�{ko�umols|�vc|�mnpzw�noicgox�csgjqo�jlmnoxjolgf�jlgp�c�nomjfgncgjplnoqjor�scfo�rkol�gko�csgjqo�jlmnoxjolgf�cno�fp�sipfoi|�noicgox�jl�skovjsci�fgnzsgzno�clx�gp}jspipmjsci�wnpyjio�cf�gp�ciiprspvvpl�zfo�py�fpvo�pn�cii�no~zjnox�xcgc�ypn�kc�cnx�cffoffvolgtb�d�e}jfgjlm�wofgjsjxoft�{ko�umols|�rjii�cffjml�ocsk�wofgjsjxo�nomjfgonox�pl�pn�hoypno�gko�oyyosgjqo�xcgo�py�gkjfnomzicgjpl�gp�c�nomjfgncgjpl�noqjor�scfotb�d��or�wofgjsjxoft�{ko�umols|�rjii�cffjml�ocsk�wofgjsjxo�nomjfgonox�cygon�gko�oyyosgjqo�xcgo�py�gkjf�nomzicgjpl�gp�clo}jfgjlm�nomjfgncgjpl�noqjor�scfo�pn�gp�c�lor�nomjfgncgjpl�noqjor�scfotb�d�u�wofgjsjxo�wnpxzsg�gkcg�splgcjlf�vzigjwio�csgjqo�jlmnoxjolgf�rjii�hoiplm�gp�gko�nomjfgncgjpl�noqjor�scfof�ypn�ocskpy�jgf�csgjqo�jlmnoxjolgftbhd��pxjy|jlm�nomjfgncgjpl�noqjor�scfoft��or�xcgc�pn�jlypnvcgjpl�vc|�fzmmofg�gkcg�c�nomjfgncgjpl�noqjor�scfo�fkpzix�hovpxjyjoxt�{ko�umols|�vc|�vpxjy|�c�nomjfgncgjpl�noqjor�scfo�jl�gko�ypiiprjlm�rc|f�b�d�uxx�c�lor�csgjqo�jlmnoxjolg�gp�c�nomjfgncgjpl�noqjor�scfot�{ko�umols|�vc|�xogonvjlo�gkcg�c�lor�csgjqo�jlmnoxjolgjf�skovjscii|�clx�gp}jspipmjscii|�fjvjicn�gp�csgjqo�jlmnoxjolgf�jl�cl�o}jfgjlm�nomjfgncgjpl�noqjor�scfo�clx�fkpzix�homnpzwox�rjgk�gko�jlmnoxjolgf�jl�gko�o}jfgjlm�nomjfgncgjpl�noqjor�scfotb�d��wijg�c�nomjfgncgjpl�noqjor�scfo�jlgp�grp�pn�vpno�nomjfgncgjpl�noqjor�scfoft��pn�o}cvwio��lor�xcgc�pn�jlypnvcgjplvc|�fzmmofg�gkcg�csgjqo�jlmnoxjolgf�jl�c�nomjfgncgjpl�noqjor�scfo�cno�lpg�cf�fjvjicn�cf�wnoqjpzfi|�hoijoqox�clx�gkcggko|�hoiplm�jl�grp�pn�vpno�fowcncgo�nomjfgncgjpl�noqjor�scfoftb�d��pqo�cl�jlmnoxjolg�ynpv�plo�nomjfgncgjpl�noqjor�scfo�gp�clpgkont��pn�o}cvwio��lor�xcgc�pn�jlypnvcgjpl�vjmkgfzmmofg�gkcg�cl�jlmnoxjolg�fkpzix�lpg�ho�mnpzwox�rjgk�gko�pgkon�jlmnoxjolgf�jl�gko�nomjfgncgjpl�noqjor�scfo�clx�gkcgjg�hoiplmf�jl�c�xjyyonolg�nomjfgncgjpl�noqjor�scfotADD 044
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 108 of 139
������������ �� ����������������������������������
���������� !" #�$%&'%(")�* �+,-.!�' � (./.#-,�0)1)�2 3%(#!%#'�4 (5") �
678�9:;<:�=>?�?;�@?;:�;:<AB=;C=A?D�;:EA:>�FCB:B�AD=?�C�BAD<G:�;:<AB=;C=A?D�;:EA:>�FCB:H�I?;�:JC@KG:L�D:>�MC=C�?;ADN?;@C=A?D�@A<O=�BP<<:B=�=OC=�=O:�CF=AE:�AD<;:MA:D=B�AD�=>?�?;�@?;:�;:<AB=;C=A?D�;:EA:>�FCB:B�BO?PGM�Q:�<;?PK:M=?<:=O:;�N?;�;:<AB=;C=A?D�;:EA:>H6R8�S:G:=:�CD�CF=AE:�AD<;:MA:D=�N;?@�C�;:<AB=;C=A?D�;:EA:>�FCB:H�I?;�:JC@KG:L�=O:�T<:DFU�>AGG�;:@?E:�=O:�AD<;:MA:D=N;?@�=O:�FCB:�AN�=O:�;:<AB=;C=A?DB�?N�CGG�K;?MPF=B�F?D=CADAD<�CD�CF=AE:�AD<;:MA:D=�AD�C�;:<AB=;C=A?D�;:EA:>�FCB:�C;:FCDF:G:MH6F8�VG?BAD<�C�;:<AB=;C=A?D�;:EA:>�FCB:H�WO:�T<:DFU�>AGG�FG?B:�C�;:<AB=;C=A?D�;:EA:>�FCB:�AN�CGG�K;?MPF=B�AD�=O:�FCB:�C;:FCDF:G:MH6M8�XB=CQGABOAD<�C�QCB:GAD:�MC=:�N?;�C�;:<AB=;C=A?D�;:EA:>�FCB:H�I?;�=O:�KP;K?B:�?N�BFO:MPGAD<�;:<AB=;C=A?D�;:EA:>BL�=O:T<:DFU�>AGG�:B=CQGABO�C�QCB:GAD:�MC=:�N?;�:CFO�;:<AB=;C=A?D�;:EA:>�FCB:H�YD�<:D:;CGL�=O:�QCB:GAD:�MC=:�>AGG�Q:�=O:�MC=:�?NADA=ACG�;:<AB=;C=A?D�?N�=O:�?GM:B=�K:B=AFAM:�K;?MPF=�AD�=O:�FCB:�?;�=O:�MC=:�?N�;:;:<AB=;C=A?DL�>OAFO:E:;�AB�GC=:;H�I?;�=O:KP;K?B:�?N�=O:B:�K;?F:MP;:BL�=O:�MC=:�?N�;:;:<AB=;C=A?D�AB�=O:�MC=:�?D�>OAFO�=O:�Z:;:<AB=;C=A?D�XGA<AQAGA=U�S:FABA?D�?;YD=:;A@�Z:;:<AB=;C=A?D�S:FABA?D�>CB�BA<D:ML�>OAFO:E:;�MC=:�=O:�T<:DFU�M:=:;@AD:B�=?�Q:�@?;:�CKK;?K;AC=:�QCB:M�?D�=O:F?@K;:O:DBAE:D:BB�?N�=O:�;:EA:>H6[8�WO:�T<:DFU�<:D:;CGGU�>AGG�D?=�FOCD<:�=O:�QCB:GAD:�MC=:�N?;�C�;:<AB=;C=A?D�;:EA:>�FCB:�>O:D�A=�@?MANA:B�C�FCB:�QUCMMAD<�?;�M:G:=AD<�AD<;:MA:D=B�?;�K;?MPF=BH6\8�]O:D�=O:�T<:DFU�BKGA=B�C�;:<AB=;C=A?D�;:EA:>�FCB:�AD=?�=>?�?;�@?;:�FCB:BL�=O:�D:>�FCB:6B8�<:D:;CGGU�>AGG�OCE:�=O:QCB:GAD:�MC=:�?N�=O:�?;A<ADCG�;:<AB=;C=A?D�;:EA:>�FCB:H68�]O:D�=O:�T<:DFU�@:;<:B�=>?�?;�@?;:�;:<AB=;C=A?D�;:EA:>�FCB:B�AD=?�C�BAD<G:�FCB:L�=O:�T<:DFU�<:D:;CGGU�>AGG�PB:=O:�:C;GA:B=�QCB:GAD:�MC=:�CB�=O:�QCB:GAD:�MC=:�N?;�=O:�D:>�FCB:H6:8�TDD?PDFAD<�;:<AB=;C=A?D�;:EA:>�FCB:B�CDM�QCB:GAD:�MC=:BH�WO:�T<:DFU�>AGG�@CAD=CAD�C�GAB=�?N�;:<AB=;C=A?D�;:EA:>�FCB:BLADFGPMAD<�QCB:GAD:�MC=:BL�?D�A=B�>:QBA=:H_ aZVXb�Rc�IZ�7dcc[L�e?EH�\fL�[dgRh�R[�IZ�[ff[iL�9CU�[7L�[dgih�f[�IZ�7Rf\L�TP<H�dL�\ccih�f�IZ�fRRdRL�S:FH[\L�\ccgL�PDG:BB�?=O:;>AB:�D?=:MHTaWj ZYWkb�f�aH_HVH�[iC�CDM�[i>HVP;;:D=�=O;?P<O�9C;FO�\dL�\c[gh�g�IZ�[i\cHlmn�op�qorstumv w�\c[g�WO?@B?D�Z:P=:;BH�e?�FGCA@�=?�?;A<ADCG�aH_H�x?E:;D@:D=�]?;yBHADD 045
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 109 of 139
������������� ��������� ������������ �� ������������������������������
���� !"�#$%&'%(�)*+,*-'.�/%�0123&�,%�%-343(21�5.6.�7%8*-(&*(,�9%-:'. !
;<=>�<?�@>=>ABC�D>EFCBGH<IJKHGC>�LMN�OA<G>PGH<I�<?�QIRHA<IS>IG;TBUG>A�VN�QIRHA<IS>IGBC�OA<G>PGH<I�WE>IPX�YD>?J�Z�WII<J[\F]PTBUG>A�QN�O>JGHPH=>�OA<EABSJOBAG�__N�D>EHJGABGH<I�\GBI=BA=J�BI=�D>EHJGABGH<I�D>RH>�YD>?J�Z�WII<J[\F]UBAG�;N�D>EHJGABGH<I�D>RH>�OA<P>=FA>J�YD>?J�Z�WII<J[LM�;N@NDN�a�__N_ba�__N_b�;<I=FPG�<?�B�U>JGHPH=>cJ�A>EHJGABGH<I�A>RH>NQ??>PGHR>d�ePG<]>A�Mf�gMMh;FAA>IGI>JJijk�lmknop�qrss�tkurkq�vwxw�wnv�rnyzt{wxrzn�vk|otr}kv�rn�~��������w����}���wnv��o��zt�|�}{rxxkv�rn�tk|�zn|k�xz�w��wxw�wss��n�nzxrok�xjwx�rx�}ksrkuk|�|jz�sv�}k�ozn|rvktkv�rn�xjk��k|xrorvk�|�tkmr|xtwxrzn�tkurkq��w��l||k||�ojwnmk|�|rnok�w��k|xrorvk�|�sw|x�tkurkq��ijk�lmknop�qrss�w||k||�wnp�ojwnmk|�xjwx�{wp�jwuk�zoo�ttkv�|rnok�xjklmknop�|�sw|x�tkmr|xtwxrzn�vkor|rzn�rn�ztvkt�xz�vkxkt{rnk�xjk�|rmnryrownok�zy�|�oj�ojwnmk|�wnv�qjkxjkt�xjk��k|xrorvk�|xrss|wxr|yrk|�xjk�����l�|xwnvwtv�yzt�tkmr|xtwxrzn��ijk�lmknop�qrss�ozn|rvkt�qjkxjkt�xz�oznv�ox�w�nkq�tr|��w||k||{knx�xzxw�k�rnxz�wooz�nx��w{znm�zxjkt�xjrnm|��wnp�ojwnmk|�rn�|xwx�xk|�zt�tkm�swxrzn|���zsrop��tr|��w||k||{knx��tzokv�tk|�zt{kxjzv|��zt�vwxw�tk��rtk{knx|��ijk�lmknop�qrss�ozn|rvkt�qjkxjkt�wnp�nkq�vwxw�zt�rnyzt{wxrzn�zn�xjk��k|xrorvk��rnos�vrnmwnp�vwxw�zt�rnyzt{wxrzn�|�}{rxxkv��nvkt�~��������zt�rn�tk|�zn|k�xz�w��wxw��wss��n�nzxrok��qwttwnx�oznv�oxrnm�w�nkqtr|��w||k||{knx�zt�w�nkq�tr|��}knkyrx�w||k||{knx��ijk�lmknop�qrss�ws|z�ozn|rvkt�qjkxjkt�wnp�nkq�vwxw�zt�rnyzt{wxrzntkmwtvrnm�wn�rnvrurv�ws��k|xrorvk��tzv�ox��rnos�vrnm�wnp�vwxw�zt�rnyzt{wxrzn�|�}{rxxkv��nvkt�~��������zt�rn�tk|�zn|k�xz�w�wxw��wss��n�nzxrok��|�oj�w|�vwxw�zt�rnyzt{wxrzn�w}z�x�wn�rnktx�rnmtkvrknx�rn�xjk��k|xrorvk��tzv�ox�zt�zxjkt�rnyzt{wxrznzt�vwxw�tkswxrnm�xz�xjk�oz{�z|rxrzn��sw}ksrnm�zt��|k�zy�xjk��k|xrorvk��tzv�ox��qwttwnx�wvvrxrznws�tkurkq�zy�w��k|xrorvk�tzv�ox�|�tkmr|xtwxrzn��}���znv�ox�nkq�w||k||{knx|�w|�nkkvkv�����loxruk�rnmtkvrknx�|��rn�xjk�tkmr|xtwxrzn�tkurkq�ow|k���y�xjk�lmknop�yrnv|�xjwx�w�nkq�w||k||{knx�zy�xjk��k|xrorvk�r|nkkvkv��rx�qrss�vkxkt{rnk�qjkxjkt�rx�own�}w|k�xjk�nkq�w||k||{knx�zn�wuwrsw}sk�vwxw�zt�rnyzt{wxrzn��rnos�vrnm�vwxwzt�rnyzt{wxrzn�|�}{rxxkv��nvkt�~��������zt�rn�tk|�zn|k�xz�w��wxw��wss��n�nzxrok���y�|�yyrorknx�vwxw�zt�rnyzt{wxrznwtk�wuwrsw}sk��xjk�lmknop�qrss�oznv�ox�xjk�nkq�tr|��w||k||{knx�zt�tr|��}knkyrx�w||k||{knx���y�xjk�lmknop�vkxkt{rnk|xjwx�wvvrxrznws�vwxw�zt�rnyzt{wxrzn�wtk�nkkvkv�xz�oznv�ox�xjk�tkurkq��xjk�lmknop�qrss�r||�k�w��wxw��wss��n�nzxrok�nvkt�����l�|koxrzn���o�������������nvrurv�ws��tzv�ox�tkmr|xtwxrzn|���y�xjk�lmknop�yrnv|�xjwx�wvvrxrznws�tkurkq�zy�wn�rnvrurv�ws��tzv�ox�|�tkmr|xtwxrznr|�nkkvkv��rx�qrss�tkurkq�xjk��k|xrorvk��tzv�ox�sw}ks��oznyrvknxrws�|xwxk{knx�zy�yzt{�sw���tzv�ox�|�koryro�vwxw��zt�zxjkt�ktxrnknx�vwxw�zt�rnyzt{wxrzn��w|�w��tz�trwxk��xz�vkxkt{rnk�qjkxjkt�xjk�tkmr|xtwxrzn�zy�xjk�rnvrurv�ws��tzv�ox�{kkx|xjk�����l�|xwnvwtv�yzt�tkmr|xtwxrzn���y�xjk�lmknop�vkxkt{rnk|�xjwx�wvvrxrznws�vwxw�zt�rnyzt{wxrzn�wtk�nkkvkv�xzoznv�ox�xjk�tkurkq��xjk�lmknop�qrss�r||�k�w��wxw��wss��n�nzxrok��nvkt�����l�|koxrzn���o��������ADD 046
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 110 of 139
������������� ��������� ������������ �� ������������������������������
���� !"�#$%&'%(�)*+,*-'.�/%�0123&�,%�%-343(21�5.6.�7%8*-(&*(,�9%-:'. �
;<=�>?@AB<�CDEFB<BCDFBGH�I?EBHJ�D�CKLFB<BIKML�EKJBLFEDFBGH�EKNBKOP�QRK�SJKH<T�OBAA�JKHKEDAAT�UDVK�DNDBAD@AK�WGE�C?@AB<EKNBKO�DHI�<GUUKHF�D�IEDWF�EBLV�DLLKLLUKHF�WGE�D�CKLFB<BIK�BW�D�HKO�EBLV�DLLKLLUKHF�RDL�@KKH�<GHI?<FKIP�QRK�SJKH<T�OBAAC?@ABLR�D�HGFB<K�BH�FRK�XKIKEDA�YKJBLFKE�DHHG?H<BHJ�FRK�DNDBAD@BABFT�GW�FRK�IEDWF�EBLV�DLLKLLUKHF�DHI�CEGNBIK�D�<GUUKHFCKEBGI�GW�DF�AKDLF�Z[�<DAKHIDE�IDTLP�QRK�SJKH<T�OBAA�C?@ABLR�D�HGFB<K�BH�FRK�XKIKEDA�YKJBLFKE�DHHG?H<BHJ�FRK�DNDBAD@BABFTGW�D�EKNBLKI�EBLV�DLLKLLUKHF\�DH�K]CADHDFBGH�GW�DHT�<RDHJKL�FG�FRK�CEGCGLKI�IG<?UKHF\�DHI�BFL�EKLCGHLK�FG�<GUUKHFLP�WFRK�EKNBLKI�EBLV�DLLKLLUKHF�BHIB<DFKL�EBLVL�GW�<GH<KEH\�FRK�SJKH<T�UDT\�BH�FRK�HGFB<K�DHHG?H<BHJ�FRK�DNDBAD@BABFT�GW�FRKEKNBLKI�EBLV�DLLKLLUKHF\�CEGNBIK�D�<GUUKHF�CKEBGI�GW�DF�AKDLF�Z[�<DAKHIDE�IDTL�WGE�FRK�C?@AB<�FG�L?@UBF�L?JJKLFBGHL�WGEUBFBJDFBHJ�FRK�EBLV�BIKHFBWBKI�BH�FRK�EKNBLKI�EBLV�DLLKLLUKHFP;_=�QRK�SJKH<T�UBJRF�HGF�EK?KLF�<GUUKHFL�GH�D�IEDWF�EBLV�DLLKLLUKHF�BH�<DLKL�ORKEK�FRK�SJKH<TML�BHBFBDA�L<EKKHBHJGW�D�CKLFB<BIK�BHIB<DFKL�FRDF�BF�RDL�AGO�?LKa?LDJK\�DWWK<FL�WKO�BW�DHT�LFDVKRGAIKEL�GE�UKU@KEL�GW�FRK�C?@AB<\�CGLKL�AGOEBLV\�DHIaGE�EK?BEKL�ABFFAK�GE�HG�EBLV�UBFBJDFBGHP�H�L?<R�<DLKL\�FRK�SJKH<T�OBAA�UDVK�D�IEDWF�EBLV�DLLKLLUKHF�DNDBAD@AKWGE�C?@AB<�EKNBKO�DHI�<GUUKHF�ORKH�BF�BLL?KL�D�CEGCGLKI�IK<BLBGH�GH�FRK�EKJBLFEDFBGH�EKNBKO�<DLKP;b=�W�FRK�SJKH<T�WBHIL�FRDF�BF�BL�HGF�HK<KLLDET�FG�<GHI?<F�D�HKO�EBLV�DLLKLLUKHF\�BF�OBAA�BLL?K�D�CEGCGLKI�IK<BLBGH�GHFRK�EKJBLFEDFBGH�EKNBKO�<DLK�DL�IKL<EB@KI�BH�c�_ddPdePfghYijk�d[�XY�lm[[_\�nGNP�bo\�_medp�d_�XY�_oo_q\�rDT�_l\�_meqp�o_�XY�ldoZb\�S?JP�m\�b[[qp�oZ�XY�oddmd\�sK<P_b\�b[[e\�?HAKLL�GFRKEOBLK�HGFKIPShQtgYQuk�o�hPfPiP�_ZqD�DHI�_ZqOPi?EEKHF�FREG?JR�rDE<R�bm\�b[_ep�eZ�XY�_Zqb[Pvwx�yz�{y|}~�w� ��b[_e�QRGULGH�YK?FKELP�nG�<ADBU�FG�GEBJBHDA�hPfP��GNKEHUKHF��GEVLP
ADD 047
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 111 of 139
������������ ������� �������������������������������������
������ �!"#$%#&�'()*(+%,�-#�./01$�*#�#+121&0/�3,4,�5#6(+&$(&*�7#+8%, �
9:;<�:=�><;<?@A�B<CDA@EF:GHIFEA<�JKL�M?:E<NEF:G�:=�OGPF?:GQ<GE9R@SE<?�TL�OGPF?:GQ<GE@A�M?:E<NEF:G�UC<GNV�WB<=H�X�UGG:HYZD[NR@SE<?�OL�M<HEFNF;<�M?:C?@QHM@?E�\]L�_@E@�B<DF?<Q<GEH�=:?�M<HEFNF;<H�WB<=H�X�UGG:HYZD[S@?E�UL�a<G<?@A�M?:PFHF:GH JK�9L>LBL�b�\]Lc]b�\]Lc]�B<DF?<Q<GEH�=:?�@;;FEF:G@A�;@E@LO==<NEFP<d�_<N<Q[<?�efg�eKKc9D??<GEG<HHhij�klml�nopmqrjst�njupqnjk�vt�miqw�xlnm�ylt�rom�vj�wpzzq{qjrm�mo�xjnyqm�|}~�mo�j�lsplmj�j�jnt�xjwmq{qkj�xnokp{m���zmij�qrzonylmqor�njupqnjk�prkjn�miqw�xlnm�qw�rom�wpzzq{qjrm�mo�j�lsplmj�mij�xomjrmqls�oz�mij�xnokp{m�mo�{lpwj�prnjlworlvsjlk�jnwj�jzzj{mw�or�ylr�on�mij�jr�qnoryjrm��lkkqmqorls�klml�njupqnjyjrmw��qss�vj�qyxowjk���o�j�jn��|}~�j�xj{mw�milmmij�qrzonylmqor�njupqnjk�vt�miqw�xlnm��qss�vj�lkjuplmj�qr�yowm�{lwjw�zon�lr�lwwjwwyjrm�oz�mij�xnoxjnmqjw�lrk�jzzj{mw�ozmij�xjwmq{qkj������|����������������{m������������prsjww�omijn�qwj�romjk�~�h����h���������������������t���������������l��pnnjrm�minop�i��ln{i���������������������������� �¡�¢£¤¥�¦ §������hioywor��jpmjnw��o�{slqy�mo�onq�qrls������©o�jnryjrm�ªon«w�
ADD 048
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 112 of 139
ADDENDUM OF DECLARATIONS IN SUPPORT OF STANDING
Table of Contents
Declaration of Joan Bristol ............................................................................ ADD 50
Declaration of LeRoy Gruber ......................................................................... ADD 57
Declaration of Gina Trujillo ........................................................................... ADD 64
Declaration of Diane Wetzel .......................................................................... ADD 68
ADD 049
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 113 of 139
UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT
NATIONAL FAMILY FARM COALITION, et al.,
Petitioners,
v. UNITED STATES ENVIRONMENTAL PROTECTION AGENCY, et al.,
Respondents, DOW AGROSCIENCES LLC,
Respondent-Intervenor.
)))))))))))))))))
No. 17-70810
NATURAL RESOURCES DEFENSE COUNCIL, INC.,
Petitioner,
v. E. SCOTT PRUITT, et al.,
Respondents, DOW AGROSCIENCES LLC,
Respondent-Intervenor.
))))))))))))))))
No. 17-70817
DECLARATION OF JOAN BRISTOL
ADD 050
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 114 of 139
2
I, Joan Bristol, declare as follows:
1. I am currently a member of NRDC, and have been for about twenty
years. I appreciate and support NRDC’s work on human health and wildlife
protection.
2. I live about an hour west of Philadelphia in a rural area. I’m always
concerned about what farmers are putting into their crops because there are many
agricultural fields around where I live. We’re on an eight-acre farm surrounded by
other farms, and we also live right along a run which goes into the Brandywine and
Delaware Rivers. In addition, a lot of land around here has been put into
conservancy, but they can still be affected by pesticide use on nearby farms.
3. My neighbors’ fields are extremely close, less than a football field
away from my house. Fields that are directly adjacent to our property have always
been used for hay, but around here there are also soy, corn, and wheat fields. I have
noticed the farms nearby use a sprayer attached to a big tractor. I tried to find out
which pesticides they use but couldn’t get an answer.
4. I know that EPA has approved the use of the herbicide Enlist Duo for
use on corn, soybeans, and cotton in Pennsylvania, and I understand that Enlist
Duo contains glyphosate and 2,4-D, which have been linked to a number of human
health harms. I am concerned that Enlist Duo will be applied to the corn and
ADD 051
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 115 of 139
3
soybean fields near my property, and especially concerned about cancer and other
health risks related to its use.
5. There are fields near our property that are also adjacent to our water
supply. We being rural are on our own well water, so even people just spraying
their lawns upstream can have an impact on our aquifer. I believe that pesticides
from adjacent fields—possibly including Enlist Duo—could get into our water
supply, and I don’t have a way of knowing how bad the impact is.
6. We ride horses in our neighbors’ fields three or four times a week for
an hour-and-a-half to two hours each time. We also walk twice a day, for about an
hour each day. I plan to continue living in my current home, and riding horses and
going for walks regularly.
7. I am concerned about being exposed to Enlist Duo since it can travel
through the air after being sprayed. If we’re walking around the neighboring farms
and a farmer has sprayed recently, I worry about inhaling the spray, and also worry
about my dog and other domestic pets in the area which might be impacted.
8. I also worry that residue on my own foods can contain Enlist Duo. I
purchase fresh corn from local farmers every week during the summer, and
although I try to verify with the famers that they do not use genetically modified
seeds or spray pesticides on their crops, I fear that the corn I purchase from them
may still contain traces of Enlist Duo that is applied to neighboring fields.
ADD 052
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 116 of 139
4
Additionally, I fear that my horses could be eating hay contaminated with Enlist
Duo that has drifted through the air or hay grown in soil which has been exposed to
the pesticide.
9. I worked in the pharmaceutical industry for over thirty years, and
understand that if a new drug is going into the market that people are going to
ingest or swallow, it goes through rigorous testing. I believe a pesticide should
have to go through that process, too. A doctor must prescribe a drug, and if EPA is
“prescribing” Enlist Duo, it should make sure that the pesticide is actually safe for
people and the environment. I also think there should be a greater emphasis on
measuring and reining in the amount of contamination from chemicals like this.
10. I am also aware that Enlist Duo kills milkweed, the only source of
food for the monarch caterpillar, and that glyphosate and 2,4-D have been linked to
the decline of monarch populations.
11. As a kid I was always interested in the monarch butterfly, but at that
point they weren’t imperiled. Back then they were fairly common; I saw them all
the time and just considered them as part of nature. I remember going to camp and
easily catching butterflies. Now they’re much more rare, and when I see them it’s
such a treat.
12. Five or six years ago I learned about their plight, through
organizations like NRDC, World Wildlife Fund, and Friends of the Earth, as well
ADD 053
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 117 of 139
5
as through films made by PBS, NRDC, World Wildlife Fund, and National
Geographic. There is a group called Natural Habitat Adventures which takes
people on tours down to Mexico to watch the Monarch migration. I have not yet
participated in the tour because spots fill up quickly and the timing has not worked
out so far, but given the opportunity I would do so.
13. Pennsylvania is in the path of the monarch migration, and I try to
observe monarchs whenever they’re here. Whenever I walk outside I try to keep an
eye out for monarchs. My husband and I have milkweed in the garden, and if they
have eggs out we try to observe without harming them. I hope to continue
watching the monarch migration in future years.
14. Monarchs are beautiful and wonderful insects, and the fact that
monarchs have decreased by ninety percent in twenty years is pathetic. We need to
do something about that.
15. My understanding of EPA’s role in regulating pesticides is that it is
required to make sure that they don’t pose unreasonable risks to people and the
environment. I think EPA should be taking a closer look at the effects of Enlist
Duo and scrutinizing the science on what’s really happening here. I think EPA
should put a hold on this chemical until it can prove it’s not unsafe, and in the
meantime nobody should be able to use it. I support NRDC’s lawsuit to revoke
EPA’s approval of Enlist Duo. If NRDC were to prevail, my health-related
ADD 054
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 118 of 139
6
concerns regarding the risks posed by Enlist Duo would be resolved, and I would
be happy to know that monarch butterflies are protected from this threat.
ADD 055
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 119 of 139
ADD 056
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 120 of 139
UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT
NATIONAL FAMILY FARM COALITION, et al.,
Petitioners,
v. UNITED STATES ENVIRONMENTAL PROTECTION AGENCY, et al.,
Respondents, DOW AGROSCIENCES LLC,
Respondent-Intervenor.
) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) )
No. 17-70810
NATURAL RESOURCES DEFENSE COUNCIL, INC.,
Petitioner,
v. E. SCOTT PRUITT, et al.,
Respondents, DOW AGROSCIENCES LLC,
Respondent-Intervenor.
) ) ) ) ) ) ) ) ) ) ) ) ) ) ) )
No. 17-70817
DECLARATION OF LEROY GRUBER
ADD 057
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 121 of 139
2
I, LEROY GRUBER, do hereby affirm and state:
1. I am currently a member of the Natural Resources Defense Council
(NRDC) and have been for nearly fifteen years.
2. Among other reasons, I support the NRDC because I am concerned
about the impacts of chemicals, including pesticides, on human health and the
environment. Reading Rachel Carson’s Silent Spring was a major turning point in
my life, opening my eyes to the detrimental effects of indiscriminate pesticide use
on the natural world. Another critical moment in my life occurred when I read The
Limits to Growth, a report commissioned by the Club of Rome. Through this
report, I became convinced that mankind is releasing chemicals into the
environment much more quickly than we can neutralize the resulting harmful
effects; I firmly believe that we must take action to reverse this trend. I understand
that one of NRDC’s central purposes is to safeguard human health and the
environment from the toxic effects of pesticides and other chemicals, and I
strongly support this objective.
3. I worked in the environmental field for thirty-five years. As a
Supervising Engineer at the Hamilton County Department of Environmental
Services (DES) in Ohio, I became acutely aware of the human health risks, such as
cancers and neurodevelopmental harms, posed by exposure to chemicals in the
environment. I realized that exposures to even low concentrations of chemicals can
ADD 058
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 122 of 139
3
pose serious health risks over time. I also realized that exposures to high
concentrations of chemicals, even if briefly, can result in significant health harms.
This awareness has heightened my concerns regarding exposure to pesticides,
including the herbicide Enlist Duo.
4. Since 2001, I have lived in rural Goshen, Ohio. My property is
situated near large agricultural fields planted with soybeans and corn. I am aware
that chemicals are sprayed on these fields, even though I do not know the exact
identity of those substances. I have seen machines spraying chemicals in the
morning, even when winds are blowing at higher speeds.
5. I am aware that EPA recently approved the herbicide Enlist Duo for
use on soybeans, corn, and cotton in Ohio. In addition, I am aware that Enlist Duo
contains 2,4-D and glyphosate, and that both chemicals are associated with various
human health risks. In particular, I understand that glyphosate is a probable human
carcinogen. I am concerned that Enlist Duo will be used on the fields next to my
property, and that I will be exposed to this herbicide and the health risks it poses,
including increased risk of developing cancer.
6. I am particularly concerned about exposure to Enlist Duo through
aerial pathways between my property and the adjacent fields. I am aware that
pesticides do not end up only on target crops. Rather, they invariably travel off site,
including through spray drift and volatilization. Among my other responsibilities at
ADD 059
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 123 of 139
4
the Hamilton County DES, I used to model air pollutant emissions. Through this
experience, I became aware of the ease with which chemicals can be borne through
the air. I am thus especially worried about breathing in Enlist Duo through spray
drift and volatilization from the fields next to my home.
7. I had a three-quarter acre pond put on my property after moving in. I
stocked the pond with fish. We eat fish we catch from the pond. I am concerned
that pesticides and herbicides could settle out from the air into the pond or be
carried in by the stream that feeds into the pond. The fish could be contaminated.
We also grow vegetables to eat. Rain or fallout on our garden is another concern.
8. When I first moved to Goshen, I obtained drinking water from a
cistern on my property. Because I was concerned about pesticide spray drift
contaminating my cistern water, however, I spent about $5,000 installing a water
line that would allow me to obtain public drinking water from Clermont County.
Although I am now less concerned about herbicide exposure through my drinking
water, I remain very concerned that I may be exposed to harmful chemicals such as
glyphosate and 2,4-D through inhalation of airborne Enlist Duo from the
neighboring fields.
9. I avoid using herbicides on my own property, in part because I am
concerned about the health risks associated with exposure to these chemicals.
However, there is nothing I can do to prevent Enlist Duo from being used on the
ADD 060
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 124 of 139
5
fields next to my property, where I intend to stay.
10. I understand that the monarch population has declined by nearly
ninety percent over the past twenty years, and that a main cause of this decline is
due to the destruction of milkweed, their only food source, by pesticides such as
glyphosate and 2,4-D.
11. I love to watch butterflies and even started a collection of photographs
of butterflies. When I was in college in downtown Cincinnati many years ago, I
used to watch countless monarchs fly by my window. I just don’t see as many now.
12. This year I planted milkweed on my property. It’s been a personal joy
of mine this year and every year to watch the monarch caterpillars, observe them
going through the chrysalis stage, release them and have them fly back to Mexico
in their final stage. Although there are fewer now, I plan to watch them as long as I
have eyes and monarchs continue to go through the area.
13. EPA has a duty to protect the public from the health risks and to
ensure the evaluation of environmental consequences posed by exposure to
herbicides. I am aware that NRDC has challenged EPA’s decision to approve Enlist
Duo in part because the agency failed to take into account adequately the health
and environmental risks the pesticide poses. I support NRDC’s lawsuit to revoke
EPA’s approval of Enlist Duo. If the court were to invalidate EPA’s approval of
Enlist Duo, and thereby prevent the herbicide from being used near my home, this
ADD 061
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 125 of 139
6
would protect me from the health risks posed by glyphosate and 2,4-D. It would
also help protect the annual migration of monarchs through my area and the joy
that I attain from watching them.
ADD 062
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 126 of 139
ADD 063
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 127 of 139
UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT
NATIONAL FAMILY FARM COALITION, et al.,
Petitioners,
v. UNITED STATES ENVIRONMENTAL PROTECTION AGENCY, et al.,
Respondents, DOW AGROSCIENCES LLC,
Respondent-Intervenor.
)))))))))))))))))
No. 17-70810
NATURAL RESOURCES DEFENSE COUNCIL, INC.,
Petitioner,
v. E. SCOTT PRUITT, et al.,
Respondents, DOW AGROSCIENCES LLC,
Respondent-Intervenor.
))))))))))))))))
No. 17-70817
DECLARATION OF GINA TRUJILLO
ADD 064
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 128 of 139
2
I, GINA TRUJILLO, do hereby affirm and state:
1. I am the Director of Membership for the Natural Resources Defense
Council (NRDC). I have served in this position since January 2015.
2. My duties include supervising the preparation of materials that
NRDC distributes to members and prospective members. Those materials describe
NRDC and identify its mission.
3. NRDC is a membership organization incorporated under the laws of
the State of New York. It is recognized as a not-for-profit corporation under section
501(c)(3) of the United States Internal Revenue Code.
4. NRDC’s U.S. offices are located in New York, New York;
Washington, D.C.; Chicago, Illinois; Bozeman, Montana; San Francisco,
California; and Santa Monica, California.
5. NRDC currently has approximately 410,260 members in the United
States. There are NRDC members residing in each of the fifty United States and in
the District of Columbia.
6. NRDC’s mission statement declares that the organization’s purpose is
“to safeguard the Earth: its people, its plants and animals, and the natural systems
on which all life depends.” The mission statement goes on to declare that NRDC
strives “to protect nature in ways that advance the long-term welfare of present and
future generations,” and “to help create a new way of life for humankind, one that
ADD 065
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 129 of 139
3
can be sustained indefinitely without fouling or depleting the resources that support
all life on Earth.” Accordingly, protecting human health by preventing pollution
ranks among NRDC’s top institutional priorities. As set forth in NRDC’s statement
of priorities: “Toxic chemicals in our environment . . . have been linked to cancer,
birth defects and brain impairments. Reducing or eliminating the load of these
dangerous chemicals in . . . the air we breathe, the food we eat and the water we
drink can help reduce the toll of human disease and suffering.”
7. Protecting monarch butterflies from the adverse effects of Enlist Duo
is paradigmatic of NRDC’s efforts to safeguard wildlife. NRDC has dedicated
significant resources to defending animal species against toxic chemicals,
including pesticides.
8. Protecting human health from the adverse effects of Enlist Duo
likewise exemplifies NRDC’s work. NRDC has sought for years to limit human
exposure to toxics.
ADD 066
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 130 of 139
ADD 067
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 131 of 139
UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT
NATIONAL FAMILY FARM COALITION, et al.,
Petitioners,
v. UNITED STATES ENVIRONMENTAL PROTECTION AGENCY, et al.,
Respondents, DOW AGROSCIENCES LLC,
Respondent-Intervenor.
)))))))))))))))))
No. 17-70810
NATURAL RESOURCES DEFENSE COUNCIL, INC.,
Petitioner,
v. E. SCOTT PRUITT, et al.,
Respondents, DOW AGROSCIENCES LLC,
Respondent-Intervenor.
))))))))))))))))
No. 17-70817
DECLARATION OF DIANE WETZEL
ADD 068
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 132 of 139
2
I, DIANE WETZEL, do hereby affirm and state:
1. I am currently a member of the Natural Resources Defense Council
(NRDC) and have been for approximately thirteen years.
2. My support for NRDC stems from my love of the outdoors and my
profound concerns about environmental degradation and its impacts on both
human beings and other creatures. Being a member of NRDC helps me give voice
to my environmental concerns. I support NRDC’s efforts to safeguard human
health and wildlife, including monarch butterflies, from the harms arising from
rampant pesticide use in America.
3. I have lived in West Lafayette, Indiana, for the past twenty years, and
plan to continue to live there for the foreseeable future. My home is located in a
heavily agricultural area, where corn and soybeans are the dominant crops. There
is a field directly behind my home, where corn and soybeans are planted in
alternating years. Half a mile down the road in the opposite direction, there is
another field planted with corn and soybeans. In addition, the entire area starting
from about two miles north of my home is devoted to agriculture, with corn and
soybean fields stretching as far as the eye can see.
4. I have seen pesticides being sprayed on the corn and soybean fields
near my home. Sometimes, vehicles with large, liquid-filled tanks, bearing
“flammable” warning labels, use mechanical arms to spray chemicals on the fields.
ADD 069
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 133 of 139
3
I have also seen crop-dusting planes spraying pesticides on the fields two miles
from my home.
5. I am aware that EPA has approved the use of the herbicide Enlist Duo
for use on corn, soybeans, and cotton in Indiana. I understand that Enlist Duo
contains the chemicals 2,4-D and glyphosate. I am aware that 2,4-D has been
linked to thyroid disorders and other human health harms, and that glyphosate is
probably carcinogenic to humans, according to recent findings. I am concerned that
Enlist Duo will be applied to the corn and soybean fields near my property, and
that my health will be detrimentally affected by both inhalation of 2,4-D or
glyphosate and consumption of drinking water contaminated with 2,4-D or
glyphosate.
6. I am worried about direct exposure to Enlist Duo through
volatilization and spray drift. When the weather permits, I go running or biking
through the countryside three or four times a week. Doing so takes me past the
corn and soybean fields near my home. I have breathed in pesticides on some of
these excursions. While biking, for example, I have smelled heavy chemical odors
emanating from the fields. I am therefore concerned that I will inhale Enlist Duo
used in the fields around my property during my regular runs and bike rides.
7. I am also concerned about being exposed to Enlist Duo through my
drinking water. Although my drinking water comes from the West Lafayette
ADD 070
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 134 of 139
4
municipal water system rather than local wells, testing has revealed high levels of
the pesticide atrazine in that system. This indicates to me that pesticides enter, and
are not fully removed from, the municipal water supply from which I obtain my
drinking water. Accordingly, I fear that Enlist Duo, like atrazine, will contaminate
the water that I drink.
8. I plan to continue living in my current home for at least the next five
years, and perhaps indefinitely. My husband is Director of Convocations at Purdue
University, and given the job market, it is unlikely that he will take a post
elsewhere in the near future. In addition, maintaining an active lifestyle is
important to me, so I plan to continue running and biking in the area around my
home three to four times a week. EPA’s approval of Enlist Duo for use in my area
thus threatens to expose me to 2,4-D and glyphosate, thereby putting my health at
risk.
9. In addition, I am concerned that my sixteen-year-old son—who
breathes the same air and drinks the same water as I do—will suffer health harms
through exposure to Enlist Duo. I understand that there has been an increase in
thyroid disorders among children in my area in recent years. One of my friend’s
doctors informed her, for example, that he has observed more and more cases of
thyroid conditions among local children. I am aware that 2,4-D has been
implicated in thyroid and developmental disorders. I am also aware that children
ADD 071
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 135 of 139
5
are particularly vulnerable to the health risks posed by 2,4-D. I am therefore
especially concerned that my son will be harmed by inhalation of Enlist Duo
applied to the corn and soybean fields in my area, and by drinking municipal water
contaminated with 2,4-D.
10. My misgivings about EPA’s approval of Enlist Duo are grounded not
only in my concerns about my health and the health of my family, but also in my
concerns about the fate of the monarch butterfly migration. I am aware that
glyphosate and 2,4-D have contributed significantly to the decline of the monarch
butterfly. I have personally observed this decline in the area where I live.
11. I first became interested in monarch butterflies about ten years ago,
when my son was in kindergarten. As part of a school project, my son was given a
monarch cocoon. I bought my son books on monarchs and, upon reading about the
butterflies myself, became fascinated by these complex and lovely creatures. I have
since followed news on monarchs in newspapers and magazines, and on the
websites of organizations including NRDC.
12. I moved to West Lafayette in the summer of 1997. During my initial
years here, I saw approximately twenty monarchs every spring and summer. I saw
the butterflies while running or biking near my home and sometimes on my own
property. Seeing these marvelous insects filled me with delight. About fourteen
years ago, however, I began noticing a decline in the monarchs migrating through
ADD 072
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 136 of 139
6
my area. Although the decline took place gradually, it has reached a point where I
see only one monarch—or no monarchs at all—each year.
13. When I first moved to West Lafayette, milkweed grew naturally along
the road at the edge of my property, but there was nothing growing on my lot. I
have since tried to attract monarchs to my property by planting a variety of
flowering, butterfly-attractive plants to complement the milkweed that grows on
nearby roads. For example, I have planted purple asters, sedum, black-eyed susans,
lavender, basil, and thyme. Despite these efforts, I see almost no monarchs now.
On the rare occasion that I do spot a monarch, I am filled with excitement.
However, the sighting also fills me with anxiety, as I fear that it will be my last.
Witnessing the monarch’s decline has filled me with great sadness, diminishing the
fulfillment I derive from observing these marvelous creatures. It has also lessened
my pleasure in gardening, insofar as the plants that I cultivate fail to attract and
benefit the butterflies.
14. I understand that glyphosate and 2,4-D both destroy milkweed, which
is the only food source for monarch caterpillars. I am also aware that glyphosate is
an ingredient in “Roundup Ready” pesticides. When I drive through the area
around my home, I see signs bearing the “Roundup Ready” logo along the corn
and soybean fields. I am concerned that EPA’s approval of Enlist Duo for use in
Indiana will increase the amount of glyphosate used in West Lafayette, further
ADD 073
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 137 of 139
7
decimating the milkweed upon which monarchs depend. That Enlist Duo might
also increase the amount of 2,4-D used in my area troubles me further. I have been
dismayed by the significant decline in the number of monarchs migrating through
my area, a loss that has taken away from my enjoyment of living in the
countryside.
15. EPA should do more to protect both humans and monarchs from the
adverse effects of Enlist Duo. I am aware that NRDC has challenged EPA’s
decision to register Enlist Duo, based on harms to both human health and monarch
butterflies. I support NRDC’s lawsuit to nullify EPA’s approval of Enlist Duo. If
the court were to invalidate EPA’s approval of Enlist Duo, this would safeguard
the air I breathe and the water I drink from contamination by 2,4-D and glyphosate,
thereby protecting me from the health risks linked to exposure to these chemicals;
it would likewise protect my son from these same health risks. Revocation of
Enlist Duo’s registration would also limit further expansion in the use of 2,4-D and
glyphosate in West Lafayette, protecting the fragile migration of monarchs through
my area and the satisfaction I derive from observing the butterflies.
ADD 074
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 138 of 139
ADD 075
Case: 17-70810, 04/11/2018, ID: 10832785, DktEntry: 63, Page 139 of 139